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MicroRNA-21 expression in Vestibular Schwannoma: potential 
effect on growth and possible prognostic factor. 
 
Abstract 
 
Background: Vestibular schwannomas are benign slow growing 
tumors arising from VIII cranial nerve. They are potential life 
threatening benign tumor because of intracranial located. The 
management could be surgical or conservative, but, left untreated, the 
tumor preserve the possibility to further growth and complication may 
arise. The natural history is however not predictable and prognostic 
factor to select patients manageable conservatively should be studied.  
The molecular pathways that lead to tumorigenesis and growth are not 
completely defined and a role could be played by microRNA. 
Elevated levels of microRNA-21 may contribute to tumor growth by 
deregulating the tumor suppressor phosphatase (PTEN) and 
consequent activation of protein kinase B (AKT). 
Aims: evaluation of microRNA-21 expression and measurement of 
PTEN levels in vestibular schwannoma specimens, compared with 
expression in normal nerve tissue, to assess a possible overexpression. 
A correlation of micorRNA-21 expression with tumor size and growth 
rate of the tumor, when available, was hypothesized to make a 
prognostic factor.  
Methods: collection of vestibular schwannomas and great auricular 
nerve specimens was done sterilely during surgery and immediately 
stored at -80°C, until its use. Quantitative real-time PCR was used to 
assess levels of expression of micro-RNA 21 and mRNA for PTEN. 
FRANCESCO DISPENZA MD MicroRNA-21 expression in vestibular schwannoma 
 4 
Levels of PTEN protein were assessed with immunohistochemical 
analysis. A retrospective correlation was done between data obtained 
and clinical notes of patients: tumor size and growth rate.  
Results: 31 patients with vestibular schwannoma were studied. 
MicroRNA-21 was founded overexpressed in all cases when 
compared with normal nerve tissue. Levels of microRNA-21 were not 
statistically related with tumor size at time of surgery, but a positive 
correlation with growth rate was noted in 10 cases in which this data 
was available. PTEN mRNA was founded in all cases. The PTEN 
protein levels were low in 10 specimens of 13 in which the data was 
available, and an inverse correlation with levels of microRNA-21 was 
noted.  
Conclusions: The microRNA-21 plays a role in tumor development 
and in growth regulation also in vestibular schwannoma. MicroRNA-
21 may be a proper molecular target for therapies act to reduce the 
tumor growth and could represent a prognostic factor in selecting 
patients manageable with observation or early hearing preservation 
surgery. 
 
 
 
 
 
 
 
 
 
FRANCESCO DISPENZA MD MicroRNA-21 expression in vestibular schwannoma 
 5 
Introduction 
 
Vestibular schwannomas (VS) are benign slow growing 
tumors, arising from the VIII cranial nerve, generally involving the 
inferior vestibular nerve. This tumor could be part of a systemic 
disease called Neurofibromatosis type 2 (NF2), in which the tumors 
are bilateral and more aggressive. Vestibular schwannomas represent 
about 6% of all intracranial tumors and accounts for about 80% of all 
tumors diagnosed in the cerebello-pontine angle (CPA). The incidence 
reported is 10-20:1000000 per year1. The incidence apparently 
increased in the last 10 years, but it was due to the enlarged 
availability of MRI done for others reasons. However, the true 
incidence could be different and greater than the actually known, 
because of a lot of tumors remain silent and undiagnosed. 
The typical presentation of the solitary VS includes: unilateral 
progressive sensorineural hearing loss (SNHL) in the high frequency 
range, unilateral tinnitus, and vertigo spells or imbalance2. However, 
abnormal clinical presentation may be present characterized by sudden 
sensorineural hearing loss, facial weakness, brainstem compression, 
and hydrocephalus. Sometime VS is completely asymptomatic and 
diagnosed casually. Generally, the retard of diagnosis since the 
development of the tumor is about 5 years.  
Although slow, the growth rate is not estimable and the regulating 
factors are still unknown. It was estimated that the size of VS 
increases in diameter at an average of 1 to 2 mm per year. In 30% to 
70% a growth is demonstrable over a variable period of time, but in 
some patients it could be observed a spontaneous tumor regression. 
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The variable percentage of growth reported may depend, at least in 
part, on the length of the observation period3. A rapid growth could be 
present in some tumors with cystic component due to accumulation of 
fluid into cystic space or to an improvise intratumoral hemorrhage4.  
 
Fig. 1: MRI coronal scan T1-weighted after Gadolinium enhancement showing a giant 
vestibular schwannoma of the right cerebello-pontine angle. 
 
The treatment of VS may be surgical, with radiotherapy or 
conservative by a wait and see program. Surgical management 
represents the classical and the widest adopted management of such 
tumors since first operations with modern approach that William 
House introduced5. The surgical excision includes total or subtotal 
(programmed) removal, depending on tumor size and location; the 
subtotal removal is generally selected in case of high risk of damage 
for the brainstem or facial nerve. The aim of the surgical treatment is 
FRANCESCO DISPENZA MD MicroRNA-21 expression in vestibular schwannoma 
 7 
dual: remove a potential life-threatening disease, and preserve the 
hearing and facial nerve function as possible. In patients with 
unserviceable hearing the translabyrinthine approach is the standard 
technique adopted regardless the tumor size, because this approach 
give to the surgeon wide field for operation and low risks. The 
translabyrinthine approach, which damages completely the hearing, is 
mandatory also for tumor larger than 25 mm not considering the 
hearing status, because of the hearing preservation is not reasonably 
practicable in big sized tumor. The middle fossa approach is done 
generally in about one third of patients. This latter approach is used on 
patients with good hearing with intracanalicular tumors, or tumor with 
minimal extension into CPA, generally the size should be less than 20 
mm. The retrosigmoid approach is done in patients with good hearing 
and medial tumors with prevalent extension toward CPA and minimal 
into IAC. The results of the surgery are quite homogeneous, with an 
average of hearing preservation in about 50% of patients treated with 
MCF or RS; correlated with the number of treated cases, every 
institute may have a better results in one of the two techniques. It is 
general idea that completely excised VSs do not recur and it is 
reasonable to consider less than complete removal despite the 
attendant increased risk of regrowth. The subtotal removal may be 
planned preoperatively under certain conditions. A planned 
incomplete resection may be undertaken when a more prolonged 
operation is judged unwise because of the patient’s advanced age or 
performance status. Incomplete removal may be decided 
intraoperatively when dissection planes are poor and the surgeon think 
that total removal carries a high risk of damage of the facial nerve. In 
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selected cases subtotal removal increases the odds of hearing 
conservation, in particular in case of contralateral ear disease. 
The aim of all therapies should be to prevent morbidity and 
mortality in the safest, non-invasive fashion that can yield effective 
results. For this reason, the management of VS has shifted in recent 
decades away from microsurgical resection toward more conservative 
strategies such as radiotherapy or observation. Vestibular 
schwannoma have all the characters of a disease manageable with the 
simple observation for a long period: slow growth, benign behavior, 
and few symptoms in early phases. Furthermore, a considerable 
number of tumors seem to be quiescent and do not become clinically 
significant within a patient’s lifetime; such tumor may never warrant 
treatment. The conservative management consists of observation of 
the tumor by MRI scan, without any active treatment, delaying the 
treatment until the lesion exhibits a dangerous modification.  
Vestibular schwannomas are being diagnosed earlier and smaller 
because of improvement of imaging techniques and aggressive 
audiological screening in case of patients with tinnitus, dizziness, 
facial nerve weakness and unilateral hearing loss. Conservative 
management of VS have been reported since 19856. From this 
beginning, successive reports affirmed that the majority of VS grew 
during the follow-up period. Others Authors reported patients who 
benefited from wait and see policy; 78% had growth rate of < 2 
mm/year7. In a big observational study of the Danish Otoneurologic 
school emerged that VS exhibit growth only in the first 5 years after 
diagnosis1. It should be noted that, although serial observation may 
represent the conservative management, it is not without risks. 
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Deferring definitive treatment may lead to progression of hearing 
impairment or to evolution from an easily resectable lesion to one that 
carries increased surgical risks. The tumor size at initial presentation 
seems to be predictive of tumor growth. However the diagnosis of VS 
does not occur at a uniform stage in their natural history, then the 
tumor size at diagnosis may reflect a biological proclivity for growth, 
such that the detection of a large tumor at initial presentation may be 
indicative of past growth; to consider it as a marker for future growth 
potential is only a supposition. In 2003 the Tokyo Consensus Meeting 
on System for Reporting Results in Vestibular Schwannoma accepted 
the measuring system, described before, with the measurement of the 
largest extrameatal diameter of the tumor8. Actually is still the widest 
adopted system because of applicable in quite all institution with all 
type of MRI devices. The follow-up program is developed with a 
yearly MRI for 5 years, followed by MRI every other year for 4 years, 
and a new MRI after 5 years. After such period the observation is 
terminated if the tumor don’t show new growth or some disabling 
symptoms occur.  
Certainly, the unpredictable behavior of the tumor is a concern 
in choosing a treatment plan that is generally consequent to: hearing 
status, tumor size, and performance status of patient. The 
identification of prognostic factor should help the otoneurologist in 
selecting a proper management. Whereas radiological features and 
presenting symptoms did not result good prognostic factor or predictor 
element of tumor development, molecular elements, as well as 
microRNA, could be useful to act as predictive factors of biological 
behavior of VS in time. 
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MicroRNA are small noncoding RNA molecules that regulate 
posttranscriptional gene expression, and are evolutionarily conserved. 
Mature microRNA binds to specific mRNA targets in region 
complementary to the microRNA and, by a mechanism that is not 
completely understood, resulting in translational repression or 
degradation of the mRNA9. It has been demonstrated that tumors 
exhibit aberrant microRNA expression profiles, this indicate that such 
molecules play an important role in cellular differentiation, 
development, metabolism, apoptosis, and cancer10. 
MicroRNA-21 (miR-21) has been founded overexpressed in many 
tumors including: breast, liver, and glioblastoma11,12. One of the target 
of miR-21was identified as mRNA encoding for phosphatase and 
tensin homolog (PTEN), a tumor suppressor12. The protein PTEN acts 
as tumor suppressor inhibiting phosphoinositide 3-kinase/protein 
kinase B (PI3K/AKT) pathway that promotes cell proliferation cell 
survival and tumor growth13. The PI3K/AKT pathway was founded 
activated in human VS development. The activation of antiapoptotic 
growth-promoting pathways such as the PI3K/AKT system may be a 
key mechanism whereby tumors gain a survival advantage14. 
Increased levels of miR-21 in VS have a determinant role in 
downregulating PTEN expression and, as consequence, 
hyperactivating AKT signal; input to VS development. 
The deregulation of proliferation activity and cell apoptosis lead to 
tumor formation and growth, often associated with mutation of the 
NF2 gene, which encodes the tumor suppressor protein called 
“merlin”. This mutation is constitutionally present in NF2 patients, 
while is often acquired in sporadic VS. Whereas the merlin alteration 
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is well known in NF2, the development mechanism of the solitary VS 
was only recently studied.  
The aim of the present investigation was to identify some possible 
molecular prognostic or predicting factor for VS growth, making also 
a correlation with presenting symptoms and post-operative follow-up.  
Discovering of some predictor factor of VS growth could avoid risky 
operations and aimless sacrifice of hearing and facial nerve. 
 
Methods 
 
The patients selected for surgical removal of VS were enrolled 
in this study started in 2008. All patients underwent to: head and neck 
examination, cranial nerve clinical evaluation, clinical vestibular tests, 
pure tone audiometry, MRI with gadolinium of the brain and IAC. 
MRI done in the previous years were recorded for the analysis of the 
growth rate, when available. The calculation of the tumor size was 
effectuated by measurement of the greater diameter of the extrameatal 
component of the VS on MRI. The surgical treatment was adopted for 
all patients evaluated in this series. 
The collection of specimens was done during surgical removal of 
unilateral sporadic VS via translabyrinthine approach. The fresh tumor 
specimens, dissected with cold blades, were sterilely collected and 
immediately stored at -80°C until its use. As health tissue control we 
used specimens of great auricular nerve, which were collected in the 
same manner, during neck dissection for head and neck malignancy, 
but without signs metastatic neck disease.  
FRANCESCO DISPENZA MD MicroRNA-21 expression in vestibular schwannoma 
 12 
Real-time RT-PCR was used to confirm data showing elevated 
expression of miR-21 in VS. Briefly, RT reactions containing total 
RNA, primers, 1 x RT buffer, RT, and RNAse inhibitor were 
incubated for 30 minutes each at 16°C and at 42°C. Primers were 
annealed to miRNA targets and extended by reverse transcription. 
Reactions containing miRNA specific forward primer, and reverse 
primers were loaded into a PCR plate in quadruplicate and incubated 
in a thermocycler for 10 minutes at 95°C and then 40 cycles of 
denaturing (15 s at 95°C), annealing, and extension (60 s at 60°C). 
Mean threshold cycles (CT) were calculated by averaging the technical 
replicates for each experiment and then by averaging the mean 
replicate CT across the 3 runs. Quadruplicates with an SD greater than 
0.50 were eliminated, and these assays were repeated. The expression 
of miR-21 was normalized to U6B small nuclear RNA (∆CT) for each 
tissue. PTEN mRNA was evaluated with quantitative real-time PCR. 
Furthermore, we performed immunohistochemical (IHC) assays for 
the detection of PTEN. Nuclear PTEN protein expression was 
evaluated according to rank scale of 0 to 2. Inflammatory and normal 
stromal cells were used as control markers of staining intensity. PTEN 
staining in tumor cells was graded as: 2, if the staining intensity was 
equal to or higher than that of control cells; 1, if their staining 
intensity was lower than that of control cells; and 0, if no staining was 
found in the tumor cells. Tumors with PTEN scores of 0 or 1 were 
considered to have PTEN loss. Cases with staining of 2 in more than 
10% of the cells were considered positive for PTEN expression by 
IHC. 
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The follow-up of the patients was of 2 years, and consisted of a 
clinical evaluation and a MRI scan with fat suppression. The 
correlation was done between clinical notes recorded and data 
obtained from laboratory investigation. Statistical significance was 
determined using the Student’s t test assuming unequal variance. 
 
Results 
 
31 patients affected by vestibular schwannoma were studied. 
The mean age of the series was 52 years (range 29-73). The sex 
distribution was: 18 males and 13 females. The symptoms recorded 
were: hearing loss in 28 patients, disequilibrium in 8 patients. Tinnitus 
was present in all series. Ten patients were in follow-up with 
periodical MRI scan but underwent surgery because of hearing 
deterioration and/or evidence of tumor growth. No disturbances of the 
equilibrium were present at time of the first evaluation. All patients 
were treated surgically by a translabyrintyne approach. The 
preoperative imaging showed the morphologic status of the tumors: 
cystic in 5 cases and solid in 26 cases. The mean tumor size of the 
series was 16,2 mm (range 0-40 mm; SD ± 10,1mm). The tumor 
growth rate was calculated in those patients in whom several MRI 
were done during a follow-up protocol and revealed an average rate of 
2,9 mm per year. 
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Fig. 2: MRI axial scan T1-weighted after Gadolinium enhancement showing a vestibular 
schwannoma involving the right internal auditory canal with a minimal extension into 
cerebello-pontine angle. The size measured was 3 mm.  
 
MicroRNA-21 was founded overexpressed in all cases when 
compared with normal nerve tissue of 12 samples of normal great 
auricular nerve, respectively 7,56 ΔCt (SD ± 0,21) and 4,92 ΔCt (SD ± 
0,54) in controls. The difference between cases and control was 
statistically significant with a t-score: 16.53 and a p-value < 0.001. 
 
 
Fig. 1: miR-21 expression in Cases (specimens of VS) and Controls (specimens of great 
auricular nerve). The difference between the two groups is statistically significant, indicating 
a deregulation in miR-21 expression in tumoral nervous tissue. (p<0.001) 
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Levels of microRNA-21 were not statistically related with tumor size 
at time of surgery (p > 0.07), although was noted a linear correlation 
between the two data. This data is presumably due to presence of 
other factors and small size of the series. In fact, applying a correction 
for the age of patients the relation between miR-21 overexpression 
and final size becomes statistical significant (p< 0.04).  
 
 
 
Fig. 2: Correlation between tumor size and miR-21 expression. The tumor size seems to be 
linearly correlated with miR-21 expression rate, but the data was not statistically significant 
(p>0.07). 
 
 
A positive linear correlation between miR-21 expression and growth 
rate was noted in 10 cases in which this data was available. The small 
sample does not allow a statistical significance (p > 0.07).  
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Fig. 3: Effect of miR-21 expression on the tumor growth rate. In 10 patients, in whom the 
growth was calculable, there was a positive linear correlation between miR-21 expression 
and growth rate expressed in mm per year. 
 
 
The overexpression of miR-21 was more marked in cystic tumors 
rather than solid tumors. 
 
 
Fig. 4: The morphology of the tumor (i.e. cystic or solid) was correlated with miR-21 
expression. Cystic tumors displayed a higher expression levels of miR-21 rather than solid 
type. 
 
PTEN mRNA was founded in all cases. On IHC analysis of the 
specimens showed the PTEN protein expression: low in 14 specimens, 
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absent in 16 cases and normal in only 1 case. An inverse correlation 
with levels of microRNA-21 was noted.  
 
 
Fig. 5: miR-21 regulates levels of PTEN protein. The expression of PTEN was founded 
inversely correlated with the levels of miR-21.  
 
After surgery no major complications were noted. All the patients 
have no evidence of residual or recurrent disease at last MRI control 
after 2 years. Any correlations of miR-21 with symptoms or surgical 
outcome were present. 
 
Discussion 
 
The discovery of microRNAs has broadened our understanding 
of the mechanism that control gene expression with the addition of an 
entirely novel level of regulatory control. These small noncoding 
transcripts of 18-25 nucleotides modulate protein expression by 
binding to complementary or partially complementary target mRNAs, 
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and thereby targeting the mRNA for degradation or translational 
inhibition15. 
The study of miRNA in VS originates by the observation of its 
behavior and effects in other tumors. Inhibition of miR-21 in 
hepatocellular carcinoma cell lines increased expression of tumor 
suppressor PTEN and decreased cellular proliferation, migration and 
invasion, whereas enhancing miR-21 expression caused opposite 
effects12. MicroRNA-21 has a role in several cancer-related processes. 
In breast cancer was showed that transfection of cells lines with anti-
miR-21 resulted in increased apoptosis and inhibition of cell growth16. 
Also in VS cell cultures the proliferative rate an the cell survival was 
downregulated by a same procedure, indicating that miR-21 have a 
similar role17. In colorectal cancer has been demonstrated that the 
tumor suppressor PDCD4 (programmed cell death 4) is a target of 
miR-21 and its downregulation stimulated invasion, extravasation and 
metastasis18.  
In primary brain tumors high levels of miR-21 were founded, 
with maximum overexpression in glioblastomas11. MicroRNA-21 
might block the expression of gene products that promote normal glia 
differentiation or that induce apoptosis, holding tumor cells in an 
inappropriately primitive and proliferative developmental state. 
Schwann cells are part of the glia tissue, hence may exhibit some 
deregulation of miR-21 expression in tumor cases as well. 
MicroRNA-21 overexpression in VS may become, consequently, a 
key point in the control of growth and development by PTEN 
regulation and its effects, as stated before, on AKT pathway. PTEN is 
the most highly mutated tumor-suppressor gene in the post-p53 era; it 
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play a role not only in inducing cell cycle arrest and programming 
apoptosis, but also in other aspects of cell physiology, including cell 
adhesion, migration and differentiation. Perturbations in AKT 
signaling have been shown to induce malignant transformation in 
ovarian cancer, lymphomas, pancreatic cancer, hepatocellular 
carcinoma, gastric cancer, prostatic cancer, and thyroid cancer19.  
Decreased expression of PTEN would enhance proliferative signaling 
through the pathway of AKT regulation, by activating this kinase, and 
finally leading to proliferation, decreased apoptosis or both. The 
PI3K/AKT signaling pathway is a growth-promoting system in several 
human malignant tumors. AKT has been involved in cell survival and 
growth, in differentiation and apoptosis as well20. PI3K is a 
membrane-associated lipid kinase that catalyzes the conversion of 
phosphatidylinositol diphosphate (PIP2) to phosphatidylinositol 
diphosphate (PIP3). This event recruits AKT from the cytoplasm to 
the membrane to a direct action between PIP3 and AKT20. The 
activation of AKT is mediated by phosphoinositide-dependent protein 
kinase (PDK) by phosphorylation of an AKT site; a second 
phosphorylation is required for a maximal activation21.  
The principal negative regulator of AKT activation is PTEN, which 
role consists in the conversion of PIP3 in PIP2. PIP3 levels are very 
low in quiescent cells, but rapidly increase upon stimulation by 
growth factors, through activation of PI3K, as mentioned. Generally a 
loss of the PTEN function is secondary to a deletion on chromosome 
10, but in low grade glioneural tumors PTEN mutation are rare, hence 
is the regulation of its activity that is deregulated. PTEN have opposite 
function of PI3K in regulating cell proliferation and survival by 
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regulation of PDK phosphorylation state. The activity of PTEN is also 
regulated by a phosphorylation that decreases its phosphatase activity. 
The series that we presented showed the importance of miR-21 role in 
VS growth with a linear correlation between expression and size at 
time of diagnosis. Furthermore, an interesting relationship emerged 
between miR-21 expression and growth rate that, although without 
statistical evidence, seems to be related with the level of miR-21, 
opening the perspective to perform an early hearing preservation 
surgery in those patients with high risk of tumor growth. 
Probably other mRNA that may be targeted by miR-21 may either 
serve unrelated functions, or may serve to modulate the effect of 
PTEN. Based on target prediction algorithms, PTEN potentially could 
be targeted by miRNA other than miR-21, but PTEN needs to be 
verified experimentally as a good target for these miRNA, and a 
biologically relevant role shown. 
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The microRNA-21 gene presents an upstream enhancer region 
containing two binding site for STAT3 (signal transducer and 
activator of transcription 3). It was also demonstrated that the 
activation of STAT3 induces expression of miR-2122. STAT3 is a 
regulator of gene expression in response to many growth factors and 
cytokines. The neuropoietic cytokines ciliary neurotrophic factor 
(CNTF) bind to specific ligand-binding receptor subunits and share 
with others ligand the signal transduction subunit gp130, activating 
the transcription pathway23. STAT3 is activated also by the 
neuropoietic cytokines IL-6 playing an important role in nerve repair 
and regeneration23. STAT3 may induce miR-21 expression also in 
multiple myeloma cells22.  
Merlin, the protein product for the NF2 gene, is structurally 
similar to the ezrin/radixin/moesin cytoskeletal proteins, but has 
unique tumor-suppressive properties24. Overexpression of merlin 
suppresses growth of rat schwannoma cells, whereas merlin 
inactivation leads to loss of contact inhibition and increased cell 
proliferation25. The merlin regulate also the PI3K activation through 
its interaction with an enhancer, consequently and indirectly acts as a 
suppressor of the AKT pathway activation26. The merlin was founded 
mutated in sporadic VS with loss its biological function in 53-70% of 
examined cases27, and also our previous unpublished data confirm 
these information. As showed by Scoles et al., merlin protein play a 
role in suppressing STAT3 activation through interaction with 
hepatocyte growth factor-regulated tyrosine kinase substrate (HRS) in 
human schwannoma cell line28. The mutation occurring in NF2 
patients interferes with binding of HRS with merlin abolishing the 
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ability of merlin to inhibit STAT3 activation. This open the possibility 
that overexpression of miR-21 in VS may be a consequence of a 
deregulated activation of STAT3 by an autocrine or paracrine 
mechanism involving neuropoietic cytokines17. 
The activation of STAT signaling is regulated also by epidermal 
growth factor receptor (EGFR) pathway, which contribute to cell 
proliferation in tumoral cell of NF2 patients and in primary VS 
cultures29. This mechanism is not clear, but the use of a EGFR 
inhibitor in NF2 subjects showed some benefit in term of arrest of 
growth30, although not statistically proved, the targeted therapy hold 
some promise. 
MicroRNA-21 acts as an antiapoptotic factor in glioblastoma cells. An 
aberrant increased expression of miR-21 may down-regulate the 
translation or stability of mRNA coding for apoptosis-related genes, 
this was showed by an inhibition of miR-21 expression that leaded to 
caspase activation and associated apoptotic cell death11. The precise 
target is still now unknown.  
The cystic phenotype of VS was indicated as more aggressive 
form of tumor, because of the accumulation of fluid into cyst may 
determine a rapid expansion of the mass, compressing rapidly the 
surrounding structures31.  
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Fig. : MRI axial scan T2-weighted showing a cystic vestibular schwannoma. The cystic 
component is the prevalent portion displayed with an intermediate gray due to difference in 
proteins content compared to cerebrospinal fluid. 
 
MicroRNA-21 increases matrix metalloproteinase-2 (MM2) 
expression in cardiac fibroblasts by the PTEN pathway, and MM2 has 
been associated with cyst formation in VS32. Our results indicate that 
the cystic type of VS exhibits a higher expression of miR-21 
compared with solid type and it is presumable that the cyst formation 
has a close relationship with the overexpression of miR-21. 
Recently, it was discovered that extracellular miRNAs 
circulate in the blood of both healthy and diseased patients, although 
ribonuclease is present in both plasma and serum33. Most of the 
circulating miRNAs are included in lipid or lipoprotein complexes, 
such as apoptotic bodies, microvesicles, or exosomes, and are, 
therefore, highly stable. The existence of circulating miRNAs in the 
blood of cancer patients has raised the possibility that miRNAs may 
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serve as a novel diagnostic marker. However, the secretory 
mechanism and biological function, as well as the meaning of the 
existence of extracellular miRNAs, remain largely unclear. These 
findings may resolve the problem of difficulty access to VS specimen 
to analyze preoperatively the miR-21 levels and, consequently, 
establish a prognosis.  
 
Conclusions 
 
 It is clear that miR-21 plays a significant role in the regulation 
of multiple pathways controlling cell proliferation in many cancers, 
and this attribute makes it a very attractive target for the development 
of new therapies. Future experiments aimed at manipulating miR-21 
expression in schwannoma models will allow us to test the relative 
importance of miR-21 on VS growth in vivo. The close relationship 
between growth and miR-21 expression lead to considerate such 
molecular factor as a prognostic indicator, after further verifications, 
to select patients manageable with observation or with an early 
hearing preservation surgery. 
Furthermore, the application of proteomics strategies in these cells 
should help identify new molecular targets of miR-21 as has been 
demonstrated in the breast cancer cell line34,35. The application of 
these methods and findings in other biologic systems may shed new 
light on the molecular pathways controlling tumor growth and help 
identify novel therapeutic targets for the treatment of VS. 
Should miR-21 be confirmed to be integral to the growth and 
regulation of VS, it is possible to clinically manipulate this biologic 
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phenomenon. Using molecules that can bind and interfere with these 
microRNAs, would be one strategy to downregulate this pathway. 
Early clinical trials using this approach have been used in patients 
with macular degeneration and respiratory syncytial virus infections36. 
A miR-21 specific RNA interference knockdown could be achieved 
systemically by administering a viral gene expression vector; 
however, the side effects on a patient may be undesirable because of 
off target effects. A more focused delivery via an endoscopic direct 
injection or delivery during an intentionally incomplete resection of 
the VS could be an alternative method. 
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Management of Chronic Otitis by Middle Ear
Obliteration With Blind Sac Closure
of the External Auditory Canal
*Mario Sanna, *†Francesco Dispenza, *‡Sean Flanagan, *Alessandro De Stefano,
and *Maurizio Falcioni
*Gruppo Otologico Piacenza, Rome; ÞDipartimento Scienze Otorinolaringoiatriche, Universita` degli Studi
di Palermo, Palermo, Italy; and þSt. Vincent Hospital, Sydney, Australia
Objective: Description of a technique of middle ear oblitera-
tion (MEO) with blind sac closure of the external auditory
canal with discussion of the indications for its use in cases
of recalcitrant chronic otitis and in far advanced disease.
Patients: All patients underwent otologic examination and
audiologic and radiologic assessments in a quaternary center.
Results: Fifty-three cases of MEO were analyzed. For 9
patients, primary surgery was performed. One case of residual
disease was identified. The minimum follow-up was 2 years.
Conclusion: The decision to perform a MEO is one that is
made only rarely. However, this is a technique that should be
part of every otologist`s armamentarium. Whereas the indica-
tions for its use are more straightforward in an ear with unser-
viceable hearing, a MEO is occasionally required in an ear with
good cochlear reserve due the severity of disease. All of our
patients managed by MEO have had an improvement in their
quality of life and a high rate of successful eradication of dis-
ease. Key Words: CholesteatomaVChronic otitisVMastoid
obliterationVMeningoencephalic herniationVMiddle ear
obliterationVMiddle ear revision surgery.
Otol Neurotol 29:19Y22, 2008.
Middle ear obliteration (MEO) using abdominal fat
with blind sac closure of the external auditory canal
(EAC) and obstruction of the eustachian tube is a surgi-
cal option for difficult cases of chronic ear disease. It is
a technique that aims to give the patient, often plagued
with chronic discharge, multiple previous surgical inter-
ventions, and unserviceable hearing a safe dry ear.
Althoughmost chronic ear disease is managed success-
fully using an individualized approach, it is the meticu-
lous eradication of disease and the creation of a stable
cavity able to prevent recurrence that is the cornerstone of
success. The restoration of hearing function is a second-
ary, albeit important, goal. There are cases, however,
where even the most experienced otologist is unable to
prevent ongoing suppuration despite multiple revision
surgeries and assiduous office-based management.
The presence of large areas of exposed dura, and/or
meningoencephalic herniation, coexisting with active
disease places the patient at significant risk of serious
complications (1). Whether iatrogenic or the result of
the disease process, most cases can be managed using
a combined transmastoid and extradural middle cranial
fossa approach (2,3). There are those instances, how-
ever, where this is impracticable or inadequate, and a
MEO provides the safer option.
Readily available magnetic resonance imaging (MRI)
with the use of fat suppression and diffusion sequences
makes surveillance of these cases more straightforward,
removing the need for second-look surgery but still
requiring long-term follow-up (4,5).
In this study, we analyzed the indications and results
of our series of 53 patients undergoing MEO for the
management of chronic suppurative otitis media with
or without meningoencephalic herniation at the Gruppo
Otologico between 1983 and 2005.
MATERIALS AND METHODS
A retrospective chart review of 53 patients with an MEO
treated at Gruppo Otologico (quaternary center) between
1983 and 2005 was conducted. We included in the present
study only patients with a minimum of 2 years of follow-up.
Thirty-four patients were men, and 19 were women. Average
age was 57 years (range, 7Y84 yrs). The right side was involved
in 28 cases, and the left side in 25. All patients underwent
Address correspondence and reprint requests to Francesco Dispenza,
M.D., Gruppo Otologico Piacenza Via Paolo Emiliani Giudici, 37,
90127 Palermo, Italy; E-mail: francesco-dispenza@libero.it
Otology & Neurotology
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clinical otologic examination, preoperative, and postoperative
audiologic assessment, including pure-tone average (PTA;
average of 0.5-1-2-4 kHz) and SDS (speech discrimination
score) and a computed tomographic scan of temporal bone.
These cases represented a very small proportion (1.06%) of
more than 5,000 cases of chronic suppurative ear disease trea-
ted by the senior author (M.S.).
INTERVENTION
Meticulous technique is required to perform a blind
sac closure. Care not to tear the skin flap of the EAC is
important, and the use of a second layer of soft tissue to
reinforce the closure is preferable. In the setting of pre-
vious surgery, however, especially with the presence of
a large meatoplasty, this can be challenging.
Complete exenteration of the disease, mastoid air
cells, and mucosa with removal of all skin, tympanic
membrane, malleus, and incus is performed. Canal
plasty and lowering of the floor of the canal is essential
to ensure complete removal of squamous epithelium.
The presence of cholesteatoma matrix adherent to
dura can be difficult to manage. The dura itself is
often friable, and attempts to achieve complete removal
can lead to a dural defect and cerebrospinal fluid (CSF)
leak. Bipolar devitalization of residual matrix should be
performed as opposed to dural resection (6).
In the presence of meningoencephalic herniation, the
prolapsed tissue is reduced using the bipolar diathermy,
and a muscle plug or cartilage is placed to reinforce the
defect (7).
Once eradication of disease has been completed, the
opening of the eustachian tube is abraded and packed
with bone wax and soft tissue. The cavity is then oblit-
erated with an abdominal fat graft and immersed in
rifampicin. Fibrin glue is also used in the presence of
a CSF leak.
Because of the closure of the EAC, radiologic follow-
up is mandated. Although CT will give information
regarding further bone destruction, an MRI scan using
fat suppression and diffusion sequences allows accurate
identification of residual disease. We advocate an initial
scan 1 year postoperatively, followed by a further scan
at 3, 5, and 10 years (4,5,8).
RESULTS
Primary MEO
Middle ear obliteration as the primary surgery was
performed in 9 of 53 cases. Cholesteatoma with menin-
goencephalic herniation was found in 5 cases. In 4 cases,
PTA showed a conductive hearing loss (air conduction
PTA, 50 dB; bone conduction PTA, 18 dB), all of whom
had significant meningoencephalic herniation with cho-
lesteatoma. The remaining 5 cases had a preoperative
profound sensorineural hearing loss (SNHL), 4 of which
had extensive cholesteatoma, the other with persisting
otorrhea after a temporal bone fracture associated with a
facial nerve injury.
Sensorineural hearing function was preserved in 3
patients with preoperative conductive hearing loss
(interestingly, the air conduction worsened in only 1
case). In 1 patient with mesotympanic cholesteatoma,
meningoencephalic herniation, and a CSF leak, a com-
plete SNHL occurred unexpectedly 1 year after MEO.
Secondary MEO
Of the 44 patients undergoing revision surgery; 18
patients had already undergone more than 2 procedures,
whereas in the remaining 26 patients, MEO was the
second operation. Thirty-five cases revealed recurrent
cholesteatoma. Twenty-five patients were found to
have meningoencephalic herniation (16 cases with CSF
leak), and in 6 cases, significantly exposed dura with the
intraoperative discovery of a CSF leak were identified
(Table 1).
Nineteen patients had a dead ear at preoperative
audiologic assessment. The average air conduction
PTA of the remaining 25 patients was 79 dB (range,
50Y110 dB), whereas mean bony conduction PTA was
42 dB (range, 20Y70 dB). After MEO, both conductive
and sensorineural hearing function were preserved in 20
patients. In 1 case with a primary LSC (lateral semicir-
cular canal) fistula, the bony threshold worsened by 10
dB. Worsening of bony conduction and improvement of
air conduction were obtained in 1 case. Two patients
suffered a complete SNHL, 1 of whom had a deep fistula
into the LSC.
During follow-up, 1 case of residual cholesteatoma
was identified 2 years postoperatively on routine MRI
scanning. This was easily removed, with evidence of
only minimal infiltration of the surrounding fat (Fig. 1).
One patient developed a postaural fistula 2 months
after surgery recalcitrant to conservative management.
Reinforcement using a mucoperiosteal flap was success-
ful in resolving this problem.
DISCUSSION
From the first description of MEO by Rambo in 1957,
there have been sporadic reports regarding its use (9Y13).
Most recently, Kos et al. (9) published their series of 46
patients undergoing tympanomastoid obliteration for
TABLE 1. Intraoperative finding
Primary surgery
(9 patients)
Revision surgery
(44 patients)
Whole series
(53 patients)
Stenosis of external
auditory canal
0 8 8
Cholesteatoma 8 35 43
Facial nerve
exposed
3 15 18
Dura exposed 6 30 36
Meningoencephalic
herniation
5 25 30
CSF leak 1 16 17
Labyrinthine fistula 2 12 14
CSF indicates cerebrospinal fluid.
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chronic ear disease. Of 32 cases with cholesteatoma, they
reported 4 recurrences, 1 of which required the reversal of
the obliteration due to multiple recurrences. Seven cases
of postoperative abscess formation or discharge were also
noted, with no continuing problems after secondary inter-
vention. Our reduced rate of infective complications can
be explained by the routine use of antibiotics with anti-
pseudomonal action. The other interesting aspect of this
article was that, despite long-term success, 1 of 4 patients
was not satisfied. This emphasizes the importance of
patient selection and detailed preoperative counseling.
A high proportion of our series had evidence of
meningoencephalic herniation (30 of 53). Meningoence-
phalic herniation of the temporal bone is most com-
monly associated with chronic suppurative ear disease,
with a high proportion of cases having undergone pre-
vious surgery (1,2,14Y16). In this series, 25 of 30 cases
had had previous surgery at alternate centers. Although
there is no doubt that iatrogenic injury plays a role in the
cause, active disease also plays a significant part. This
can often be a difficult diagnosis to make preopera-
tively, and a high index of suspicion should be main-
tained in all revision mastoid surgery. Magnetic
resonance imaging scanning is a helpful adjunct in this
setting to delineate cholesteatoma, granulation tissue,
and meningoencephalic tissue.
The treatment of meningoencephalic herniation is
dependent on the status of middle and inner ear, the
extent of herniation, and the presence or absence of
active disease. When conditions are favorable, a middle
cranial fossa approach is used, allowing preservation of
middle ear function (1,2,14,16), which is the situation in
a high proportion of cases. However, in ears with poor
reserve, in cavities unable to sustain a middle cranial
fossa repair, and those with extensive herniation, MEO
is the safest and most definitive treatment modality. This
is especially so when there is a combination of active
disease and an active CSF leak. The significant degree
of herniation in 4 of our primary cases with good cochlear
reserve was the essential reason to perform a MEO.
The decision on whether to obliterate after EAC clo-
sure and what material to use is an important point. We
advise the use of abdominal fat, as supported by Kos
et al. (9) and Mehta and Harris (13), for a number of
reasons. First, in cases of meningoencephalic herniation
and CSF leak, obliteration minimizes the risk of persist-
ing leak and meningitis. The presence of obliterative
material also reinforces the closure of the external
canal and minimizes the cosmetic defect. Others have
reported the use of muscle, pericranial, and or periosteal
flaps to obliterate their cavities, but in revision cases,
there is often insufficient local tissue to adequately oblit-
erate the cavity without significant tissue mobilization
and attendant morbidity. Despite some expressed con-
cerns in the literature regarding infection of the fat graft,
this did not present a problem in this series. Indeed, the
fat itself has been reported to have inherent immunore-
active properties that may suppress infection (17).
Importantly, the use of fat provides a ready contrast
medium to help detect residual cholesteatoma. The use
of fat suppression and diffusion sequences on MRI pro-
vides us with a very accurate method to detect early
recurrence. The routine use of postoperative radiologic
surveillance obviates the need for reexploration unless
suspicions are raised by these investigations.
The decision to perform an MEO is one that is made
only rarely. Of the more than 5,000 cases of chronic
suppurative ear disease we have performed, only 53
had MEO. However, this is a technique that should be
part of every otologist`s armamentarium no matter how
skilled or experienced. Whereas the indications for its
use are more straightforward in an ear with unservice-
able hearing, an MEO is occasionally required in an ear
with good cochlear reserve due the severity of disease.
Follow-up scanning is essential in all cases, and this
must be reinforced to the patient before the procedure.
In almost all cases, the patient greatly appreciates the
creation of a safe, dry ear, with minimal associated mor-
bidity and no lifestyle restrictions, at the cost of a max-
imal conductive hearing loss in an ear that is already
significantly impaired.
It also provides definitive management of CSF leaks
through the temporal bone and in the management of
meningoencephalic herniation.
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Abstract
Neoplasms originating from plasma cell are rare in the head and neck region. A correct clinical evaluation is very important in order to
formulate a differential diagnosis as well as to distinguish local from metastatic disease. We report a case of larynx involvement by an IgA
multiple myeloma in a 69-year-old female diagnosed in October 2004 and treated with chemotherapy; the 1 year control do not show
progression of disease and the laryngeal lesion is unchanged.We highlight the radiological findings and clinical features to suspect plasma cell
tumors in cases with a similar presentation.
# 2007 Elsevier Ireland Ltd. All rights reserved.
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1. Introduction
Neoplasms originating from plasma cell are rare in the
head and neck region. They arise as a monoclonal
proliferation of plasma cells during their various stage of
differentiation (classified as a peripheral B-cell neoplasm in
a revised European-American classification [1]). The
clinical classification divides these neoplasm into three
types: multiple myeloma (MM), solitary plasmacytoma of
bone (SPB) and extramedullary plasmacytoma (EMP).
A correct clinical evaluation is very important in order to
make the correct diagnosis as well as to distinguish this kind
of tumor and the extent of disease, to institute the correct
treatment and to estimate survival time. A plasma cell tumor
classified as a solitary plasmacytoma of bone if evidenced in
bone; in soft tissue as a extramedullary plasmacytoma, while
the systemic form of the disease is called multiple myeloma.
These three clinical entities are considered as represent-
ing distinct manifestations of a continuum of disease. About
20–30% of EMP may progress to a MM [2].
We report the clinical and radiological features of a
patient affected by IgA MM with laryngeal involvement,
treated by chemotherapy; we outline the importance of
differential diagnosis considering also this rare entity.
2. Case report
A69-year-oldwomanaffectedbyhigh-plasma level of IgA
was diagnosed with a monoclonal gammopathy of undeter-
mined significance (MGUS). She experienced progressive
hoarseness and slight dysphagia. The patient did not complain
of dyspnea nor did she have risk factors for laryngeal cancer
(smoking and alcohol). She had no previous intubation,
trauma or surgical procedures. Shewas a type II diabetic with
hypertension, both efficiently controlled by medical therapy.
Indirect laryngoscopic examination revealed sub-muco-
sal swelling of the right ventricular fold (false cord),
ventricle and true vocal cord, reduction of right side motility,
normal mucosa (Fig. 1). A mass in the right thyroid ala was
found during neck examination; after a CT scan without
contrast enhancement of the neck, a structural alteration
within thyroid cartilage in right ala with cortical thinning
and right supraglottic and concentric cricoid ring thickness
was evidenced (Fig. 2).
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Biopsy of the mucosa and sub-mucosal layer was
performed under direct microlaryngoscopy. Histopathology
demonstrated a diffuse massive infiltration of plasma cells.
Haematological consultation was sought in order to
further assess the nature of the disease. Serum and urine
electrophoresis was performed which confirmed the
previous findings of a high-plasma level of monoclonal
IgA; bone marrow biopsy revealed plasma cell infiltration of
20%. Routine laboratory tests showed anaemia (haemoglo-
bin 8.9 g/dl; RBC 2,980,000/mmc; WBC 3200/mmc;
plasmatic albumin 3.5 g/dl, beta-2-microglobulin 5.6 g/dl).
All these findings affirmed the diagnosis of MM stage IIIa.
The patient underwent chemotherapy with VAD protocol
(vincristine, doxorubicin and dexamethasone) for a total of 4
cycles; 1-year clinical and radiological follow-up did not
show progression of disease with the laryngeal involvement
unchanged.
3. Discussion
Laryngeal involvement in patients affected byMM is rare
and few cases are reported in literature [3–9].
Two pathogenetics mechanisms are postulated by several
authors to explain the involvement of laryngeal cartilage: (1)
cartilage may be involved by an adjacent plasmacytoma; (2)
cartilage, particularly in older people, may undergo to
osseous metaplasia with formation of central marrow space,
therefore a plasmacytoma may directly originate from this
bone marrow [10]. Thyroid cartilage expansion and
destruction evidenced in the CT scans suggests as in our
case a myelomatous involvement of extraskeletal bone
marrow formed by osseous metaplasia [8].
Consideration of this process is mandatory considering
that laryngeal involvement in EMP is between 5% and 18%
[11–13] with different treatment and with a better prognosis
than MM. As a matter of fact EMP may evolve to MMmany
months or years later after diagnosis [14,15]. When a plasma
cell tumor involving the larynx is diagnosed the next step is
to exclude systemic disease. The patient must undergo
detection of monoclonal gammopathy in serum or urine, a
bone marrow aspiration biopsy and complete radiological
examination in order to demonstrate osteolytic bone lesions.
Diagnosis of MM is based on: histological evidence of
plasmacytoma or plasmacytosis in bone marrow; clinical
signs of disease such as bone pain, anaemia and renal failure;
detection of the monoclonal gammopathy in serum or urine
and demonstration of osteolytic bone lesion. EMP and SBP
are diagnosed if plasmacytoma is present in soft tissue or
bone with no dissemination of disease.
Involvement of the thyroid cartilage is very rare [8,9]. CT
examination can demonstrate a typical pattern: thinning and
expansion of the lamina of the thyroid ala (as in our case),
thus confirming its origin within the thyroid structure caused
by osseous metaplasia of the cartilage [8]. Treatment of
different form of plasma cells tumors is related to their
extension: EMP and SBP can be treated by external radiation
therapy with 40–50 Gy for a 4-week period including
cervical lymph nodes in order to prevent lymph node
recurrences [16]. Surgical removal is a second line treatment
particularly in case of salvage therapy after radiation failure.
The treatment of symptomatic patients affected by MM,
even with larynx involvement, involves chemotherapy or
bone marrow transplantation. Surgery is mainly diagnostic
in the majority of cases and tracheotomy is performed in
case of airway obstruction.
Usually plasma cell neoplasms appear in the elderly
while MM variant about 10 years later than the others two.
After diagnosis MM have a mean survival of about 2–3
years, while EMP and SPB have a better prognosis.
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Fig. 1. Indirect laryngoscopic examination show a sub-mucosal swelling of
right false cord, ventricle and true vocal cord and normal mucosal surface.
Fig. 2. CT scan of larynx without contrast enhancement showing a struc-
tural alteration within thyroid cartilage in right ala with cortical thinness.
4. Conclusion
Plasma cell neoplasms are unusual in the head and neck
region and are histologically indistinguishable because they
represent a continuum disease, as illustrated by progression
of EMP and SPB to MM. The diagnosis is made on the basis
of clinical, radiological and pathological findings, and the
distinction between EMP, SPB and MM is critical for
treatment and survival. In the case of typical CT scan larynx
pattern a plasma cell tumor must be suspected for correct
management.
References
[1] Harris NL, Jaffe ES, Stein H, Banks PM, Chan JKC, Cleary ML, et al.
A revised European-American classification of lymphoid neoplasms: a
proposal from the International Lymphoma Study Group. Blood
1994;84:1361–92.
[2] Gorenstein A, Neel HB, Devine KD. Solitary extramedullary plas-
macytoma of the larynx. Arch Otolaryngol 1997;103:159–61.
[3] Hayes DW, Bennett WA, Heck FJ. Extramedullary lesions in multiple
myeloma. Arch Pathol 1952;53:262–72.
[4] Agarwal MK, Samant HC, Gupta OP, Khanna S. Multiple myeloma
invading the larynx. Ear Nose Throat J 1981;60:395–7.
[5] East D. Laryngeal involvement in multiple myeloma. J Laryngol Otol
1978;92:61–5.
[6] Georghiou PR, Hogg ML. Immunoglobulin A myeloma presenting
with laryngeal obstruction. Med J Aust 1988;149:447–9.
[7] Maniglia AJ, Xue JW. Plasmacytoma of the larynx. Laryngoscope
1983;93:741–4.
[8] Van Dyke CW, Masaryk T, Lavertu P. Multiple myeloma involving the
thyroid cartilage. AJNR 1996;17:570–2.
[9] Aslan I, Yenice H, Baserer N. An indolent course of multiple myeloma
mimicking a solitary thyroid cartilage plasmacytoma. Eur Arch Otor-
hynolaryngol 2002;259:84–6.
[10] Jones NS, KenyonGS,Mahy N.Multiple myeloma in bonymetaplasia
of the cricoid cartilage. J Laryngol Otol 1987;101:1301–5.
[11] Wax MK, Yun KJ, Omar RA. Extramedullary plasmacytomas of the
head and neck. Otolaryngol Head Neck Surg 1993;109:877–85.
[12] Poole AG, Marchetta FC. Extramedullary plasmacytoma of the head
and neck. Cancer 1968;22:14–21.
[13] Kost KM. Plasmacytomas of the larynx. J Otolaryngol 1990;19:
141–6.
[14] Mochimatsu I, Tsukuda M, Sawaki S, Nakatami Y. Extramedullary
plasmacytoma of the larynx. J Laryngol Otol 1993;107:
1049–51.
[15] Webb HE, Harrison EG, Masson JK, ReMine WH. Solitary extra-
medullary myeloma (plasmacytoma) of the upper part of the respira-
tory tract and oropharynx. Cancer 1962;15:1142–55.
[16] Knowling MA, Harwood AR, Bergsagel DE. Comparison of extra-
medullary plasmacytomas with solitary and multiple plasma cell
tumors of bone. J Clin Oncol 1983;1:225.
F. Dispenza et al. / Auris Nasus Larynx 35 (2008) 288–290290
87
CASE REPORT
Post-traumatic lipoma of the parotid gland: 
case report
Lipoma post-traumatico della parotide: caso clinico
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SUMMARY
The incidence of lipoma among parotid tumours ranges from 0.6% to 4.4%, with most series reporting an incidence of 1%. 
7KHPRVWFRPPRQRULJLQRIWKHVHWXPRXUVLQWKHSDURWLGJODQGLVIURPWKHVXSHUÀFLDOOREHDQGRQO\UDUHO\IURPWKHGHHS
OREH/LSRPDVXSRQFOLQLFDOKLVWRU\DUHIRXQGWREHPRVWIUHTXHQWO\UHODWHGWRDQHSLVRGHRIWUDXPD&RPSXWHG7RPRJUDSK\
VFDQDQG0DJQHWLF5HVRQDQFH,PDJLQJFDQOHDGWRDSUHRSHUDWLYHGLDJQRVLVRIOLSRPD7KHFDVHLVGHVFULEHGRIOLSRPDRIWKH
VXSHUÀFLDOOREHRIWKHSDURWLGJODQG
KEY WORDS: 3DURWLG/LSRPD)DFLDOSDOV\'LDJQRVLV6XUJLFDOWUHDWPHQW
RIASSUNTO
,OLSRPLGHOODSDURWLGHUDSSUHVHQWDQRORGHLWXPRULGHOODJKLDQGROD'LYHUVLVWXGLULSRUWDQRXQ·LQFLGHQ]DGHOO·
3LFRPXQHPHQWHTXHVWLWXPRULRULJLQDQRQHOORERVXSHUÀFLDOHGHOODSDURWLGHHVRORUDUDPHQWHGDTXHOORSURIRQGR,OLSRPL
VRQRIUHTXHQWHPHQWHFRUUHODWLDGXQSUHJUHVVRHSLVRGLRWUDXPDWLFRGHOODUHJLRQHFRLQYROWD/DWRPRJUDÀDFRPSXWHUL]]DWDH
ODULVRQDQ]DPDJQHWLFDSRVVRQRFRQGXUUHDGXQDGLDJQRVLGLOLSRPDSUHRSHUDWRULD5LSRUWLDPRXQFDVRGLOLSRPDGHOORER
VXSHUÀFLDOHGHOODSDURWLGH
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Introduction
/LSRPDLVDFRPPRQEHQLJQWXPRXURIPHVHQFK\PDORUL-
JLQDULVLQJLQHYHU\ORFDWLRQZKHUHIDWLVQRUPDOO\SUHVHQW
13% of which occurring in the head and neck region. Rare-
O\OLSRPDVFDQDULVHLQWKHRUDOFDYLW\SKDU\Q[ODU\Q[DQG
parotid gland 1. The incidence of lipoma among parotid tu-
mours ranges from 0.6% to 4.4%, with most series report-
ing an incidence of 1% 2. A case of post-traumatic lipoma of 
WKHSDURWLGJODQGLVGHVFULEHG
Case report
$ \HDUROG IHPDOH KDG H[SHULHQFHG D SDLQOHVV VORZ
JURZLQJPDVVRQ WKH ULJKW VLGHRI WKH IDFH \HDUVSUH-
YLRXVO\DIWHUD WUDXPDGXH WRDELWHRQ WKDWDUHD([DPL-
QDWLRQUHYHDOHGDVRIWPRELOHQRQWHQGHUUHJXODUPDVVLQ
WKHULJKWSDURWLGH[WHQGLQJWRZDUGWKHQHFN7KHUHZDVQR
GHWHFWDEOHFHUYLFDOO\PSKQRGHV3URJUHVVLYHSDUHVLVRIWKH
PDQGLEXODUEUDQFKRIWKHIDFLDOQHUYHKDGEHFRPHHYLGHQW
RYHU WKH ODVW PRQWKV7KH FRPSXWHG WRPRJUDSK\ &7
VFDQ UHYHDOHG DZHOO GHPDUFDWHG ORZGHQVLW\PDVV[
FPLQWKHVXSHUÀFLDOOREHRIWKHULJKWSDURWLGJODQG)LJ
7KHPDJQHWLF UHVRQDQFH LPDJLQJ 05, VFDQ VKRZHG
DKLJKVLJQDOLQWHQVLW\RQ7ZHLJKWHGLPDJHV)LJDQG
LQWHUPHGLDWH LQWHQVLW\RQ7ZHLJKWHG LPDJHV7KH OHVLRQ
H[WHQGHG WR ERWK VXSHUÀFLDO DQG GHHS OREHV RI WKH JODQG
OHDYLQJDVPDOOSRUWLRQLQWKHGHHSOREH7KHVHUHVXOWVZHUH
consistent with a lipomatous lesion. Surgical removal of the 
tumour with facial nerve preservation was performed. Post-
operative facial nerve function was normal with resolution 
RI PDQGLEXODU EUDQFK SDUHVLV +LVWRSDWKRORJ\ FRQÀUPHG
the diagnosis of lipoma.
Discussion and conclusion
$GLSRVHWLVVXHLVQRUPDOO\SUHVHQWLQWKHSDURWLGJODQGEXW
WKHLQFLGHQFHRIOLSRPDVKHUHLVYHU\ORZ'LIIHUHQWFDXVHV
RIOLSRPDVDUHPHQWLRQHGLQWKHOLWHUDWXUHKHUHGLW\REHVLW\
GLDEHWHV UDGLDWLRQ HQGRFULQH GLVRUGHUV LQVXOLQ LQMHFWLRQ
FRUWLFRVWHURLGWKHUDS\DQGWUDXPD$VLQRXUFDVH WUDXPD
DQGOLSRPDDUHIRXQGWREHPRVWIUHTXHQWO\FRUUHODWHGRQ
FOLQLFDO KLVWRU\ 37UDXPD WR VRIW WLVVXH KDV EHHQK\SRWK-
HVL]HGWRUHVXOWLQKDHPDWRPDZLWKVXEVHTXHQWO\PSKDWLF
effusion, fat necrosis and lipoma formation located in the 
VXEFXWDQHRXVSODQH 4. The local effects related to the trauma, 
LQRXUFDVHZHUHQRWZHOOGHÀQHGVLQFHDORQJSHULRGRIWLPH
KDGHODSVHGIURPSUHVHQWDWLRQRIWKHSDWLHQWEXWDORFDOKDH-
PDWRPDZDVSUHVHQWLQWKHFOLQLFDOKLVWRU\7KHIDFLDOQHUYH
LVQRWXVXDOO\LQYROYHGEXWRQHFDVHZLWKFRPSOHWHSDOV\
$&7$2725+,12/$5<1*2/2*,&$,7$/,&$
)'LVSHQVDHWDO
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KDVEHHQUHSRUWHGLQWKHOLWHUDWXUH5. The highest reported in-
cidence of lipoma in the parotid gland is 4.4% 2, with males 
PRVWIUHTXHQWO\DIIHFWHG66RQRJUDSK\FDQEHXVHG
DV WKH LQLWLDOVWXG\DQGVKRZVDK\SHUHFKRLFHOOLSWLFDORU
URXQGHGPDVVVRPHWLPHVLVRHFKRLFRUHYHQK\SRHFKRLF6. 
&7 VKRZV D KRPRJHQHRXVPDVVZLWK IHZ VHSWDWLRQV DQG
OHVV WKDQZDWHUGHQVLW\ 105,SUHVHQWV WKH W\SLFDO VLJQDO
LQWHQVLW\SDWWHUQVDOUHDG\GHVFULEHG$EODFNULPLVSUHVHQW
DURXQGWKHPDVVFOHDUO\GHÀQLQJWKHERUGHUVIURPWKHVXE-
FXWDQHRXV WLVVXH ,Q WKH OLWHUDWXUH FRUUHFW FDWHJRUL]DWLRQ
RIEHQLJQ vs. PDOLJQDQWSDURWLGJODQGWXPRXUKDVEHHQUH-
SRUWHGWREHDIWHU&705,H[DPLQDWLRQ, lipoma can 
EH GLVWLQJXLVKHG IURPZHOOGLIIHUHQWLDWHG OLSRVDUFRPD E\
WKHSUHVHQFHRIWKLFNVHSWDWKHSUHVHQFHRIQRGXODUJOREX-
lar or non-adipose mass-like areas )LQHQHHGOHDVSLUDWLRQ
ELRSV\ )1$% FRPPRQO\ SHUIRUPHG LQ WKH GLDJQRVWLF
ZRUNXSIRUSDURWLGPDVVGRHVQRWSURYLGHVXIÀFLHQWGDWD
for diagnosis 9'XULQJVXUJHU\WKHIDFLDOQHUYHLVLGHQWLÀHG
DQGIROORZHGXSWRLWVSHULSKHUDOEUDQFKHVDVIDUDVQHFHV-
VDU\IRUWXPRXUGLVVHFWLRQ,QRXUFDVHWKHIDFLDOQHUYHZDV
FRPSUHVVHGDQGGLVSODFHG7KLVFRXOGH[SODLQWKHSDOV\RI
WKHLQIHULRUEUDQFKGXHWRFRPSUHVVLRQFRUUHVSRQGLQJWRD
ÀUVWGHJUHH LQMXU\GHVFULEHGE\6XQGHUODQG 10. The neural 
EORFNLVFUHDWHGE\LQFUHDVHGLQWUDQHXUDOSUHVVXUHDQGWKH
nerve cannot conduct an impulse across the site of compres-
sion. If the compression is relieved, return of facial move-
PHQWPD\EHJLQLPPHGLDWHO\RUZLWKLQZHHNV10.
A correct clinical and instrumental evaluation of parotid 
JODQGPDVVHV LQFOXGLQJERWK&7VFDQDQG05,FDQOHDG
to a pre-operative diagnosis of lipoma. Imaging is also im-
portant to evaluate the location of the tumour and to pro-
gramme the correct surgical approach.
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CASE REPORT
Pleomorphic adenoma of the lateral nasal wall: 
case report
Adenoma pleomorfo della parete nasale laterale: caso clinico
D. SCIANDRA, F. DISPENZA, R. PORCASI1, G. KULAMARVA2, C. SARANITI
Otorhinolaryngology Department; 1 Human Pathology Department, University of Palermo, Palermo, Italy; 2 ENT Clinic, 
Nayak’s Road, Kasaragod, India
SUMMARY
Pleomorphic adenoma is the most common tumour of the salivary glands. However, it is extremely rare for these to originate in 
the nose and even when they do so, it is most commonly in the nasal septum. It is important to be aware of the paucity of present-
ing symptoms (nasal obstruction and epistaxis), as the lesion may not be recognized immediately. Growth is generally restricted 
locally and the tumour is not known to spread to the neighbouring structures. Surgical resection is the treatment of choice. Re-
currences and evolution to malignancy are not frequent, but long-term follow-up is recommended. The case is presented of pleo-
morphic adenoma arising from the lateral wall of the right nasal cavity, in a 34-year-old male, which was resected completely, 
endoscopically. Histological and immunohistochemical evaluation revealed the presence of a pleomorphic adenoma.
KEY WORDS: Nose • Nasal tumour • Pleomorphic adenoma • Diagnosis • Histopathology
RIASSUNTO
/·DGHQRPDSOHRPRUIRqLOWXPRUHEHQLJQRSLFRPXQHGHOOHJKLDQGROHVDOLYDUL&RPXQTXHODVXDORFDOL]]D]LRQHQDVDOHqPRO-
WRUDUDHSLFRPXQHPHQWHRULJLQDGDOVHWWR,PSRUWDQWHqFRQVLGHUDUHFKHLVLQWRPLGLSUHVHQWD]LRQHVRQRPROWRVFDUVLRVWUX-
]LRQHQDVDOHHHSLVWDVVLSHUFXLODOHVLRQHSXzGHFRUUHUHDOXQJRPLVFRQRVFLXWD/DFUHVFLWDqJHQHUDOPHQWHORFDOHHQRQVRQR
QRWLFDVLGLGLIIXVLRQHQHOOHVWUXWWXUHDGLDFHQWL/DUHVH]LRQHFKLUXUJLFDqLOWUDWWDPHQWRGLVFHOWD/DUHFLGLYDHO·HYROX]LRQH
PDOLJQDQRQVRQRIUHTXHQWLPDXQOXQJRIROORZXSqGDUDFFRPDQGDUH3UHVHQWLDPRXQFDVRGLDGHQRPDSOHRPRUIRDGRULJLQH
GDOODSDUHWHODWHUDOHGHOODIRVVDQDVDOHGLGHVWUDLQXQSD]LHQWHGLDQQLWUDWWDWRFKLUXUJLFDPHQWHFRQUHVH]LRQHHQGRVFRSLFD
FRPSOHWD/DYDOXWD]LRQHLVWRORJLFDHGLPPXQRLVWRFKLPLFDKDQQRGLPRVWUDWRODSUHVHQ]DGLXQDGHQRPDSOHRPRUIR
PAROLE CHIAVE: 1DVR7XPRULQDVDOL$GHQRPDSOHRPRUIR'LDJQRVL$QDWRPLDSDWRORJLFD
Acta Otorhinolaryngol Ital 2008;28:150-153
Introduction
Mixed tumour of the salivary gland or the pleomorphic 
adenoma is a benign tumour, arising mainly in the major 
salivary glands (65%), especially in the parotid and, less 
frequently, in accessory salivary glands (35%) 1. Rare cases 
have been reported in the lip 2, the hard and soft palate 3, 
the lacrimal gland 4, and the external auditory canal 5. It is 
H[WUHPHO\UDUHWRÀQGWKHVHLQWKHUHVSLUDWRU\WUDFW6-8. The 
incidence is even lower in the upper respiratory tract, such 
as the nasal cavity, maxillary sinus and nasopharynx 8 9. The 
largest reported case series of intra-nasal pleomorphic ad-
enomas are those of Spiros et al. 10 with 40 cases, Compag-
no and Wong 11 with 40 cases and, more recently, Suzuki 
et al. 4 with 41 cases.
Intranasal pleomorphic adenomas generally arise in the 
nasal septal mucosa (reported incidence varies between 
82.5% 11 and 90% 12), even though the seromucosal glands 
are mainly located within the lateral nasal wall, in particular 
in the turbinates 13 14.
Various theories have been proposed to explain this obser-
vation. According to Stevenson 15, remnants of the vomero-
nasal organ, an epithelium-lined duct in the cartilaginous 
nasal septum degenerated in early foetus, could be the rea-
son for the appearance of these tumours in this particular 
region. According to Ersner and Saltzman, in 1944, the 
precursors of the septal pleomorphic adenoma are ectopic 
embryonic epithelialised cells on the nasal septum mucosa, 
found during the migration of the nasal buds 16. According 
to Evans and Cruikshank, it originates directly from the ma-
tured salivary glandular tissue 6; Dawe, in1979, proposed a 
viral aetiology from polyoma virus 17.
Case report
A 34-year-old male, non-smoker, presented at our Depart-
ment, in January 2003, reporting an isolated episode of 
epistaxis from the right nasal cavity. He also complained of 
worsening of a right nasal obstruction which had been present 
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for 10 years, frontal cephalalgia and anosmia. External clini-
cal examination showed a mass arising from the lateral wall 
RIWKHULJKWQDVDOFDYLW\DQGÀOOLQJWKHQDVRIDFLDOIXUURZ
Anterior rhinoscopy revealed a smooth, pink-grey, translu-
cent, painless mass, obstructing the nasal cavity, not bleed-
ing on touch, and a deviated nasal septum to the left. The 
rest of the ear, nose, and throat examination was normal and 
there was no evidence of cervical lymphadenopathy. Com-
puted Tomography (CT) scan revealed a soft tissue mass in 
the right nasal cavity, not involving the paranasal sinuses, 
with thinning of the nasal process of the maxilla (Fig. 1). 
(QGRVFRSLFVXUJHU\XQGHUJHQHUDODQDHVWKHVLDFRQÀUPHG
the mass (2 cm in diameter) to be arising from the lateral 
wall of the right nasal cavity and extending from the an-
terior end of the inferior turbinate to the DJJHU QDVL. We 
excised the tumour completely, including the sub-periostal 
layer and a healthy margin of mucosa.
Histopathological analysis of the tumour showed a mixed 
epithelial and myxoid stromal appearance. Epithelial struc-
tures displayed different solid, trabecular and cystic growth 
patterns (Fig. 2). Immuno-histochemical stainings for 
smooth muscle actin (Fig. 3) and S100 (Fig. 4) highlighted 
the presence of an abundant myoepithelial component. The 
histo-morphological and immunophenotypical features ob-
served were consistent with the diagnosis of pleomorphic 
adenoma. There is no endoscopic evidence of recurrence 
DIWHU\HDUV·IROORZXS
Discussion
Nasal pleomorphic adenoma is seen predominantly in fe-
males 4-11XVXDOO\EHWZHHQWKHWKLUGDQGÀIWKGHFDGHVRIOLIH18. 
There is no reported correlation with occupational expo-
sure or inhaled toxic chemical compounds. It is generally 
known to be a slow-growing tumour and, therefore, clinical 
symptoms appear after a long silent period. Patients com-
monly present with gradual worsening of monolateral nasal 
obstruction and occasional epistaxis. Less commonly, when 
the tumoural mass reaches a relatively large size, to that of 
the nasal cavity, external swelling of the nasal pyramid as 
well as pain may be present.
Clinically, it appears as a polypoid, unilateral, sessile, trans-
lucent, pinkish-grey mass, with smooth surface and soft 
consistency. Tumours can range in size from < 0.7 cm to 
> 7 cm.
7KHFOLQLFDOIHDWXUHVVXFKDVDEVHQFHRIVXSHUÀFLDOXOFHUD-
tion, no bleeding either on touch or spontaneously and lack 
of invasion of surrounding structures suggest a benign na-
ture of the mass.
Histologically, all pleomorphic adenomas have a collagen-
ous thin capsule, with a clear-cut distinction of the tumour 
tissue from the surrounding normal connective tissue. The 
tumours consist of three main structures: tubuloductal 
structure, solid area, and myxoid area. The tubuloductal 
structure presents ducts with double cell layers: cuboi-
Fig. 4. Immunostaining for S100 protein (x 400).
Fig. 1. Axial CT scan showing soft density mass in anterior por-
tion of right nasal fossa with thinness of nasal process of maxillary 
bone.
Fig. 2. Epithelial structures showing solid, trabecular and cystic 
patterns intermingled with myxoid stroma (H&E, x250).
Fig. 3. Immunostaining for smooth muscle actin (x 250).
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dal-shaped epithelial cells at the inner layer, and spindle-
shaped myoepithelial cells at the outer. Predominantly the 
solid areas consist of the spindle-shaped cells with high 
cellularity; the myxoid areas are characterised by their low 
cellularity 18.
The intra-nasal pleomorphic adenoma shows a predomi-
nance of epithelial rather than stromal elements, as com-
pared with major salivary gland tumours. The epithelial 
cells are small, oval-shaped and often arranged in cor-
dons; sometimes, they are organized in small acinous 
structures 13.
Immunohistochemical stains prove positive for various cy-
WRNHUDWLQV6SURWHLQJOLDOÀEULOODU\DFLGSURWHLQ*)$3
Vimentine, a smooth muscle actine (SMA). This describes 
the “mixed” nature of the tumour, namely, the stromal and 
the epithelial line 19.
Differential diagnosis of intra-nasal pleomorphic adeno-
ma includes both malignant and benign tumours such as 
squamous cell carcinoma (the most common intra-nasal 
malignancy), adenocarcinoma, adenoid cystic carcinoma, 
mucoepidermoid carcinoma, melanoma, olfactory esthe-
sioneuroblastoma 20, polyps, papillomas (including inverted 
SDSLOORPDDQJLRÀEURPDVDQGRVWHRPDV
'LIIHUHQWLDOGLDJQRVLVFDQDOVREHGLIÀFXOWLQWKHSUHVHQFHRI
a “neuroestesioepithelioma” (even though the site of origin 
of such a lesion, i.e., the ethmoid plate, should suggest its 
nature, since the lateral nasal wall is extremely rare), as, in 
the early stage, it presents a small cell proliferation organ-
ized like a “rosette”, positive for S100 protein. Diagnosis 
is possible on account of the lack of an extracellular neu-
URÀEULOODU VWUXFWXUHQHXURWXEXOHVQHXURVHFUHWLYHJUDQXOHV
and due to the presence of mucinous material and the rar-
ity of malpighian lobules disseminated on the pleomorphic 
adenoma 21.
Regardless of where the lesion originates, the main treat-
ment modality should be surgical. While complete excision 
of the tumour with histologically clear margins is mandato-
ry, the surgical approach will depend upon the size, location 
and extension. A radical and wide resection lowers the risk 
of recurrence, especially when the capsule is interrupted 
and a direct contact with the surrounding normal tissue is 
present. Approaches include lateral rhinotomy 22-24, trans-
nasal or mid-facial degloving 13-18 and intra-nasal excision. 
The present patient underwent endoscopic resection since 
the tumour was small enough to observe under the endo-
scope. The advantages of endoscopic resection include no 
external scar, less blood loss. In the presence of large mass-
es, the mid-facial degloving approach is preferred, since it 
has the advantage of wide exposure of the mass and direct 
approach to the nasal cavity.
Recurrences are not frequent, Compagno and Wong re-
ported 3 cases of local recurrences in 40 patients (7.5%) 11, 
probably, as they thought, due to the amount of myxoid 
stroma of the tumour, which could be split into the surgical 
ÀHOG
The potential risk of malignant transformation of the pleo-
morphic adenoma is about 6% and is predominantly seen 
in the female patients 25. The risk is increased by delay in 
diagnosis.
$KLVWRSDWKRORJLFDOO\ FRQÀUPHGFDVHZLWK DGHQRLG F\VWLF
and squamous carcinomatous differentiation has been re-
ported 26.
There has also been a report of metastasis to the submandib-
ular lymph-node, in a recurrent septal pleomorphic adeno-
PD\HDUVDIWHUWKHÀUVWGLDJQRVLV(YHQLQWKLVFDVHWKH
microscopic features of both the primary and metastatic le-
sion were benign. In this regard, a iatrogenic theory has been 
proposed. This theory suggests that the metastasis occurs as 
a result of incomplete excision or inadvertent disruption of 
the tumour with consequent spread through haematogenous 
or lymphatic routes. Pulmonary, hepatic and bone metasta-
sis have also been reported 27.
Long term follow-up is therefore necessary for early diag-
nosis of loco-regional recurrences by endoscopic examina-
tion followed by imaging (CT or MR) in case of clinical 
evidence of disease.
Conclusions
In the presence of a slow-growing unilateral mass of the 
nasal cavity, it is important to consider, among the various 
diagnoses, the presence of pleomorphic adenoma, even if 
it is not frequently encountered. Early diagnosis offers the 
possibility of a more complete excision with adequate care 
being taken not to disrupt the tumour in order to prevent 
local and distant spread of neoplastic cells. The endoscopic 
approach is preferred, as it allows complete control of the 
margins under direct vision and reduces the post-operative 
recovery period when compared to open surgery. Long-
term follow-up, both endoscopic and radiologic, to exclude 
malignancy is mandatory, even if the tumour appears to be 
clinically benign and resected completely.
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CASE REPORT
Meningioma of the Cerebellopontine Angle Mimicking
Benign Paroxysmal Positional Vertigo
Alessandro De Stefano, MD, Francesco Dispenza, MD, Giuseppe Di Trapani, MD, and
Gautham Kulamarva, MS, DNB, MRCS, DOHNS
B enign paroxysmal positional vertigo (BPPV) is themost common cause of peripheral vertigo.1 It
accounts for approximately 24% of all cases of peripheral
vestibular disorders.2 This type of vertigo is generally seen
in individuals aged 40 years and older, with the highest age
distribution between 50 and 70 years.3 The exact etiology
of BPPV is still under debate. Over 50% of all reported
cases are idiopathic in nature.4 The signs and symptoms of
BPPV are generally thought to arise from the peripheral
vestibular system, although a conclusive demonstrable
lesion at this level has not been confirmed.
Diagnosis of BPPV is based mainly on a history of
characteristic positional vertigo along with the classic
clinical signs. The nystagmus typically has a latency of a
few seconds and is of limited duration, transient,
fatiguable, and reversible on return to an upright
position.5 Classic BPPV involving the posterior semicir-
cular canal (PSC) is the most common type of BPPV.5 The
Dix-Hallpike manoeuvre induces nystagmus, which is
typically torsional, upbeating with the torsional compo-
nent beating toward the lowermost ear.6 The liberatory or
Semont manoeuvre7 and other canalith repositioning
manoeuvres8,9 are used in the treatment of canalolithiasis
of the PSC.
Central vertigo is most commonly secondary to
cerebellopontine angle (CPA) tumours, cerebrovascular
disease (transient ischemic attack or stroke), migraine,
multiple sclerosis, and other demyelinating diseases.10 In
central vertigo, the nystagmus is typically spontaneous;
purely vertical, horizontal, or torsional; uninhibited by
visual fixation; and direction changing.5,11 It is usually rare
for a patient with a central lesion to present with
symptoms and signs typical of BPPV. In this report, we
present a case of CPA menigioma presenting with signs
and symptoms similar to those of BPPV.
Case Report
A man aged 51 years presented with a 1-month history of
transient, episodic spells of vertigo, lasting for a few
seconds and brought on by sudden movements of the
head. There was no associated history of nausea, vomiting,
tinnitus, or aural fullness. Also, there was no history of
previous vertiginous spells, head trauma, cerebrovascular
accidents, or metabolic diseases.
Otoscopy showed an intact and normal tympanic
membrane. Audiologic assessment revealed a high-fre-
quency bilateral symmetric sensorineural hearing loss
between 4000 and 8000 Hz with bilateral speech dis-
crimination scores of 100%. A Romberg test was normal,
and an Unterberger stepping test showed minimal
deviation to the left. Clinically, the cerebellar system was
normal. A head shake test revealed a second-degree
horizontal right-beating nystagmus that was unaffected
by visual fixation. On performing the Dix-Hallpike
manoeuvre in the left head-hanging position (30u below
horizontal and 45u head turned to the left), a clockwise
torsional nystagmus was observed after 5 to 6 seconds and
extended up to 20 to 25 seconds. The nystagmus was
reversed on bringing the patient back to the sitting
position. Videonystagmography did not show any sponta-
neous nystagmus.
A provisional diagnosis of BPPV of the left PSC was
made based on the Dix-Hallpike diagnostic manoeuvre.
Subsequently, a left PSC-BPPV Semont manouevre
was performed. This therapeutic manoeuvre did not
evoke a liberatory nystagmus (nystagmus was similar in
character to that obtained during the Dix-Hallpike
test, indicating movement of otoconia in an ampull-
ofugal direction toward the common crus and the
utricule). Postmanoeuvre, the patient continued to
Alessandro De Stefano Gruppo Otologico Piacenza-Roma and Clinica
Otorinolaringoiatrica, Universita` degli Studi ‘‘G. d’Annunzio’’ Chieti-
Pescara, Italy; Francesco Dispenza: Gruppo Otologico Piacenza-Roma,
Italy; and Giuseppe Di Trapani and Gautham Kulamarva: Gruppo
Otologico Piacenza–Roma, Piacenza, Italy.
Address reprint requests to: Alessandro De Stefano, MD, Via Di Palma
10–74100, Taranto, Italy; e-mail: dr.adestefano@gmail.com.
DOI 10.2310/7070.2008.E0018
E46 Journal of Otolaryngology-Head & Neck Surgery, Vol 37, No 2 (April), 2008: pp E46–E48
have vertigo without any improvement in symptoms.
Electronystagmography revealed a normal caloric
response. Pursuit saccade and optokinetic nystagmus were
within normal limits. As the symptoms were persistent, we
performed an auditory brainstem response (ABR) exam-
ination. This revealed an abnormal interpeak latency
between waves I and V (. 4.4 milliseconds in accordance
with the criteria of Marangos and colleagues12) in the left
ear (Figure 1). This finding suggested a not exclusive
labyrinthine pathology.
Contrast-enhanced magnetic resonance imaging (MRI)
(gadolinium) done in axial and coronal planes showed amass
of 1.7 cm occupying the left CPA (Figure 2). T1-weighted,
postcontrast images revealed homogeneous enhancement of
the mass. The lesion was suspected to be a meningioma of the
left CPA based on the MRI findings as described above, along
with the presence of a characteristic dural tail. The tumour
was completely excised by the translabyrinthine approach.
Histopathology confirmed the diagnosis of menigioma.
Postoperatively, the patient had appreciable relief of his
vertigo.
Discussion and Conclusion
Vertigo is a common and frustrating symptom for which
patients seek help from an otolaryngologist. The history,
findings from a clinical neuro-otologic examination,
characteristic pattern of nystagmus, and audiometric
results provide the clue in differentiating peripheral from
central vertigo.1 Nystagmus seen in peripheral vertigo is
either spontaneous or provoked, horizontal or torsional,
fatiguable, reversible, and inhibited by visual fixation.9,13
BPPV is the most common cause of peripheral vertigo.2
Vertigo is brought on by sudden changes in head position,
lasting for a few seconds or minutes and associated with
paroxysmal symptoms.14
In central positional vertigo, the nystagmus is often
spontaneous; purely vertical, horizontal, or torsional;
direction changing; and uninhibited by visual fixation.5,11
Common causes of central vertigo are cerebrovascular
insults, CPA tumours, multiple sclerosis, and other
demyelinating neurologic conditions.10 Among the lesions
of the CPA, vestibular schwannoma (VS) accounts for up
to 90% of the lesions, with meningiomas (10–15%)15
being the second most common neoplasm.16
Meningiomas commonly present with unilateral tinnitus
(87%) and unilateral hearing loss (75%) followed by
dizziness or vertigo (62%).17 These lesions demonstrate
similar density and intensity patterns on computed tomo-
graphy andMRI and can usually be distinguished from VS by
their shape and position.15 Meningiomas in the CPA appear
as a sessile mass on the posterior surface of the petrous bone,
with its axis eccentric to the internal auditory canal.15 In
addition, intratumoral calcification occurs in 25 to 35% of
cases and an associated dural tail is seen on contrast-
enhancedMRI in 50 to 70% of the cases.15 Both calcifications
and a dural tail may be present in VS, albeit rarely.16
Froehling and colleagues in 1991 and Franco-Vidal and
colleagues in 2005 explained the pathophysiology of this
paroxysmal positional vertigo secondary to a CPA
mass.18,19 It is present when the tumour is involving and
eroding the labyrinth, when the endolymphatic sac is
attached or compressed by the tumour, or when the lesion
Figure 1. Auditory brainstem response examination showing an
abnormal I–V interpeak latency in the left ear.
Figure 2. Magnetic resonance image axial section showing a
gadolinium-enhanced mass in the left cerebellopontine angle with
the characteristic dural tail.
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injures or stretches the vestibular nerve, as in VSs or
meningiomas.
In our patient, vertigo was probably related to the
external compression or traction on the vestibular nerve by
the tumour. Marangos and colleagues in 2001 showed that
in CPA tumours, the oto-neurologic evaluation, electro-
nystagmography, and caloric response testing can be
normal.12 The ABR evaluation was pathologic in the
present case, but prospective studies comparing ABR and
MRI for the screening of CPA tumours suggest abandon-
ing the ABR as a screening test for CPA tumours.20
Further, Ruckenstein and colleagues in 1996 showed that
the sensitivity of the ABR is only 63%.21 Gizzi and
colleagues indicated that the probability that a patient with
dizziness has a CPA mass is 0.004 or only 1 in 2500 cases.22
However, the repeated failure of repositioning man-
oeuvres and the persistence of the signs and symptoms of
vertigo, along with unilateral hearing loss, warranted
exclusion of a CPA tumour presenting with peripheral
positional vertigo. MRI is the best option in suspected
cases of intracranial tumours because of its superiority in
visualizing the CPA, where most central nervous tumours
causing vertigo exist. Once the lesion is identified to be a
possible meningioma, complete removal of the tumour is
desirable. Even though the coexistence between intracra-
nial tumours and BPPV is reported,23 our patient’s
postoperative improvement in vertigo after surgical
treatment may exclude this aspect.
Intracranial tumours may occasionally present as
peripheral positional vertigo. Failure to conclusively treat
such conditions by repositioning manoeuvres, even in the
presence of normal otoneurologic and audiologic evalua-
tions, warrants further radiologic investigation to exclude
any intracranial pathology.
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Management of benign paroxysmal positional vertigo of lateral
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Abstract Benign paroxysmal positional vertigo (BPPV) of lateral semicircular canal (LSC) is one of the rarer
forms of BPPV as compared to posterior semicircular canal BPPV. Various particle repositioning
manoeuvres have been described in the literature as a mode of treating this condition.
Purpose: Evaluation and discussion of the procedure of the Gufoni's manoeuvre and its advantages
in the treatment of BPPV of LSC.
Material and methods: Prospective study of 58 patients affected by LSC BPPV who were office-
treated with Gufoni's manoeuvre.
Results: Seventy-nine percent of the patients so treated had complete resolution of symptoms, and
6.9% did not show any improvement in their symptoms. The remaining 13.8% had a conversion into
posterior semicircular canal BPPV during treatment and were successfully treated with Epley's or
Semont's manoeuvre.
Conclusions: Gufoni's manoeuvre is effective in treating patients suffering from BPPVof LSC; it is
simple to perform; there are not many movements to execute, it needs low time of positioning, and
positions are comfortable to the patient.
© 2009 Elsevier Inc. All rights reserved.
1. Introduction
Any patient presenting with history of vertigo is a
challenge for the ear, nose, and throat (ENT) specialist.
Vertigo affects the patients both physically and psychologi-
cally as it becomes impossible for the patient to go through
daily routines of life without external help from others. Many
of these patients are usually managed by primary care
physicians medically for a long time before they are referred
to an ENT surgeon. Because of this reason, they have to go
through several unnecessary diagnostic procedures before
arriving at a diagnosis or being referred further to a specialist
centre. Fortunately, in patients affected by vertigo crisis due
to benign paroxysmal positional vertigo (BPPV), correct
diagnostic evaluation and appropriate management allows,
in the great number of cases, to solve the problem quickly,
without the need for any medical treatment.
Benign paroxysmal positional vertigo is the most
common cause of peripheral vertigo [1]. It accounts for
approximately 24% of all cases of peripheral vestibular
disorders [2]. This type of vertigo is generally seen in
individuals aged 40 years and older with the highest age
distribution between 50 and 70 years [3]. The exact etiology
of BPPV is still under debate. More than 50% of all reported
cases are idiopathic in nature [4]. Classic BPPV involves the
posterior semicircular canal (PSC) and represents the most
common type of BPPV [3,5-7]. Lateral semicircular canal
(LSC) BPPVaccounts approximately for only 10–20% of all
the patients presenting with BPPV [8]. In addition, treatment
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of LSC BPPV has got a lower success rate of between 60%
and 90% as compared to PSC BPPV. Nuti et al [7] reported a
success rate of 71% with barbecue rotation and 73% with
forced prolonged position in patients with LSC-BPPV. Fife
showed that 75% in 24 patients responded to the canalolith
repositioning maneuver [8,9].
Diagnosis of BPPV is based mainly on a history of
characteristic positional vertigo along with the classical
clinical signs. Symptoms are similar for BPPV of LSC and
PSC characterized by rotating vertigo with nausea and
vomiting, elicited by movements of the head (when rising up
or when lying down). The nystagmus typically has a latency
(of few seconds) and is of limited duration, transient,
fatigable, and reversible on return to upright position [5].
Patients of LSC BPPV have traditionally been treated
with various particle repositioning manoeuvres. Therapeutic
head-shaking, as suggested by Vannucchi et al [10],
Lempert's so called “barbecue rotation” [11], Baloh's
modification of the same with 360° rotation [3], Vannucchi's
forced prolonged position or FPP [12], Epley's 360° rotation
suggested in 1995 [13] and modified Semont's manoeuvre
are few of the various treatment modalities currently being
followed in treating this condition [14]. Gufoni [15] proposed
a repositioning manoeuvre based on the hypothesis of the
presence of free-floating debris with a higher density than
endolymphatic fluid in the anterior arm of the horizontal
semicircular canal [16]. This manoeuvre has the advantage
of simplicity while maintaining the efficacy in treating this
condition. We studied 58 patients having horizontal
semicircular canal BPPV who were treated with Gufoni's
manoeuvre.
The aim of our study was to evaluate the efficacy of
Gufoni's manoeuvre in office management of patients
affected with BPPV of LSC.
2. Materials and methods
We prospectively studied 58 patients (23 men and 35
women), aged between 27 and 81 years, presenting with
BPPV secondary to LSC in the period 2001–2004. The
inclusion criteria were as follows: first-time diagnosis of
BPPVof LSC, no previous medical treatment for vertigo, no
history of chronic ear disease. We study only geotropic
variant of LSC BPPV. All patients diagnosed and managed
in the emergency department were excluded from the
present study.
All the patients underwent ENT and head and neck
examination, posture evaluation, pure tone audiometric test,
impedance, and stapedial reflex study. Spontaneous nystag-
mus was assessed with Frenzel's glasses in the seated
position, with head rotated to right and to left, in the supine
position, and in the Rose' position (patient lay in supine
position with the head falling down over the end of a table).
Evoked nystagmus was evaluated by Dix-Hallpike's
Fig. 1. Position 1, patient seated on the examination couch with both the legs
hanging out from the same side, arms held close to the body and hands
resting on the knees.
Fig. 2. Position 2, patient is then made to lie down on the uninvolved lateral side with a quick lateral movement and maintained in this position for 2 minutes until
the end of evoked geotropic nystagmus.
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manoeuvre [17] and by Pagnini's manoeuvre (patient in
supine position and quick rotation of the head to right and to
left) [10] in order to identify the involved semicircular canal.
After ruling out other possible causes for the patients'
symptoms, a diagnosis of LSC was arrived at.
Once the patients were diagnosed with BPPV of LSC,
they were managed by Gufoni's manoeuvre.
Before performance of the treatment, an informed consent
was obtained from each patient and the institutional ethical
commission approved the procedure. This included putting
Fig. 3. Position 3, quick 45° rotation of the head towards the floor, position being maintained for 2 minutes.
Fig. 4. Position 4, slow return back to the starting position.
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the patients through the following positions: (1) patient
seated on the examination couch with both the legs hanging
out from the same side, arms held close to the body, and
hands resting on the knees (Fig. 1); (2) patient is then made
to lie down on the uninvolved lateral side with a quick lateral
movement and maintained in this position for 2 minutes until
the end of evoked geotropic nystagmus (Fig. 2); (3) quick
45° rotation of the head towards the floor, position being
maintained for 2 minutes (Fig. 3); (4) slow return back to the
starting position (Fig. 4).
Gufoni's manoeuvre was executed twice, and after this,
the patients were reevaluated. The presence of attenuated
vertigo, or persistence of nystagmus, implies the need for a
repetition of the manoeuvre. At the end of the treatment,
patients were discharged home. Postural restriction, even
during night, was not advised. First clinical follow-up was 3
days after the procedure. Patients were further followed up
on 2 more occasions, at the end of the first week and again at
3 months after the initial procedure.
Our institutional review board reviewed and approved the
present study, and an informed consent was obtained from all
patients before treatment.
3. Results
In 46 patients (79.3%) we obtained a complete resolution
of vertigo and nystagmus after the first session (Table 1).
This improvement was maintained up to the last clinical
review. In all these patients a slight sensation of unsteadiness
was present for two weeks after the treatment, which
however resolved completely, spontaneously. Eight patients
(13.8%) had a conversion to PSC canalolithiasis during the
treatment, and those patients were managed promptly with
Epley's manoeuvre (6 cases) or Semont's manoeuvre (2
cases) with resolution of symptoms. Four patients (6.9%) did
not have any benefit after the treatment. They were advised
Vannucchi's positions with resolution of symptoms subse-
quently, after several weeks.
4. Discussion
Etiology of BPPV is not always related to a definite cause
and may be a sequelae of several inner ear diseases such as
posttraumatic, viral, and vascular causes, as is described in
the literature [18]. However, 70% of cases are thought to be
idiopathic. Currently, the hypothesis that is widely accepted
is that of displacement of otoliths from the utricular macula
and consequent deposition of these fragments in the LSC or
PSC. These otoliths provoke a piston-like mechanism of
action on endolymph flowing from or toward the ampullae,
causing activation or inhibition of the canals respectively
[19]. Diagnosis of LSC BPPV is based on the history and
features of the positioning nystagmus provoked by a quick
turn of the head to either side with the patient lying supine.
The characteristics of the positioning nystagmus leading to a
diagnosis of LSC BPPV have been well summarized by
Ciniglio Appiani et al [16] as having the following features
typically: (1) very short latency (a few seconds), (2)
paroxysmal character, (3) duration b1 minute, (4) purely
horizontal (geotropic or apogeotropic direction changing)
position and greater intensity on one side, and (5) not
fatigable with repeated positioning.
Various manoeuvres have been proposed for the treatment
of LSC BPPV. Most of these manoeuvres constitute quickly
rolling the supine patient towards the unaffected side. This is
thought to shift the otoconial debris out of the nonampullated
end of the horizontal canal into the utricle [16]. Gufoni
introduced a manoeuvre for treating LSC BPPV in 1998. The
advantage of this manoeuvre was that, apart from showing
very good results in geotropic LSC BPPV, it can be
conducted even in patients with cervical spondylosis and
obesity. This brisk deceleration manoeuvre was based on the
rationale that the otoconial debris is moved from the lateral
semicircular canal to the utricle, exploiting its inertia and
correct disposition in the canal outlet, obtained by correct
positioning of patient's head [12].
Based on this theory, the lateral decubitus position on the
affected side should give rise to migration of otolithic debris
to the posterior end of the lateral semicircular canal with a
concomitant flow of endolymph toward the ampulla. This, in
turn, causes activation of the hair cells with resultant vertigo
and geotropic nystagmus. The rotation of the patient to the
unaffected side should give rise to a reversal of flow with
posterior migration of the otoliths and an inhibitory
endolymphatic flow. In this case, the vertiginous symptoms
are not as severe as in the precedent one, and also, the
nystagmus is less intense. This pathophysiologic mechanism
has 2 possible explanations: (1) Pagnini, in accordance with
the Ewald's laws, suggested that after intense accelerations
the excitatory stimulus is much more strong respect to
inhibitory one [18]; (2) Baloh et al [4] hypothesized that
otoliths present in the posterior arm of the LSC are placed in
an asymmetric fashion and, consequently, the amplitude of
its movement is different on assuming lateral decubitus
posture on the affected and unaffected side, symptoms and
nystagmus being much more intense on the affected side.
Gufoni's manoeuvre consists of the following steps (1)
the patient sits on the edge of the bed; (2) the patient is made
to lie down suddenly on one side: for geotropic LSC-BPPV,
the patient lies on the healthy side, in the apogeotropic form
on the affected side; (3) patient's head is rotated 45°
Table 1
Outcome of treatment of BPPVof LSC by Gufoni's manoeuvre
Patients Outcome
46 (79.3%) Complete resolution
8 (13.8%) BPPV of PSC conversion
4 (6.9%) No benefits
58
BPPV: benign paroxysmal positional vertigo; LSC: lateral semicircular
canal; PSC: posterior semicircular canal.
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downward and held for 2–3 minutes; (4) patient returns to
sitting position; (5) outcome of the manoeuvre is checked.
Vannucchi et al. [12] quoted a success rate of 96% for
geotropic LSC BPPVand 77% for apogeotropic LSC BPPV.
No side effects were observed in any of the 174 cases studied
by them. Ciniglio Appiani et al [16], in their case review,
quoted 100% success in 32 patients of geotropic LSC BPPV,
treated with this manoeuvre, after 2 attempts. In comparison,
we had an overall success of 93.1% in our patient population
studied. In the first instance, 48 patients (79.3%) improved.
The 8 patients (13.8%) whose vertigo was converted into a
PSC BPPV had their vertigo corrected with Epley's
manoeuvre or Semont's manoeuvre (Table 2). The remaining
4 patients (6.9%) who did not benefit from this manoeuvre
were advised Vannucchi's forced prolonged position with
which their symptoms resolved subsequently. All the
patients complied well with our treatment, and there were
no dropouts. In addition, we didn't observe any adverse
effects of this manoeuvre on any of our patients.
Gufoni's manoeuvre is believed to clear the nonampullary
arm of the LSC from otoliths using gravity and inertia of the
particles. The quick variation from seated position to lateral
decubitus on the unaffected side, putting the LSC on a
vertical plane, causes movement of otolithic debris towards
the nonampullary end of the canal. The subsequent 45°
downward head rotation moves the otoliths, by inertia, into
the utricle [15]. One of the main advantages of this
manoeuvre is its acceptability to the patients. This is because
the patients are made to roll on to the unaffected side, making
it more readily acceptable. This also helps to keep the
dropout rates very low [12]. It is possible to execute the
Gufoni's manoeuvre under videonystagmographic control in
order to evaluate step by step the nystagmus and verifying
the efficacy of the several positions as suggested by Asprella
et al [2]. In situations where the patient is having neck pain/
stiffness and severe neurovegetative symptoms such as
vomiting, causing them to refuse this treatment; in very
elderly patients; and also in severe obesity, repositioning the
manoeuvre may be difficult to perform. In these patients who
are unable to tolerate the positional manoeuvres or in whom
the treatment is unsuccessful, vestibular suppressant drugs
and vestibular rehabilitation may be used [14].
5. Conclusion
Gufoni's manoeuvre is effective in treating patients
suffering from BPPV of LSC and offers significant
advantages. It is simple to perform; there are not many
movements to execute, it needs low time of positioning,
and positions are comfortable to the patient. Because of
these favorable features, there are not many contra-
indications for its reasonable application in any patient.
In our experience, we obtained good results in 79%
(overall 93.1% after including the PSC-PPV converted
patients) of the patients studied, and only 6.9% of patients
did not have any benefit with this treatment. The clinical
evidence, from the application of Gufoni's manoeuvre,
allows considering its use as the treatment of first choice
in cases of BPPV of LSC.
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Imaging Case of the Month
Imaging of Cervical Lymph Node Metastases in
Malignant Jugular Paraganglioma
Imaging of Paraganglioma Metastases
*†Francesco Dispenza and †Maurizio Falcioni
*Dipartimento Scienze Otorinolaringoiatriche, Universita` degli Studi di Palermo, Palermo;
and ÞGruppo Otologico, Piacenza, Italy
Tympanojugular paragangliomas are the most common
tumors of the skull base. Magnetic resonance imaging is
the gold standard for radiologic study, with a characteristic
salt-and-pepper pattern on T1-weighted images with
gadolinium enhancement. Angiography is needed to
visualize the feeding vessels to perform preoperative
tumor embolization. The typical angiographic appearance
of a paraganglioma is that of a hypervascular mass with
enlarged feeding arteries, intense tumoral blush (due to
intratumoral vascular shunts), and early draining veins (1).
Metastases from jugular paragangliomas are relatively
rare, in contrast with vagal paragangliomas (incidence
varies between 1Y4%), and are the main manifestation
of malignant behavior (2). The metastases show the same
angiographic pattern as that of primary tumor.
The present case describes a patient with left tympano-
jugular paraganglioma and a left-sided mass in the neck.
Magnetic resonance imaging T1-weighted images
after gadolinium enhancement revealed a primary lesion
involving the left jugular foramen with dura involvement
and a neck mass located between the posterior belly of
digastric and the sternocleidomastoid muscles (Fig. 1).
The common carotid artery arteriography showed a
blush of the jugular foramen mass and of the neck lump
with similar features (Fig. 2A). A selective arteriography
of occipital artery was performed, revealing an enlarged
branch of occipital artery as the main feeding vessel of the
metastases (Fig. 2B).
The histopathologic diagnosis was malignant para-
ganglioma with lymph node metastases.
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FIG. 1. Magnetic resonance coronal image T1 weighted with
gadolinium enhancement displays a left-sided neck mass (white
arrow) between the posterior belly of the digastric muscle and the
sternocleidomatoid muscle, with a mild contrast enhancement.
FIG. 2. A, Arteriography of the left common carotid artery shows
a blush in the lesion of the left jugular foramen and also of the
neck mass. B, Selective arteriography of the left occipital artery
that demonstrates the enlarged feeding vessel of the neck lesion.
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Imaging Case of the Month
Imaging of Vestibular Schwannoma With Prevalent
Cystic Component: Cystic Vestibular Schwannoma
*Francesco Dispenza and †Alessandro De Stefano
*Dipartimento Scienze Otorinolaringoiatriche, Universita` degli Studi di Palermo, Palermo; and
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Studi BG. d’Annunzio[ Chieti-Pescara, Italy
Cystic vestibular schwannomas (VSs) are described as
behaving in a more aggressive fashion, with shorter pe-
riods of documented symptoms, poorer responses to
radiotherapy, and worse outcomes from surgical inter-
vention (1).
These factors include higher rates of engulfment of
neurovascular structures, the association with hypervas-
cular solid components, and the absence of an adequate
subarachnoid dissection plane.
Recommendations from BNew and Modified Report-
ing Systems from the Consensus Meeting on Systems for
Address correspondence and reprint requests to Francesco Dispenza,
M.D., Via paolo emiliani giudici, 37, 90127 Palermo, Italia; E-mail:
francesco-dispenza@libero.it
Institution where work was done was Gruppo Otologico Piacenza.
FIG. 1. T1-weighted image of the right cystic VS of the internal
auditory canal and cerebellopontine angle. The solid portion of
the tumor is hyperintense after Gd administration. The cyst con-
tent is hypointense as compared with the brain. Enhancement of
the cyst capsule is noticeable.
FIG. 2. T2-weighted image with standard TR. The cyst content
is displayed with the same intensity as the CSF. The solid portion
seems isointense as the brain.
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Reporting Results in Vestibular Schwannoma[ suggested
that multicystic tumors with a cystic component on the
surface of the tumor be documented to facilitate clinical
studies (2).
We report a case of right-sided cystic VS of the inter-
nal auditory canal and cerebellopontine angle with prev-
alent cystic component.
Magnetic resonance imaging represents the best
choice to diagnose and visualize the VSs. Cystic VSs
consist of 2 components: 1) a solid portion and 2) a
single or multiple cysts. Intravenous administration of
gadolinium (Gd) allows visualization of tumoral solid
component.
The solid portion of the tumor seems hyperintense in
T1-weighted images with Gd (Fig. 1) and hypointense in
T2-weighted images (Fig. 2). The cystic component is
displayed hypoisointense in T1-weighted images with
Gd (Fig. 1) and hyperintense in T2-weighted images
(Fig. 2). The cyst content can be distinguished from cere-
brospinal fluid (CSF) by variation of the time of re-
petition (TR) value in T2-weighted slice. This variation
has an important effect on the control of image contrast
characteristics (Fig. 3).
Tumors with cystic component have to be differen-
tiated from CPA epidermoids and subarachnoid cysts.
These latter 2 lesions are hypointense in T1 and hyper-
intense in T2 and do not enhance after Gd administration.
Fluid-attenuated inversion recovery and echo-planar
diffusion imaging are 2 kinds of sequences that can dis-
tinguish between epidermoids and arachnoid cysts (3).
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FIG. 3. T2-weighted image with modified TR. The cyst content
seems hypointense as compared with CSF, allowing differential
diagnosis with arachnoid cysts.
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Abstract Objective: The aim of the study is to review the management of petrous apex cholesterol granuloma.
The surgical approaches for drainage or total removal and the wait and see policy were analyzed, and
outcomes were evaluated.
Methods: Retrospective charts of 27 patients managed for petrous apex cholesterol granuloma with
a minimum follow-up of 12 months were analyzed in a quartenary skull base center. Presenting
symptoms and signs were recorded, and radiologic imaging was evaluated. Management options
included wait and see policy and surgery by several approaches.
Results: The mean age of patients affected by the lesion was 38.8 years. The mean follow-up was
56.7 months. Patients complained of hearing loss, vertigo, tinnitus, diplopia, hemifacial spasm,
trigeminal neuralgia, and facial paresthesia. Twelve patients were managed by wait and see policy,
and in this category, only one lesion showed growth during the follow-up. Depending upon size and
location, 15 patients were surgically treated by infralabyrinthine approach (9 patients), infratemporal
type B approach (3 patients), combined infratemporal type B transotic approach (2 patients), and
transotic approach (1 patient). One recurrence was recorded during the follow-up.
Conclusions: Radiologic evaluation is required for diagnosis and management. Patients with good
hearing can be treated by infralabyrinthine approach. Infratemporal fossa type B approach is
advocated in patients with extensive disease and internal carotid artery involvement. Wait and see
policy is recommended for asymptomatic cases. Drainage and permanent ventilation are the goals
of treatment. Complete removal is indicated in selected cases where placement of drainage tube is
not feasible.
© 2009 Elsevier Inc. All rights reserved.
1. Introduction
Cholesterol granuloma (CG) of the petrous apex (PA) is a
rare, benign expanding lesion, which was defined by
Graham [1] as a distinct clinical entity. This lesion has
been reported throughout the temporal bone—middle ear,
mastoid, and PA [2]. It consists of a cyst with a thick fibrous
capsule filled with a brown fluid formed by degradation of
blood elements as follows: globular material, lipids, and
cholesterol crystals. In literature, 2 mechanisms to explain
the possible origin are described, having a common basis—a
foreign body giant cell reaction. The first theory is based on
extravasation of intravascular fluid into the mucosa of the air
cells, leading to occlusion of pneumatized temporal bone
cells. The gas present in the cells are gradually reabsorbed
leading to a vacuum, negative pressure leads to hemorrhage
into the air cells and the following degradation of
hemosiderin, and cholesterol stimulate an inflammatory
granulomatous reaction [3,4]. The progressive expansion of
the mass results in erosion of the surrounding bone. This
theory was reviewed by Jackler et al [3], who described an
alternative mechanism of subacute hemorrhage based on
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erosion of marrow-filled cavities of PA by the development
of air cells, particularly in highly pneumatized petrous
apices. This hypothesis supports better the more aggressive
form of CG of the PA, in which a significant hemorrhage is
necessary to explain the rapid growth [5].
The clinical presentation of patients having PA CG may
vary depending on the extension; the symptoms do not occur
until it has become relatively large. Hearing loss and vertigo
are present in one third of cases, followed by tinnitus and
otalgia. Frequently, trigeminal neuralgia and diplopia are
present. Abnormal facial sensation and facial spasm are also
reported [6,7]. Other symptoms encountered are headache
and, occasionally, seizures. Surgery by means of different
approaches described [7] represents the mode of elective
management in large cases with or without symptoms.
The aim of this article is to present our series of patients
affected by PA CG and to discuss surgical management with
the review of the literature.
2. Materials and methods
Of almost 2500 skull base procedures performed in our
quaternary referral center, we retrospectively reviewed 29
charts of patients affected by PA CG, managed between 1998
and 2007. Patients included in the study had at least
12 months of follow-up. Two patients were excluded from
the study because of incomplete follow-up. The presenting
symptoms were recorded in all cases. All patients underwent
head and neck examination and audiological evaluation.
Pure tone average (PTA) (0.5, 1, 2, 4 kHz) was recorded for
air and bone conduction. Computed tomography (CT) and
magnetic resonance imaging (MRI) with and without
gadolinium were obtained in all cases preoperatively and
postoperatively and during follow-up. In all surgically
managed cases, a lateral skull base approach was adopted.
Facial nerve function was assessed preoperatively and
postoperatively and at the last visit and was reported in
accordance with House-Brackmann (HB) grading scale [8].
The English literature review was conducted through
PubMed engine search. In the literature search, we included
all studies concerning PA CG (Table 1). We excluded work
Table 1
Surgical approaches reported in the literature
Authors Year Pts Age,
mean
FU, mean,
mo
Surgery Rec WS
IL IC TM MCF P TO TL SO TS IFTB
Gherini 1985 9 49 NA 5 1 3 1
Graham 1985 4 36 NA 3 1
Thedinger 1989 12 47 47 3 2 1 4 5 2
Goldofsky 1991 9 45 NA 7 1 1 1
Brodkey 1996 17 47 29 8 2 1 6
Eisenberg 1997 14 39 36 8 2 4
Cristante 2000 8 45 60 8
Brackmann 2002 34 41 60 7 18 7 1 1 5
Mosnier 2002 12 36 18 5 2 1 4
Sanna⁎ 2008 27 38 56 9 3† 5† 1 12
Pts indicates patients; FU, follow-up in months; TM, transmastoid; P, petrosal approach (not specified); SO, suboccipital; TS, transsphenoidal; Rec, recurrences;
WS, wait and see policy.
⁎ Present study.
† In 2 cases, IFTB was combined with TO.
Fig. 1. Magnetic resonance fast spin echo sequences of patient affected by
left PA CG, managed by wait and see policy. (A) Computed tomography of
year 2005. (B) Magnetic resonance scan of year 2008.
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done in the same institute and case reports, to avoid
duplication of cases. Our institutional review board approved
the present study, and an informed consent was obtained
from each patient.
3. Results
The study includes 27 patients. Left side was involved in
15 cases and right side in 12 patients. Thirteen patients were
male and 14 were female, with mean age of 38.8 years
(range, 12–57 years) at the time of diagnosis. The mean
follow-up was 56.7 months (range, 15–112 months).
In 12 of 27 patients, imaging was done for symptoms not
related with PA CG (10 patients had chronic rhinosinusitis),
and its diagnosis was incidental. All patients at diagnosis
were asymptomatic and were managed conservatively.
During follow-up with imaging, no evidence of growth
was noted in all but one patient (Fig. 1A, B). One patient,
who had growth of lesion on follow-up, refused surgical
management. All patients to date are free of symptoms.
The hearing loss was the most common symptom and was
present in 9 patients. Four patients had vertigo and tinnitus.
Four patients complained of headache. Symptoms due to
cranial nerve deficit were also present. Six patients had
diplopia, and hemifacial spasm was present in 1 patient.
Trigeminal neuralgia occurred in 1 case and facial
paresthesia in 2 cases. One patient who underwent 2
previous operations in other center had otorrhea.
The audiological assessment of patients having hearing
loss revealed that 2 patients did not have functional hearing
preoperatively and in the remaining 7 patients, who had
sensorineural hearing loss, the mean PTAwas 55 dB (range,
25–80 dB).
The diagnosis of PA CG was done after radiologic
investigation with CT scan and MRI with and without
gadolinium (Table 2). In all patients, CT scan showed a PA
lesion, isodense with brain, with a variable degree of bone
erosion of the petrous bone and the clivus. The MRI scans
were obtained in all patients showing the typical character-
istics of hyperintensity on T1-weighted with and without
contrast enhancement and T2-weighted images (Fig. 2A). The mean size of largest diameter was 27.6 mm (range,
20–45 mm). Fifteen patients were treated by surgery as
summarized in Table 3.
An infralabyrinthine (IL) approach was performed in
9 patients (Fig. 2A, B). In 2 patients, complete removal of
the cyst was achieved by combined transotic (TO) and
infratemporal type B (IFTB) approaches (Fig. 3A, B).
Three cases were treated by an IFTB approach because of
extension of disease toward intrapetrous carotid artery and
serviceable hearing. In 2 of these patients presenting with
3.8 and 3-cm lesions, respectively, extending from the
internal auditory canal to the sphenoid sinus, medially to
the ICA, the IFTB approach was combined with a
temporal-zygomatic craniotomy. This approach was used
to control the intrapetrous carotid artery, which was
Fig. 2. Representative case with preoperative and immediate postoperative
MR. (A) Magnetic resonance fast spin echo sequence displaying a high-
signal image of a left expanding lesion of the PA. (B) Immediate
postoperative MR T1-weighted image displaying a correct position of the
drainage tube and presence of some postoperative secretion, which can be
differentiated from CG because of low-signal intensity. The high-signal rim
around the cavity, which represents the capsule of the CG, is seen.
Table 2
Differential diagnosis on imaging of nonenhancing cystic lesion of
cerebellopontine angle and PA
CT MR
T1 T2/FSE FLAIR
Epidermoid
cyst
Hypodense
or isodense
Hypointense Hyperintense Hyperintense
Arachnoid
cysts
Hypodense Hypointense Hyperintense Hypointense
Cholesterol
granuloma
Isodense Hyperintense Hyperintense Hyperintense
T1 indicates T1-weighted images; T2, T2-weighted images; FLAIR, fluid
attenuated inversion recovery; FSE, fast spin echo.
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displaced anteriorly to allow complete removal of the cyst
from the clivus and sphenoid sinus.
One patient had undergone 2 previous surgeries in
another hospital—an IL drainage and a revision procedure
1 year later; the patient after the second operation had total
hearing loss and had ear discharge and tinnitus in following
3 years. He was surgically treated in our center by a TO
approach, to drain the PA lesion, and iatrogenic cholestea-
toma of the mastoid was found during the operation.
Intraoperative cerebrospinal fluid leak occurred in 2
cases, managed by IL approach. In one case, a small
posterior fossa dura lesion was managed by the cavity
obliteration with abdominal fat at the time of the surgery;
in another case, cerebrospinal fluid leak occurred due
to accidental opening of the cochlear acqueduct. This was
managed by the obliteration of the duct with muscle
and periosteum.
In one case managed by TO + IFTB approach, a small
opening of internal carotid artery (ICA) wall, at the anterior
foramen lacerum, occurred. Because of difficulty in control-
ling the distal portion of the ICA, we opted for immediate
packing of the whole cavity with surgery. An evaluation of
the efficacy of the collateral circulation in maintaining the
perfusion of the areas that would be affected by the
manipulation of the ICAwas done, and the definitive closure
of the vessel was made by endovascular balloon 2 days later.
Immediate postoperative facial nerve palsy was noted in
4 patients. In 2 patients managed by IFTB approach, HB
grade V palsy was present. In 1 patient after IL drainage, HB
grade II deficit was noted, and in another patient with
balloon occlusion of the carotid artery, a HB grade VI was
noted. After 31 months of follow-up, HB grade II facial
deficit was noted in 2 patients managed by IFTB; in other
patients, facial nerve was normal at last follow-up.
The hearing results were good in patients managed by IL
approach, with no change between preoperative and post-
operative PTA. In 3 patients managed by IFTB approach, we
could save sensorineural hearing in 2 patients, whereas it was
lost in the other. In all patients managed by IFTB, the
masticatory function was normal.
Of 5 patients, presenting with preoperative diplopia and
managed by IL approach, 2 had complete recovery of cranial
nerve VI function, in the immediate postoperative period.
Two cases had complete recovery of nerve VI after 1 year
of operation.
One patient with more than 3-cm lesion, which was
managed by IFTB approach, complained of disequilibrium
even after 35 months of follow-up.
Only one recurrence was noted during follow-up, but the
patients refused reintervention, and he is being managed with
wait and scan policy.
4. Discussion
The term cholesterol granuloma indicates a foreign
body, giant cell inflammatory reaction to blood degrada-
tion products. It can be found inside air cells of temporal
bone, that is, middle ear, mastoid, and less commonly into
PA air cells.
Petrous apex CGs must be differentiated from the
disease of middle ear and mastoid. There is no evidence of
association of middle ear obstructive disorders and
development of this pathologic condition. Furthermore,
Table 3
Clinical and surgical details of patients surgically treated in the present study
Patients Clinical evaluation Surgery Follow-up
Age Sex Side Symptoms PTA (dB) Approach Complications Months Symptoms PTA (dB)
1 19 M R HL 25 IL 110 25
2 36 M R Diplopia 20 IL Intraoperative CSF leak 106 20
3 48 M R Diplopia, HL, hemifacial spasm 80 IFTB Intraoperative ICA bleeding,
FN palsy HB grade VI
22 FN palsy HB grade
II, diplopia
DE
TO
4 25 M L Headache, diplopia 20 IL 112 20
5 22 F L Diplopia 20 IL 93 20
6 44 M L Vertigo, HL, tinnitus 45 IL 60 45
7 42 M R Facial numbness 20 IFTB⁎ FN palsy grade 5 HB at discharge 45 FN HB grade I 20
8 28 F R DE 120 IFTB 70 DE
TO
9† 38 F L Otorrhea, tinnitus, DE 120 TO Intraoperative CSF leak 40 DE
10 52 F R HL, tinnitus, vertigo 45 IL FN palsy grade 2 HB at discharge 68 FN HB grade I 45
11 40 F L Diplopia, headache, vertigo 25 IL Cochlear acqueduct injury 34 25
12 41 M L Headache, vertigo 20 IFTB 20 Dizziness 20
13 51 M R HL, tinnitus, facial numbness 75 IFTB⁎ FN palsy HB grade V 31 FN palsy HB grade II DE
14 57 M L HL 65 IL 25 65
15 34 M L Diplopia, headache, trigeminal
neuralgia, HL
45 IL 15 45
M indicates male; R, right; HL, hearing loss; CSF, cerebrospinal fluid; FN, facial nerve; DE, dead ear; L, left; f, female.
⁎ IFTB enlarged with temporal-zygomatic craniotomy.
† Two previous operations by IL approach in another center; an iatrogenic cholesteatoma was found.
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many patients with persistent eustachian tube dysfunction
and middle ear effusion have early arrest of development
of pneumatization and thus do not have apical air cells.
Petrous apex CG arise in extensively pneumatized
temporal bone [9].
Presenting symptoms are related to size and structures
involved. In the series of Brodkey [10], dizziness was the
main symptom. Trigeminal nerve and cranial nerves VI and
VII may be also involved, causing facial paresthesia,
diplopia, and facial weakness, respectively. The cranial
nerve VIII is involved by extension of the disease into IAC
(Table 4).
Differential diagnosis of PA lesions includes PA effusion,
petrous bone cholesteatoma (apical location according to the
classification by Sanna [11]), chondromas, chondrosarco-
mas, arachnoid cysts, and vascular malformations. Diagnosis
requires imaging studies with both CT scan and MR with
gadolinium enhancement. Cholesterol granuloma is none-
nhancing in both imaging methods (Table 2). In CT images,
the margins of the lesions are sharp with bone erosion
present frequently. The loss of the trabeculae of the air cells
differentiates CG from PA effusion [12]. The contralateral
PA is often well pneumatized in PA CG. The MR is
diagnostic with high signal on T1-weighted images, on T2-
weighted images, and in all spin echo sequences, with few
exceptions due to maturity of the granuloma, which helps in
differential diagnosis with cholesteatoma and other tumors
[13-16].
There are 2 strategies to treat PA CG as follows: wait and
see policy and surgical treatment (Tables 5 and 6). The first
option is recommended to asymptomatic patients who are
diagnosed incidentally by imaging, for those symptomatic
who have poor general conditions or elderly age. Patients
managed conservatively undergo serial radiologic evaluation
with MR/CT imaging. The surgical treatment is advised to
patients with symptomatic disease and patients having
Table 4
Symptoms present in patients affected by PA CG reported in literature and
percentage
Symptoms in PA CG n %
Hearing loss 60 50
Vertigo 58 48.3
Tinnitus 44 36.6
Headache 39 32.5
Trigeminal symptoms 30 25
Diplopia 20 16.6
Facial weakness 21 17.5
Patients evaluated 120
Table 5
Flow chart of our treatment algorithm for asymptomatic PA CG
Fig. 3. Image of representative case of patient managed by IFTB approach.
(A) Magnetic resonance coronal T1-weighted scan showing a huge right
hyperintense expanding lesion spreading into sphenoid sinus and in direct
contact with brain. (B) Three-year postoperative CT showing the cavity
obliterated by soft tissue. The black arrow shows the ICA.
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cranial nerve deficit and/or extensive lesions. Several
approaches have been proposed in literature through lateral
skull base and transnasal-transsphenoidal route [7,17,18].
However, the choice of surgical approach is based on
preoperative hearing status, location, extension of the lesion,
relationship with neurovascular structures, and anatomical
variations (eg, high jugular bulb).
Eisenberg [19] proposed the total cyst wall removal by
middle cranial fossa (MCF) approach and obliteration
of the cavity with pedicled temporalis muscle flap to
avoid recurrences. Cristante et al [6] described a “key-
hole” MCF approach to drain or remove CGs (Table 1).
We do not advocate these approaches because of limited
control of the ICA and difficulty to place a drain through
this approach to establish a permanent aeration of the
cavity if total removal is not realized. Furthermore, the
“keyhole” MCF approach limits the surgical field, putting
at risk a dehiscent ICA with subsequent difficulty to
control bleeding.
The suboccipital approach has been advocated by some
authors [17,20,21]. This approach does not provide perma-
nent drainage and ventilation; thus, it becomes mandatory
that the total removal of the cyst should be accomplished.
Chemical meningitis is a risk, due to contamination of the
subarachnoid spaces by the fluid content of the cyst. This
approach is not generally recommended but was adopted by
some authors for the lesion isolated in the area near to the
internal auditory canal with high possibility of complete
excision [20].
Keeping in mind that the objective of operation is
drainage and the ventilation of the cavity, in case of
preoperative serviceable hearing, IL and infracochlear (IC)
approaches are suggested because of low complication rate
and good postoperative hearing. In 1982, House and
Brackmann [22] were first to report results using a
transmastoid approach to drain a PA CG into middle ear
cleft. Infralabyrinthine approach requires a postauricular
incision with a complete mastoidectomy. Infralabyrinthine
cells, which are limited by sigmoid sinus, third portion of
the facial nerve, posterior semicircular canal, and jugular
bulb, are opened. In our opinion, the IL approach is the
best option because of no work on ossicular chain, the
drainage tube is positioned in the mastoid cavity far from
eardrum, no risk for the ICA and revision surgery is easy
by postauricular incision. Reported complications include
sensorineural hearing loss and facial nerve injury [20].
Infracochlear approach was strongly supported by House
Ear Institute in Los Angeles (CA) [7,23,24] (Table 1). This
approach provides adequate access to the PA, but requires
maneuvers on tympanic membrane, enlargement of
external auditory canal with following reconstruction
of the tympanic plate with bone patè [7]. A significant
step of this procedure is exposure of the ICA, which may
be injured during drilling. The catheter is positioned close
to the tympanic membrane and eustachian tube; revision
surgery requires the elevation of the tympanic membrane.
The main problem regarding IL and IC approaches is the
presence of a high jugular bulb. In IC approach, if the
jugular bulb is two thirds anterior to the mastoid tract of
the facial nerve, it reduces the working window without
possibility of putting a drainage tube. To avoid injury to
the jugular bulb, particularly when it is dominant, we
prefer to approach the lesions via IFTB as described by
Fisch [25]. This approach presents adequate space for
operation and preserves sensorineural hearing. These
patients could be fitted with bone-anchored hearing aid
to aid conductive hearing.
The IFTB consists of the following steps, which lead to
some morbidity: (1) the blind sac closure of the external
auditory canal with loss of conductive hearing and (2)
exposure and retraction of mandibular condyle with section
of V3 branch of the trigeminal nerve, leading to some
difficulty in mastication. The main advantages of this
approach are direct vision and complete control of the
intrapetrous ICA and the possibility of complete cyst
removal from clivus and sphenoid sinus [26]. After tumor
removal, the cavity is obliterated with abdominal fat. To
avoid injuring the ICA, a detailed evaluation of radiologic
investigations is done to estimate the relationship between
tumor and carotid artery and to plan an eventual endovas-
cular stent positioning [27]. In all cases with intrapetrous
ICA involvement, the evaluation of cerebral circulation
should be done preoperatively, and the possibility of the
permanent ICA closure in case of intraoperative injury
should be kept in mind [28].
Table 6
Flow chart of our treatment algorithm for symptomatic PA CG
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The translabyrinthine (TL) and TO approaches are
reserved for patient without serviceable hearing [7] and
huge lesions. These 2 approaches allow a wide and direct
exposure of the PA. We advocate combining the IFTB with
the TL or TO approach for those lesions spreading
anteriorly, which are in contact with the ICA and erode
the clivus, to achieve the whole cyst wall removal and
avoid recurrences.
If the PA CG extend into sphenoid sinus or abuts its
posterior wall a transnasal endoscopic approach can be
performed [18]. The transsphenoidal endoscopic approach is
less invasive than those by lateral skull base and allows
hearing preservation. It is safer in patients with well-
pneumatized sphenoid sinus, and the patient can be followed
up with office fiber-optic examination [29]. We do not
advocate this approach in case of wide erosion of carotid
canal because it is difficult to remove the entire cyst wall and,
in case of IAC and dura involvement, because of risk of dural
opening and postoperative cerebrospinal fluid leak. This may
lead to increased risk of meningitis.
Despite use of hearing preservation techniques in PA CG
treatment, hearing loss has been reported in 16% to 44% of
cases after lateral skull base approaches [9,10].
Petrous apex CGs is termed as recurrent disease when the
disease becomes symptomatic again or it shows growth on
imaging. The presence of fluid secretion into an aerated
cavity is not considered as recurrent lesion. In the literature,
14% to 16% of the recurrence rate is reported [7,16,17,30].
Several authors attributed this failure to the closure of either
drainage catheter or fenestration, and they postulate that
drainage combined with a permanent aeration of the cavity is
the effective long-term treatment of CGs of the PA. The
pseudocapsule left in place does not seem to have any
prognostic effect on recurrence [6]. When only subtotal
excision without stable cavity ventilation is done, patients
generally have to undergo more than one operation [10].
Revision surgery has to be considered in case of growth
occurs or clinical symptoms reappear.
5. Conclusion
Petrous apex CG knowledge is required to make
differential diagnosis among other lesions of this area.
Imaging with both CT and MR is required for diagnosis
and to plan correctly the management. The petrous apex
can be widely exposed through lateral skull base approach;
the choice depends on preoperative hearing status, location,
and extension of the lesion. For patients with good
preoperative hearing, we recommend drainage via IL
approach (Table 6). In deaf patients and those with
extensive disease, TO approach combined with IFTB is
recommended. Infratemporal type B is also indicated in
case of good hearing and for lesions spreading anteriorly
toward intrapetrous carotid artery, clivus, and sphenoid
sinus. The transsphenoidal approach is indicated only in
selected cases, when the lesion abuts the posterior wall of
the sphenoid sinus without ICA, dura, and/or IAC
involvement. We advocate wait and see policy for
asymptomatic patients (Table 5). The goal of the treatment
should not be complete removal of the cyst but the
permanent ventilation of the cavity through a drainage
catheter. The complete removal of the cyst wall with
obliteration of the cavity is required in selected cases when
it is not possible to put a drainage tube. Recurrence seems
to be related with obstruction of the airflow in the cavity. If
complete excision is accomplished, the cavity may be
obliterated with fat, and the risk of recurrence is very low.
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Abstract
Objective: The classical teaching advocates a conservative approach for children presenting with various naso-septal deformities. It may not
be appropriate especially when it causes nasal obstruction to the growing child. This study has two main purposes: to contribute in identifying
the correct selection criteria for surgical management of pediatric patients and in selecting the most appropriate surgical technique.
Material and method: We reviewed a series of 46 cases of post-traumatic septal and naso-septal deformity not managed promptly or with
recurrence of nasal deviation, following bones fracture correction alone. The mean follow-up was 10 years.
Results: Patients with naso-septal deformity managed only by septoplasty had accentuation of nasal pyramid deformity; those treated by
septorhinoplasty showed a good aesthetic and functional result after long-term follow-up.
Conclusion: Our series results demonstrated that the best results were obtained when we correct all evident alterations of nasal septum and
pyramid at a single stage. Unsuccessful results seen in our first group suggest that immediate correction of septum alone with delayed
management of nasal pyramid deformity leads to a poorer outcome.
# 2009 Elsevier Ireland Ltd. All rights reserved.
Keywords: Septoplasty; Rhinoplasty; Childhood nasal deformity; Nasal trauma; Septal deviation
1. Introduction
Surgery for deformities of the nasal pyramid and septum
during childhood is shrouded with controversies. Every
surgical procedure of the nose at this young age may cause
developmental arrest [1]. Even the results may not be long
lasting in time, as the nose is a growing structure. A review
of literature showed that there is neither any solution to this
problem nor any guidelines for management, yet [2–5]. True
incidence of septal deviation in childhood is unknown. Gray
reported that in 58% of 2380 children studied a septal
deviation was present [6]. Trauma is the most common cause
for naso-septal deviation during childhood. Apart from this,
cranio-facial growth irregularity may also cause the
formation of a ridge between septal cartilage and vomeral
bone, often associated with turbino-septal contact. Connate
septal deformity due to trauma during intrauterine life or
during transit in birth canal has also been reported as a cause
for septal deviation, in the literature [7]. Surgical correction
of septal deviation is indicated, irrespective of age, if such
deformity causes nasal stenosis and oral breathing.
Conservative management may worsen the nasal morphol-
ogy, because deviated nasal septum may exert traction
during growth, to normal alar and triangular cartilages not
involved in previous trauma. Natural history of nasal trauma
in early years demonstrates that, effect of a misdiagnosed
trauma can appear during developmental age, and a nasal
deformity due to unmanaged fracture becomes worse during
growth. Cartilaginous arch involvement may cause narrow-
ing of the nostril and height and/or length asymmetry of
nasal pyramid. Delayed management of these alterations
requires difficult surgical procedures with not always good
results. Moreover the impaired nasal patency may exert
negative effect on other systems and organs that play a role
in the somatic and psychic development of the little patient.
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Such effects are seen mainly on the maxillo-facial skeleton
and rib cage, but also seen as dysventilatory syndrome of
middle ear and paranasal sinuses, vocal tract disorders and
difficulty in sleep. This study has two main purposes: to
contribute in identifying the correct selection criteria for
surgical management of naso-septal deformities in pediatric
patients and in selecting the most appropriate surgical
technique for such patients.
2. Material and method
The study was designed as a retrospective review of
charts of 46 patients with post-traumatic naso-septal
deviation, not managed promptly or with recurrence of
naso-septal deviation following initial bone fracture
correction alone. The ethical committees of our institution
have approved this study and subjects gave informed consent
to the work.
Sixteen patients out of 46 affected by septal deviation,
without nasal pyramid alterations, underwent septoplasty
and were excluded from results evaluation.
Remaining 30 patients with naso-septal deviation were
divided in two groups depending on surgical procedure
performed (Table 1).
The first group included 16 patients suffering from septal
deviation and nasal pyramid deformity. These patients too
underwent septoplasty alone. The second group had 14
patients in them affected, as those in the first group, by nasal
septum and nasal pyramid deformation. These patients were
managed by septoplasty and partial rhinoplasty (i.e.
reopening of old fracture lines and reduction). Patients
were followed up post-operatively to see for any recurrence
of septal deviation as well as the overall effect on the nasal
pyramid. The senior author (CD) performed all operations.
The long-term efficacy of treatment was determined by:
(1) evidence of residual septal deviation, (2) symmetry of
nasal pyramid, and (3) subjective satisfaction of patients for
both respiratory function and aesthetic appearance.
2.1. Surgical technique
The key in performing a conservative septoplasty is to
obtain good visualization of the deviated segment of nasal
septum during surgery. Unless we do this, there is always a
risk of removing normal septal segments, apparently causing
the deformity, using unnecessarily complex surgical
techniques. Cottle’s maxilla–premaxilla approach allows
good exposure of all the septal segments [2,3]. We
sometimes adopt the more extensive form of this approach,
in children, which entails the formation and reunion of four
tunnels. Sometimes it is sufficient to do just one anterior
tunnel and one or two posterior tunnels (Fig. 1). The
mucoperichondrium is dissected from quadrangular carti-
lage maintaining its integrity. Deformity of nasal septum can
be due to parallel, perpendicular or oblique fractures with
respect to the maxillary plane (Fig. 2). Occasionally parallel
and oblique fractures coexist. Deformity due to parallel
fractures can be usually corrected by inferior and posterior
chondrotomy, leaving the quadrangular cartilage in situ
(Fig. 3). This way we can maintain the articulation with
triangular cartilage intact. Next step is to remove the inferior
part of quadrangular cartilage, if it exceeds or is luxated
towards the floor of nasal cavity. Later, depending on
whether they are deviated or not, vomeral bone and
perpendicular lamina of ethmoid are corrected. While
performing all these steps, adequate care is taken to avoid
any superimposition of septal segments (Fig. 3). Deviations
due to perpendicular/oblique fractures with coexistent nasal
pyramid deformities and obstruction of the valvular area,
often requires total removal of the quadrangular cartilage,
remodelling it outside the body and replacing it back in its
place with external guide stitches (Figs. 4 and 5). These
stitches are positioned in order to sustain the point where
septum, nasal bone and triangular cartilage join together
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Table 1
Groups of patients enrolled in this study depending on nasal septum and pyramid alterations and on surgical procedure performed with results obtained.
Groups Number of
patients
Mean age Mean duration
of observation
Deformity Technique Outcome
I 16 9 years
(range 6–12 years)
12 years
(range 8–15 years)
Naso-septal Septoplasty In 25% of cases recurrence of septal deviation
Nasal pyramid deformity accentuated in 100%
II 14 9 years
(range 6–12 years)
14 years
(range 10–20 years)
Naso-septal Septorhinoplasty In 2 cases asymptomatic recurrence
of septal deviation
Good aesthetic result in all cases with symmetric
nasal pyramid and growth of face
Fig. 1. Scheme of tunnels in nasal septal dissection. The mucoperichon-
drium is dissected from quadrangular cartilage forming three or four
tunnels. (A) Anterior tunnel and (I) inferior tunnel.
(Cottle’s ‘‘K area’’), the nasal tip and columella. Correction
of posterior deviation is achieved by targeted removal of
deviated bony segments, following posterior chondrotomy.
Sometimes the deviated segment needs to be replaced back
between the mucoperichondral/mucoperiosteal layers after
proper remodelling, in order to reduce empty segments of
the septum, thereby giving it better stability. If there is
deviation of either bony or cartilaginous arch, we prefer to
do a partial rhinoplasty. This latter is done by opening the old
fracture lines with a thin osteotome, performing low to high
basal osteotomies. Disarticulation of triangular cartilages
from the quadrangular is the next step. This approach allows
good correction of oblique septal deviations, that often
include deformity of bony-cartilaginous junction, and helps
in restoring normal valvular angle. The nasal dorsum is
never lowered. If there is any caudal dislocation of the
septum, a columellar pouch is created to receive the inferior
aspect of quadrangular cartilage.
3. Results
The patients were aged between 4 and 12 years, and had a
follow-up period of 7–20 years (mean follow-up 10 years).
The 16 patients suffering for isolate septal deviation had
no objective growth deficit of the nasal pyramid during
follow-up after operation. The subjective functional results
in this series were also good. Only one patient (6.3%) had
sub-luxation of inferior aspect of quadrangular cartilage.
The first group included patients aged between 6 and 12
years. Four patients (25%) presented with a recurrence of
septal deviation. Nasal pyramid deformity was accentuated
in all patients (Figs. 6 and 7).
The second group consisted of children aged from 6 to 12
years. All patients had acceptable aesthetic results (Figs. 8
and 9) and two patients (14.7%) presented with asympto-
matic recurrence of septal deviation (Table 1).
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Fig. 3. Correction scheme: (1) inferior chondrotomy, (2) posterior chon-
drotomy, and (3) detachment of quadrangular cartilage and perpendicular
ethmoidal lamina contact; (a) removal of deviated vomeral bone (spurs and
ridge), (b) removal of posterior portion of quadrangular cartilage, and (c)
correction of perpendicular ethmoidal lamina, to avoid any superimposition
of septal segments.
Fig. 5. Scheme of replacing the remodelled quadrangular cartilage. The
cartilage may have a triangular (x) or quadrangular (y) shape. The new
quadrangular cartilage have to: lay on nasal spine (a), sustain the nasal tip
(b), and sustain the ‘‘K area’’ (c).
Fig. 4. Total removal of the quadrangular cartilage, remodelling and
replacing it back in its place with external guide stitches–stitch in the
‘‘K area’’.
Fig. 2. Schematic draw on a cadaver nasal septum of fracture lines. (a)
Vertical fracture, (b) oblique fracture, and (c) horizontal fracture.
4. Discussion
It is known that nasal septum plays an important role in
the harmonic growth of the face. Compelled oral
breathing due to nasal obstruction during childhood,
disrupts the normal development of skull base angle and
consequently the normal maxillo-facial growth. This in
turn can cause malocclusion and protrusion of maxillary
bone, leading to a condition called as class II skeletal
deformity, comparable to ‘‘facies adenoidea’’ [8,9]. If
septal deviation occurs during the rapid phase of
development, it may cause irregular growth of cartilagi-
nous structure of the nasal vault including in those
structures that were not originally affected by the trauma.
Trauma may involve fracture of either bony or cartila-
ginous vault. If such injuries are not corrected at an early
stage, it will lead to consolidation of the defect, thereby
affecting the aesthetics and function of the facial skeleton.
Because of all these reasons, if on the one hand surgical
management seems indicated in cases of difficult nasal
breathing, on the other hand there are still controversies
about the timing of management, the surgical technique
and the extent of surgical approach. It is our opinion that
timing of the intervention should not be related to age but
to the grade of nasal obstruction. There are different
opinions regarding surgical approach and surgical
technique to be used in these patients, they are: early
correction of septal deviation and scheduling the
rhinoplasty after the development is complete; or
performing septorhinoplasty at a single stage. In our
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Figs. 6 and 7. Group I: 9 years follow-up; evidence of accentuated nasal
pyramid deformity.
Figs. 8 and 9. Group II: 20 years follow-up; no deformity of nasal pyramid
is present.
opinion treatment of nasal septum and pyramid deformity
have to be done at the same time. Just like how a fractured
nasal bone has to be treated promptly, a fractured nasal
bone consolidated in abnormal position should also be
replaced in the correct position after reopening the old
fracture lines. If we follow this protocol, long-term results
on completion of nasal development should be the same as
with prompt treatment of fractured nasal bones. Cottle’s
approach (maxilla–premaxilla) is the best option, in our
experience. This is because, it allows us to perform
targeted dissection of deviated nasal septum and, if
necessary, a complete exposure of the entire septum. Jugo
reported that the conservative Cottle’s technique caused a
high incidence of recurrent deviation due to limited
surgical field and incomplete linkage between quadran-
gular and alar cartilages [10]. Such observations imply
poor adherence of quadrangular cartilage to the surround-
ing structures and, during the cicatrisation process, may
favour recurrence of the deviation. As a solution to such
problems, he proposed, a total reconstruction of nasal
septum by an external approach defined as ‘‘decortica-
tion’’, adopted first time by Hage [11]. Such techniques
demand long surgical time and extensive dissection.
Therefore, it should be reserved only for those rare cases
having severe deformity of nasal septum [10]. Another
technique reported in literature, used by Halstead in 1910
for approaching pituitary gland, is done through a sub-
labial incision [12]. Healy proposed an open septoplasty
by sub-labial approach to manage nasal bone fractures,
preserving as much cartilaginous part of the septum as
possible [13]. Cases reported in their study showed good
reduction of fracture without any disturbance in growth,
during follow-up. In a study based on anthropometric
measurements of 28 patients affected by severe anterior
septal deviation and managed by external septoplasty
(removal, remodelling and repositioning of quadrangular
cartilage), Bejar reported that such technique had no
effect on naso-facial growth, but may disturb the length
and development of the nasal dorsum [14]. In our
experience [15] reconstructive septal surgery does not
cause significant growth retardation in children if the
mucoperichondrium is preserved. El-Hakim et al. reported
the same opinion using an open approach [16].
Yilmaz was of the opinion that external technique for
septoplasty offers no additional advantage as against the
hemitransfixion–transfixion incision, but also is more
traumatic for the nasal growth [17]. Therefore the less
traumatic hemitransfixion–transfixion incision should be
preferred in every condition of nasal septum, except in cases
of severe septal deviations coexistent with nasal tip
deformity. We advocate the hemitransfixion incision
approach maintaining the mucoperichondrium integrity as
described before.
The objective outcome evaluation by rhinomanometry
and acoustic rhinometry has not yet proven to be
diagnostically useful, despite fervour of some centers
[18]. For this reason we believe, in accordance with other
authors [18,19], that patients subjective feelings is the main
outcome measurement of surgery success.
5. Conclusion
Obstructing deviation of nasal septum in childhood is an
absolute indication for surgical correction. Our series results
demonstrated that the best results were obtained when we
correct all evident alterations of nasal septum and pyramid at
a single stage, irrespective of age. Unsuccessful results seen
in our second group suggest that immediate correction of
septum alone with delayed management of nasal pyramid
deformity leads to a poorer outcome. In such cases the
septum, even when adequately corrected, continues to lie
between deviated structures and during growth follows a
deviated course. Moreover, during the rapid developmental
phase (pubertal period) the growth itself can cause additional
alteration of already deviated structures. The patients
subjective feelings is the main outcome measurement of
surgery success.
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Introduction
The prevalence of habitual snor-
ing in adult males and females is
about 24% and 14%, respectively.1
Among these, obstructive sleep
apnea syndrome (OSAS) affects
4% of men and 2% of women. The
pathophysiology of this condition
is thought to be excessive narrow-
ing of pharyngeal airway that also
collapses during inspiration,
resulting in increased negative
intrathoracic pressure, which in
turn exacerbates the condition.
When complete obstruction
occurs, the drastic reduction in
airflow to the lungs arouses the
patient from sleep.
Symptoms of OSAS are
 generally vague. Neurocognitive
symptoms such as memory and
learning deficits may be present,
and patients can exhibit daytime
fatigue due to loss of sleep or
hypoxia itself. In these patients,
cardiovascular diseases, such as
hypertension and stroke, are related
to sleep apnea secondary to
increased intrathoracic pressure.2
As initial therapy, life-style
modifications, such as avoiding
alcohol and drugs and weight
reduction, are encouraged. When
medical treatment is indicated,
continuous positive airway pres-
sure (CPAP) therapy during sleep
or the use of jaw/tongue advance-
ment devices may be effective.
If these prove unsuccessful,
 surgical options are available. The
choice of surgical procedure
depends on the site and degree of
obstruction. Uvulo palato pharyn -
go plasty (UPPP) is one of the
most common surgical interven-
tions used to treat OSAS.
Originally proposed by Ikematsu,3
it was popularized in 1980 by
Fujita et al.4
The aim of the present work
was to establish the efficacy of
UPPP with tonsillectomy in the
treatment of selected patients with
severe OSAS. 
Materials and methods
We retrospectively reviewed the
charts of all patients with OSAS
who were treated surgically in our
department between January 2000
and December 2005. A detailed
history of all patients was recorded.
All patients underwent a com-
plete head and neck examination,
static and dynamic endoscopic
evaluation of the upper aerodiges-
tive tract, Muller maneuver
 evaluation, body mass index
(BMI) calculation, and cardio-
pulmonary monitoring (CPM)
during sleep. The parameters
 evaluated during CPM were
1) apnea/hypopnea index (AHI),
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Abstract. Uvulopalatopharyngoplasty with tonsillectomy in the treatment of severe OSAS. Objective: To establish the
efficacy of uvulopalatopharyngoplasty with tonsillectomy for treating selected patients with severe obstructive sleep
apnea syndrome.
Methodology: Retrospective study of patients who underwent clinical/instrumental evaluation and surgical treatment. 
Setting: University ENT division with a tertiary snoring referral center.
Participants: Twenty-two patients with normal body mass index affected by severe obstructive sleep apnea syndrome.
Main outcome measures: Pre- and post-operative cardiopulmonary monitoring during sleep, daytime sleepiness evalua-
tion, post-treatment complication recording.
Results: Complete response to therapy was obtained in 78% of patients. Four patients had relief of symptoms but retained
apnea/hypopnea index scores greater than 5.
Conclusions: Uvulopalatopharyngoplasty associated with tonsillectomy can be employed safely to treat patients with
normal body mass index who suffer from severe obstructive sleep apnea.
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calculated as the summation of
total events per hour; 2) oxygen
desaturation index (ODI); and
3) saturation value reached during
sleep. Apnea was considered as
cessation of breathing for at least
10 seconds and hypopnea was
defined as reduction of breathing
effort with 4% desaturation. We
evaluated the daytime sleepiness
in all patients based on the
Epworth’s sleepiness scale ques-
tionnaire.
Patients were selected for the
study based on the following
parameters: 1) OSAS grade severe
(AHI > 30) on CPM; 2) Palate
position grade I-II according
to Friedman’s classification5;
3) Palatal tonsillar hypertrophy
grade 2-4 in accordance with
Friedman’s grading6 (Table 1);
4) Oropharyngeal (retropalatal)
collapse grade 3 (50-75% of space
reduction) to grade 4 (collapse
> 75%) on Muller’s maneuver
(Table 2); 5) BMI < 28. Patients
who did not meet the above crite-
ria were excluded from the study.
Patients receiving CPAP therapy
were excluded from the study.
Twenty-two patients were
included in the study. All
22 patients had been treated
 surgically with UPPP plus
 tonsillectomy under general
anaesthesia. CPM during sleep
was repeated three months after
the surgical intervention. Post-
operative apnea/hypopnea index
and ODI scores below 5 indicated
a complete response to therapy.
An improvement in AHI exceed-
ing 50% and an AHI less than 20
was considered successful treat-
ment.7,8 Post-operative complica-
tions and chronic adverse effects
(hemorrhage, palatal insufficien-
cy, rhinolalia, and disgeusia) were
recorded.
Our institutional review board
approved the study protocol.
Informed consent was obtained
from all patients. 
Surgical technique
Tonsillectomies were performed
using the cold dissection method.
The oropharyngeal aspect of the
soft palate mucosa was incised
25-mm distal to the posterior end
of the hard palate. The mucosa
was then dissected off the under-
lying muscle up to the free edge of
the soft palate and then removed,
leaving a myo-mucosal flap of the
soft palate mucosa on the
nasopharyngeal side (Figure 1).
The free soft palate mucosal edge
of the nasopharyngeal side was
then sutured to the original inci-
sion line on the palatal side
(Figure 2). This process increases
the velopharyngeal inlet. 
Results
Sixteen males and six females
affected by OSAS were included
in the study. The mean age of the
patients was 47 years (range 24-
58). The median pre-operative and
post-operative scores are shown in
Table 3. Mean follow up was 31
months (range 20-38; Figure 3).
According to Friedman’s staging
system,5 18 patients were stage I
and four were stage II. All of the
patients classified as stage II pre-
sented with tonsil size grade 2 and
palate position 1-2.
Complete response to therapy
was obtained in 17 patients (78%).
Four patients had relief of symp-
toms but retained AHI and ODI
scores greater than 5 (Table 3).
Thus, treatment was successful in
21 of 22 patients (96%). One
patient (4%) was classified as not
deriving any benefit from treat-
ment because their post-operative
AHI score was 21. All patients
were discharged on the second
post-operative day. Subjective
pain and swallowing discomfort
disappeared in all patients by
the eighth post-operative day
(median 6; range 6-8). Return
to normal diet was used as an
index of  swallowing improve-
ment. No patients complained
of velopharyn geal insufficiency.
Table 1
Tonsillar Hypertrophy, Friedman’s grading
Grade Clinical Features
0 Previous tonsillectomy
1 Tonsils inside the tonsillar fossa hidden behind the anterior palatal pillar
2 Tonsils partially outside the tonsillar fossa occupying 25% of the oropharynx
3 Tonsils occupying 50% of the oropharyngeal space
4 Tonsils occupying more than 75% of the oropharynx, almost meeting in the
midline
Table 2
Grading of oropharyngeal (retropalatal) obstruction on Muller’s maneuver
Grade Endoscopic Features
1 Minimal movement of pharyngeal wall with space reduction between 0-49%
2 Pharyngeal wall movement with space reduction between 50-74%
3 Pharyngeal wall movement with space reduction between 75-99%
4 Complete occlusion of pharyngeal lumen
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Three patients experienced per-
sistent dry mouth for a mean of
13 months. Two patients had a
slight subjective taste disturbance,
which recovered spontaneously
six months after surgery.
Discussion
In the last decade, attention to per-
sistent snoring, particularly when
associated with apnea syndrome,
has increased tremendously.
OSAS is a relatively common dis-
order that affects about 4% of
adults.1 It is often ignored by the
patients, which can result in seri-
ous complications and even
endanger the patient’s life. Quality
of life in such patients is generally
poor as compared to that of the
general population, because of
daytime somnolence and its asso-
ciated consequences, such as
increased risk of accidents while
driving and at work. Male sex is
known to be a major risk factor for
rhonchopathy, this is well
explained by the higher preva-
lence of OSAS in men.9
Until 1990, the procedures used
to diagnose OSAS were inade-
quate for establishing the precise
site of obstruction. Therefore,
patient selection for surgery was
not accurate, which affected the
eventual outcome of surgery. 
Currently, there are various
therapeutic options for managing
OSAS. The first approach is to
encourage the patient to reduce
their body weight, improve their
sleep hygiene, and avoid alcohol
and sedative consumption just
before sleep. Medical treatments
consist of CPAP devices and oral
appliances that advance the
mandible to allow the airway to
remain patent. Patients show a low
compliance with CPAP use and
often discontinue or interrupt the
treatment for various reasons. 
Surgery is generally considered
a second-line option. Several tech-
niques have been described in
literature , based on the grade of
OSAS. Surgery can be performed
on either an inpatient or an outpa-
tient basis, depending on the
severity of sleep apnea and the
surgical procedure chosen.
Historically, lack of under-
standing of the pathophysiology
of OSAS contributed to the erro-
neous application of some surgical
techniques, such as removing
Figure 1
Dissection of the mucosa off the underlying muscle up to the
free edge of the soft palate, creating a myo-mucosal flap of the
soft palate mucosa on the nasopharyngeal side.
Figure 2
Suturing the palatal flap using an absorbable suture
b
a
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muscles of the soft palate along
with its mucosa in order to debulk
the soft palate, which invited poor
results. Implementation of these
types of procedures was likely
main reason behind the high
prevalence of complications and
failure in the treatment of OSAS.
excluding those patients with
hypopharyngeal (retroglossal and
lateral wall) collapse from UPPP.10
For young patients in good
general health, we propose surgi-
cal correction of the predominant
cause of OSAS. Accurate patient
selection and use of the least inva-
sive technique that gives the best
success rate are paramount for
success. UPPP is a procedure with
a reasonably short post-operative
recovery period that is charac -
terized by swallowing difficulty
and pain.7 In our series, all
patients had complete resolution
of pain and improvement in swal-
lowing discomfort by the eighth
post-operative day. The long-term
success rate of UPPP ranges from
50% to 80%.11-14 In a recent meta-
analysis, Sher et al.11 found an
overall success rate of 40.7%. The
success rate was related to the
level of obstruction and was
52.3% in patients with only
palatal narrowing or collapse,
dropping to just 5.3% in patients
with a retro-glossal obstruction
with or without palatal compo-
nent.11 Because this surgery is per-
formed in patients who have expe-
rienced labored breathing for a
very long time before surgery,
they should be observed closely
following surgery. However, the
views regarding post-operative
observation vary. Spiegel and
Raval15 suggested monitoring
patients for only 2-3 hours after
surgery and then discharging them
home. Kezirian et al.16 reported a
nonfatal complications rate of
1.5% and mortality of 0.2% in a
series of more than 3000 cases of
UPPP.
Great care should be exercised
when intubating and extubating
these patients for general anaes-
thesia, because patients with
OSAS typically have difficult
Table 3
Cardiopulmonary monitoring and daytime sleepiness variations 
Pre-operative Post-operative
median score (range) median score (range)
Apnea/Hypopnea index 45 (40-56) 4 (3-21)
Oxygen desaturation index 39 (36-43) 4 (4-24)
Sleeping oxygen saturation 71% (68-80) 92% (80-95)
Epworth sleepiness scale 15 (12-17) 5 (5-9)
Advances in diagnostic devices
have allowed for more precise
evaluation of patients who suffer
from snoring. Endoscopic evalua-
tion of upper respiratory tract col-
lapse on Muller’s maneuver and
its grading have enabled more
effective surgical approaches by
Figure 3
A patient affected by severe OSAS stage II who was treated
with UPPP and tonsillectomy. a) Pre-operative photograph.
b) Post-operative features after 6 months of follow-up.
b
a
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 airways. Riley et al.17 reported that
most post-operative complications
were related to hypertension and
at that only six of 182 patients had
a post-operative saturation less
than 90% (possibly attributable to
narcotics used for general anaes-
thesia). It is mandatory that regu-
lar CPM be performed during sur-
gical follow up in order to assess
for residual disease and evaluate
treatment efficacy. Indeed, the risk
of developing cardiovascular com-
plications in patients with unre-
solved OSAS is nearly 50%.18
UPPP is associated with both
short-term and long-term compli-
cations. However, as noted by
Sher et al.,11 it is impossible to
determine the true rate of compli-
cations because of the majority of
papers on UPPP have not reported
the presence or absence of compli-
cations. The more common com-
plications described in literature
are velopharyngeal insufficiency,
post-operative bleeding, nasopha-
ryngeal stenosis, and voice
change. In our study, the main
complications encountered were
taste disturbance in two patients
and mouth dryness in three
patients. Damage to taste buds on
the soft palate during UPPP might
be a factor in post-operative taste
function impairment, which is
observed in 7-10% of patients.19
However, taste function may
recover over time, as was
observed in our patients.
UPPP is contraindicated in
those patients with only retroglos-
sal obstruction. In a previous
report, negative predictors of out-
come were combined palatal and
retroglossal obstruction and previ-
ous tonsillectomy.13 A pharyngeal
surgical approach may be recom-
mended for patients with severe
grade OSAS. As demonstrated by
our data, a greater than 50%
reduction of the pre-operative AHI
was obtained in 96% of patients
with severe OSAS, indicating
good efficacy of UPPP plus
 tonsillectomy. These data coincide
with those reported by Friedman
et al.,6 who obtained an 80%
 success rate in stage I patients
managed with UPPP. In our
 opinion, tonsillectomy should be
performed during the same
 surgical session in a day-surgery
regimen.20 Friedman et al.21
 asserted that in patients with
palatal obstruction who have
undergone previous tonsillectomy,
it might be better to perform a
Z-palatoplasty during UPPP. 
It is known that a BMI greater
than 27 drastically reduces the
efficacy of UPPP, even with
 combined genioglossus advance-
ment and hyoid suspension.
Symptomatic relief by UPPP is
known to deteriorate during long-
term follow-up. In a survey of
patients at 17-20 years post UPPP,
the percentage of symptomatic
relief had decreased significant-
ly.18 Weight gain was the main
 predisposing factor for recurrence
of symptoms. 
Conclusions
Patients suffering from OSAS
should be evaluated using a 
multidisciplinary approach. Deter -
mining the site and grade of
obstruction is mandatory for
selecting the appropriate treat-
ment strategy. Although surgery
remains a second-line option, it
can help to reduce snoring and
the frequency of sleep apnea
episodes. Our data suggest that
UPPP associated with tonsillec -
tomy can be safely employed to
treat even those patients with
severe OSAS with stage I-II
 disease and normal BMI.
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Objective: Review of postoperative morbidity and facial nerve
outcomes of cystic vestibular schwannoma (CVS) patients com-
pared with solid vestibular schwannoma (SVS) patients and a
proposal for a new CVS classification system.
Study Design: Retrospective review.
Setting: Tertiary care facility.
Patients: Ninety-six patients with surgically treated CVS
(1998Y2008). Outcomes were assessed in a subpopulation of
57 patients with greater than or equal to 1-year follow-up com-
pared with 57 SVS patients.
Intervention: Fifty-six CVS patients underwent the enlarged
translabyrinthine approach with transapical extension (Type I),
and 1 patient underwent a transcochlear/transzygomatic
approach.
Main Outcome Measure: Preoperative and postoperative
(at least 1 yr) House-Brackmann facial nerve (HBFN) grade
evaluation.
Results: Favorable HBFN grades (IYIII) were observed in 46
(81%) CVS patients, and unfavorable HBFN grades (IVYVI)
were seen in 11 (19%) CVS patients. Comparison of tumor size
and 1-year HBFN grades showed significant, moderate to
strong, Pearson correlation (0.38). Comparison of long-term
facial nerve outcomes with a sample of 57 matched SVS
patients showed no significant difference ( p = 0.74). When
the tumor was adherent to the facial nerve and a dissection
plane could not be developed between the cyst wall and the
nerve, only subtotal resection could offer the CVS patients a
normal facial nerve outcome.
Conclusion: In most CVS cases, complete resection should
be foreseen. Central and thick-walled tumors can be removed
in almost all cases. However, when peripheral thin-walled,
adherent, cystic tumors are confronted and the cysts are me-
dially or anteriorly located, we recommend subtotal resection,
leaving portions of the cyst walls on neurovascular struc-
tures and on the facial nerve. This surgical strategy allows
us to improve facial nerve outcomes and to reduce complica-
tions. Key Words: Acoustic neuromaVCystic vestibular
schwannomaVFacial nerve outcomesVTranslabyrinthine
approachVVestibular schwannoma.
Otol Neurotol 30:826Y834, 2009.
Vestibular schwannomas account for 6 to 8% of all
intracranial tumors and 80% of tumors that arise in the
cerebellopontine angle (CPA) (1). These lesions can be
divided into 3 groups: homogeneous, heterogeneous, and
cystic. Cystic vestibular schwannomas (CVS) differ from
solid schwannomas by their rapid growth, frequent in-
volvement of facial nerve, and somewhat unpredictable
biologic behavior. Cystic vestibular schwannomas have
been estimated to represent anywhere from 5.7 to 48% of
all vestibular schwannomas, with more recent studies in
favor of numbers closer to 10% (2Y5). However, the true
incidence is debatable because there are various descrip-
tions of what constitutes a CVS. (2,5Y7).
Preoperatively, CVS can be identified with magnetic
resonance imaging (MRI). Fluid-filled portions of these
lesions seem hyperintense on T2-weighted images,
whereas solid portions are isointense or hypointense
with the brain on T1-weighted imaging. The solid
tumor component and the cystic wall are enhanced
with gadolinium (8,9) (e.g., Fig. 1B and D). Enhance-
ment of the cyst wall is an imaging characteristic that can
be used to differentiate CVS from arachnoid cysts and
epidermoids (8).
In the absence of a cystic component, the growth rate
for these tumors is known to range from approximately
2 to 6 mm/yr (10). Some authors think that only a limited
number of solid vestibular schwannomas (SVS) grow
Address correspondence and reprint requests to Enrico Piccirillo,
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continuously (11). In the presence of a cyst, there can be
rapid expansion of the lesion, brainstem compression,
and hydrocephalus associated with neurologic symptoms
(12). Rapid CVS enlargement can also occur as a con-
sequence of intratumoral hemorrhage (13). In addition,
cyst expansion and neurologic impairment have also
FIG. 1. Schematic illustrations and representative MRI examples of each subtype of Type A CVS according to the proposed classification
in Table 1. Type A1 (A, B). Type A2 (C, D). Type A3 (E, F ). Cyst (C ), solid tumor (T ), facial nerve (FN ), PICA, and AICA. Images B, D, and
F are T1-weighted axial images with contrast.
TABLE 1. Proposed classification for CVS is first based on overall cyst location (central or peripheral)
and cyst wall thickness (thick or thin)
Type Overall cyst location/cyst wall thickness Subtype Definition
A Central and thick wall 1 Polycystic (multiple small intratumoral cysts with a thick cyst wall)
2 Polycystic (multiple moderate size intratumoral cysts with a thick cyst wall)
3 monocystic (single large cyst with a thick or thin cyst wall)
B Peripheral and thin wall 1 Anterior
2 Medial
3 Posterior
4 Combined
Type A lesions are further subdivided by the cyst characteristics (polycystic or monocystic) and size. Type B lesions are further classified according
to cyst orientation with respect to the internal auditory meatus (anterior, medial, posterior, or a combination of these locations).
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FIG. 2. Schematic illustrations and representative MRI examples of each subtype of Type B CVS according to the proposed classification
in Table 1. Type B1 (A, B). Type B2 (C, D). Type B3 (E, F ). Type B4 (G, H ). Cyst (C ), solid tumor (T ), facial nerve (FN ), PICA, and AICA.
Magnetic resonance images B, D, and F are T1-weighted axial images with contrast. Magnetic resonance image H is a T2-weighted
image.
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been documented after attempted treatment with radio-
surgery (12,14).
Contemporary treatment options for CVS include
observation, surgery, radiosurgery via one of a number
of modalities, and/or a combination of surgery and radio-
surgery. Because of the unpredictable growth patterns
and reported cases of cyst enlargement after radiosur-
gery, complete or subtotal microsurgical resection is
often recommended for CVS (5,15). However, literature
suggests that facial nerve outcomes after CVS resection
have been less favorable in comparison to results after
removal of SVS (3,5,16,17).
In this study, we present our series of surgically treated
CVS. We review postoperative morbidity and facial
nerve outcomes and compare these results with those
from SVS resected during the same period at our institu-
tion. Finally, we propose a classification system for CVS
that might be used to guide surgeons in the management
of these tumors to optimize surgical results.
MATERIALS AND METHODS
We retrospectively reviewed all cases of vestibular schwan-
nomas operated in our center between January 1998 and May
2008. Patients were included in this study if they had a CVS
and were treated at our institution during this period. A tumor
was labeled as a CVS if it satisfied 2 requirements: presence of
hypodense/hypointense areas on MRI and intraoperative iden-
tification of cystic elements. All CVS patients treated at our
institution during this period underwent surgery by the same
surgeon (M.S.). Of 1,416 patients that underwent vestibular
schwannoma resection during this period, we identified 96
with CVS. Fifty-seven of these CVS patients had greater than
or equal to 1 year of documented follow-up. Ninety-six SVS
patients were randomly selected from our vestibular schwan-
noma database for comparison on facial nerve outcomes, mor-
bidity, and mortality in the following manner. To compare CVS
with SVS, solid tumors were first stratified according to size
and later selected through random computer assignment. Tumor
size was stratified as less than 1.0, 1.1 to 2, 2.1 to 3, 3.1 to 4,
and 4.1 to 5 cm. The number of SVS patients selected from
each tumor size group equaled the number of CVS patients in
each group.
In 1998, we began to photographically record preoperative
and postoperative MRI scans and preoperative and postopera-
tive facial nerve function of all vestibular schwannoma patients.
The photographic MRI record allowed us to accurately identify
patients for this study, develop a proposed classification system
for CVS, and separate tumors based on this classification sys-
tem. To evaluate facial nerve function, photographs were taken
of patients with their face at rest, closing their eyes, raising their
eyebrows, and smiling. Analysis of facial nerve results was
limited to those patients with greater than or equal to 1 year
of follow-up.
The following variables were recorded from each chart: patient
demographics, tumor size and location, cyst position, cyst wall
thickness, surgical strategy, operative findings, and complications.
Preoperative and postoperative House-Brackmann facial nerve
(HBFN) grade were also recorded (18). Any statistical analysis
was completed using GraphPad Instat.
All patients underwent preoperative gadolinium-enhanced
MRI of the brain and internal auditory canals. These images
were used to determine tumor size, cyst position, and cyst wall
thickness. Tumor size was measured at the largest extrameatal
tumor diameter on the preoperative MRI (6). Tumors were first
classified based on overall cyst location and cyst wall thickness:
central and thick-walled (Type A), or peripheral and thin-
walled (Type B). Type A lesions were then subdivided by
cyst characteristics (polycystic or monocystic) and size. Type
B lesions were classified according to cyst orientation with
respect to the internal auditory meatus (anterior, medial, pos-
terior, or a combination of these; Table 1). According to the
proposed classification, schematic illustrations and representa-
tive MRI examples of each subtype of CVS are provided in
Figures 1 and 2.
The amount of tumor removal during initial operation was
used to divide CVS patients into 2 groups: complete or subtotal
resection (95% of tumor left; Fig. 3) (6). In cases of subtotal
resection, the location of adherent remaining tumor was
recorded at the time of the operation at 1 or a combination of
up to 3 locations: facial nerve, brainstem and intracranial ves-
sels (anterior inferior cerebellar artery [AICA]), posterior infe-
rior cerebellar artery, or superior cerebellar artery. The type of
resection was determined preoperatively or intraoperatively. If
the operative goal was complete tumor resection and the
involved portion of facial nerve was accidentally interrupted,
an attempt was made at facial reanimation. This was accom-
plished with either an interposition nerve graft or a hypoglos-
sofacial anastomosis (19,20). If the operative goal was subtotal
FIG. 3. Subtotal left CVS resection example on coronal and
axial MRI. A, Preoperative coronal T1-weighted image with con-
trast showing left CVS. B, Postoperative T1-weighted image with
contrast, showing subtotal resection, left cystic tumor remnant is
marked with the white arrowhead.
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tumor resection, portions of the cyst wall were left in place
when it was not possible to develop a dissection plane between
the facial nerve, brainstem, and/or major vessels.
RESULTS
Patients
Between 1987 andMay 2008, we completed 1,750 ves-
tibular schwannoma resections. Among 1,416 patients
that underwent vestibular schwannoma resection at our
institution during the period ranging from January 1998
to May 2008, 96 (6.8%) patients underwent some form
of CVS resection. Preoperatively, all CVS patients had
normal facial nerve function. A summary of all surgi-
cally treated CVS patients from this period is provided
in Table 2. This table shows patients grouped according
to date of operation, demonstrating a tendency from
2004 on toward more subtotal resections.
Complications
Table 3 provides a summary of the SVS group. Post-
operative complications that were identified among the
group of 96 CVS patients and the 96 SVS patients are
listed in Table 4. There was no mortality in either group
of patients. The total percentage of all complications
directly related to the schwannoma resection was only
slightly greater in the CVS group (6.25%) compared with
the SVS group (5.21%).
1-Year Follow-Up
Fifty-seven CVS patients had greater than or equal to
1 year of documented follow-up at our institution. The
bulk of the analysis presented here is based on these 57
patients unless otherwise stated. Of the 57 CVS patients,
29 were men and 28 were women, whereas the average
age was 51 years (median, 50 yr; range, 27Y80 yr). Fifty-
seven SVS patients with greater than or equal to 1-year
follow-up were randomly selected from the group of
96 SVS, first according to CVS tumor size and later by
computer assignment. Of the 57 SVS patients, 22 were
men and 35 were women, whereas average age was
49 years (median, 47 yr; range, 25Y79 yr).
Tumors
The average CVS size was 2.8 cm (median, 3 cm;
range, 0.8Y5 cm). Cystic vestibular schwannomas were
grouped according to the proposed classification system
presented in Table 1: Type A, 25 (44%; Type A1, 15
[26%]; Type A2, 6 [11%]; Type A3, 4 [7%]) and Type
B, 32 (56%; Type B1, 3 [5%]; Type B2, 8 (14%); Type
B3, 5 (9%); Type B4, 16 [28%]). Average SVS size was
2.8 cm (median, 3 cm; range, 0.8Y5 cm).
Surgical Strategy
Fifty-six CVS patients underwent the enlarged transla-
byrinthine approach with transapical extension (Type I),
and 1 patient underwent a transcochlear/transzygomatic
approach (21,22). Forty-seven CVS (82%) patients un-
derwent complete resection, whereas 10 (18%) under-
went subtotal resection. Among patients that underwent
complete tumor resection, 7 required interruption of the
facial nerve and grafting, and 2 required hypoglossofacial
anastomosis. Among patients that underwent subtotal
resection, the tumor was left in contact with the facial
nerve in 8 cases (2 facial nerve, 5 facial nerve and brain-
stem, 1 facial nerve, brainstem, and vessels). The tumor
TABLE 2. Summary of all CVS patients that underwent
surgery at our institution during the period from
January 1998 to May 2008
CVS patients, n
Period 1998Y2003 2004Y2008 1998Y2008
Patients 26 70 96
Male 12 34 46
Female 14 36 50
Right-sided tumors 13 34 47
Left-sided tumors 13 36 49
Complete resection 26 51 77
Subtotal resection 0 19 19
Nerve graft 1 8 9
Hypoglossofacial anastomosis 1 2 3
91 yr of follow-up 16 41 57
The patients are grouped according to date of operation. After 2004,
there is a tendency toward subtotal resection (to leave the cyst wall in
place).
TABLE 3. Summary of all SVS patients randomly selected
from groups of patients stratified for tumor size
(January 1997 to February 2007)
SVS patients, n
Period 1998Y2008
Patients 96
Male 42
Female 54
Right-sided tumors 44
Left-sided tumors 52
Complete resection 80
Subtotal resection 16
Facial nerve graft 4
Facial nerve end-to-end anastomosis 1
Hypoglossofacial anastomosis 4
91 yr of follow-up 96
The mean tumor size was 2.7 cm (range, 0.2Y5 cm).
TABLE 4. Cystic vestibular schwannoma versus SVS
complications and mortality
Complication CVS (n = 96) SVS (n = 96)
Abdominal fat graft site hematoma 1 0
Cerebrospinal fluid leak 1 0
Intracranial hemorrhage 1 0
Lower cranial nerve deficit 2 1
Sigmoid sinus thrombosis with
concurrent ipsilateral vision loss
0 1
Sixth nerve palsy 1 1
Subdural hematoma 0 2
Transient ischemic attack 1 0
Mortality 0 0
Total complications directly related
to the schwannoma resection, n (%)
6 (6.25) 5 (5.21)
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was left in contact in 1 case with the brainstem and in
another with the intracranial vessels.
All 57 SVS patients underwent the enlarged transla-
byrinthine approach with transapical extension (Type I).
Forty-eight (84%) SVS patients underwent complete
resection, and 9 (16%) underwent subtotal resection.
Among the SVS patients that underwent complete resec-
tion, none required nerve grafting, whereas 2 required
hypoglossofacial anastomosis. One SVS patient under-
went subtotal resection and required hypoglossofacial
anastomosis.
Facial Nerve Outcomes
Among the 57 CVS patients with greater than or equal
to 1 year of follow-up, favorable (Grades IYIII) HBFN
grades were observed in 46 (81%) CVS patients, and
unfavorable (Grades IVYVI) HBFN grades were found
in 11 (19%). These patients were further grouped by
HBFN grade in Table 5 and Figure 4. Twenty CVS
patients (80%) with Type A tumors had favorable out-
comes, and 5 (20%) had unfavorable facial nerve out-
comes. Twenty-six CVS patients (81%) with Type B
tumors had favorable outcomes, and 6 (19%) had unfa-
vorable facial nerve outcomes. A comparison of tumor
size and 1-year facial nerve follow-up grades showed a
significant, moderate to strong Pearson correlation
(0.38). The long-term facial nerve outcomes from the
sample of 57 CVS patients were compared with a sample
of 57 matched SVS patients through Wilcox matched-
pairs signed-ranks test. This test showed no significant
difference in long-term facial nerve outcomes between
these 2 groups ( p = 0.74). This comparison is further
demonstrated in Figure 5.
Furthermore, we compared the CVS facial nerve out-
comes after complete resection with facial nerve reani-
mation (nerve graft or hypoglossofacial anastomosis) and
subtotal resection. When the tumor was adherent to the
facial nerve, not a single case in the complete resection
group had a facial nerve outcome better than Grade III,
and normal facial nerve function was only achieved after
subtotal resection.
2-Year Follow-Up
Of the 96 CVS patients included in this study, 19 had
greater than or equal to 2 years of documented follow-up
at our institution. Of those 19 patients, 3 underwent sub-
total resection, 1 of which developed a recurrence that
required reoperation. The patient was a 60-year-old man
with a 2.5-cm (Type B4) CVS. In March 2006, he under-
went a translabyrinthine approach for resection of this
lesion. Intraoperatively, significant bleeding developed
that required additional retrosigmoid access for control.
The surgeon ended the procedure prematurely due to
blood loss. A small portion of solid tumor was left at
the internal auditory meatus along the facial nerve, and a
portion of the cyst wall was left attached to the brain-
stem. Postoperatively, his facial nerve function recovered
to normal. An MRI showed no evidence of tumor re-
growth 7 months after operation. Approximately 30
months after the operation, he returned to our institution
with Grade III facial paralysis. Follow-up MRI showed
regrowth of the residual tumor that seemed almost iden-
tical to the first lesion except for a more anterior location
of the cystic component in the CPA. He underwent a
transotic approach and subtotal resection of the recurrent
CVS 31 months after his first operation. Thus far, he has
done well postoperatively.
TABLE 5. 57 CVS patients with greater than or equal to 1-yr
follow-up grouped by HBFN
HBFN n % Mean tumor size, cm
I 15 26 2.3
II 4 7 2.9
III 27 47 2.7
IV 6 11 3.9
V 4 7 3.8
VI 1 2 2.0
Total 57 100
The number of patients (n), percentage of the total (%), and mean
tumor size for each group are shown.
FIG. 4. Facial nerve outcomes in CVS patients with greater than
or equal to 1 year of follow-up. Cystic vestibular schwannoma
patients are separated into groups according to their 1-year
HBFN outcome. Each column is further divide by tumor size.
FIG. 5. Long-term facial nerve outcomes and tumor type. Facial
nerve grades from 57 patients that had solid tumors are com-
pared with 57 patients that had cystic tumors.
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DISCUSSION
Cystic vestibular schwannomas are widely described
as being more aggressive, having shorter symptomatic
periods before presentation, poorer responses to radio-
surgery, and worse outcomes from surgical intervention
(3,5,15,16,23,24). Factors that lead to unfavorable surgi-
cal outcomes include engulfment of and adherence to
neurovascular structures, hypervascular solid portions
of the tumor, and the absence of an adequate subarach-
noid dissection plane. Although each of these elements
can be encountered during surgical removal of SVS, it
seems they occur with increased frequency during resec-
tion of CVS. In large published series, they are typically
only alluded to because they cannot be analyzed in a
systematic, objective way. Analysis is further compli-
cated because there are various descriptions of CVS,
and there is a lack of a universal classification system
for these tumors.
Fundova et al. (5), Yamakami et al. (7), Kameyama
et al. (24), and Shirato et al. (25) have offered descrip-
tions and/or classification systems for CVS. To facilitate
clinical studies, a consensus meeting was held to discuss
the reporting vestibular schwannoma results in 2003. It
was recommended that multicystic tumors be identified
as a separate group when reporting results. Tumors
included in this group are those in which the cystic com-
ponents are on the tumor’s surface (6). To assist with
preoperative surgical planning and to standardize the
reports of surgical results, we propose a simple classifi-
cation system based on preoperative imaging confirmed
with intraoperative findings (Table 1, Figs. 1 and 2).
The pathogenesis leading CVS formation is unknown.
Theoretically, CVS could form because of 1 or a combi-
nation of the following mechanisms: tumor growth and
subsequent central necrosis, coalescence of microcysts
formed in Antoni B tissue, and/or repeated intratumoral
hemorrhage (26,27). Later, gradual cyst enlargement
could be attributed to osmotic gradients set up by extra-
vasation of serum proteins from an impaired blood-tumor
barrier and/or the production of mucinous material within
the cyst (3,26). Recently, high levels of proteolytic
enzymes (matrix metalloproteinase 2) have been identi-
fied in CVS fluid and cyst walls. These enzymes are
thought to play a role in cyst formation and enlargement
in other cystic diseases. It has been inferred that these
enzymes may play an important role in the pathogenesis
of cyst formation and peritumoral adhesion in CVS (17).
Fundova et al. (5) conducted a comparison of CVS and
SVS. Their study showed that patients with CVS had a
significantly shorter initial duration of symptoms and
worse facial nerve outcomes. However, CVS were sub-
jectively evaluated to be Bless[ adherent to intracranial
structures (brainstem, trigeminal nerve, lower cranial
nerves, and dura, with no mention of adherence to the
facial nerve) than SVS. They surmised that the less
favorable surgical outcomes seen with CVS were due
to rapid tumor growth and compression of posterior
fossa structures. In contrast, Moon et al. (17) reported
significantly increased adherence of cystic tumors to the
facial nerve. Benech et al. (15) also reported increased
adherence to neural structures with increased compli-
cations related to dissection of adhesions from the
brainstem.
FIG. 6. Right Type B4 CVS that was recently operated at our institution through a translabyrinthine approach. A, Preoperative axial T1-
weighted image with contrast showing a right CVS. B, Preoperative axial T2-weighted image of the same lesion. C, Intraoperative
photograph showing the unopened CVS (uC ) through a translabyrinthine approach. D, Intraoperative photograph showing the opened
CVS (oC ). The vessels lying between the thin cyst wall and the brainstem were visible (D ). Middle fossa dura (M ), boney external auditory
canal (E ), and sigmoid sinus (S ).
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In most studies, reported facial nerve outcomes after
CVS resection have been less favorable in comparison to
results after removal of SVS (Table 5) (3,5,16,17,23,28).
Benech et al. (15) showed a trend toward worse facial
nerve outcomes after CVS resection in comparison to
solid tumors that did not reach statistical significance.
However, Jones et al. (2) found no significant difference
in facial nerve outcomes when they compared their series
of CVS and SVS.
Our comparison of long-term facial nerve outcomes
from 57 CVS patients and 57 matched SVS patients
showed no significant difference. However, we think
CVS are more adherent to neurovascular structures,
and we attribute the similar facial nerve outcomes to
familiarity with the intraoperative management of CVS,
using subtotal resection when necessary and overall sur-
gical experience. We agree with Samii et al. (29) that the
predictive factors for facial nerve preservation include
not only tumor size and extension, cystic tumor consis-
tency, previous surgery, or radiosurgery, but also a sur-
geon’s operative experience.
Vascular complications constitute a relatively rare but
significant problem seen after resection of vestibular
schwannomas. Hegarty et al. (30) reported a 2.1% rate
of distal AICA territory infarcts. Samii and Matthies (23)
reported an overall rate of symptomatic postoperative
hemorrhage of 2.2%. Sade et al. (31) reported a 2.7%
rate of vascular complications in their series of 391 ves-
tibular schwannomas. We reported a hemorrhagic com-
plication rate of 1.3% without analysis of solid versus
cystic tumors in a series of 707 patients (32). In our
present series, 1 patient (È1%) had a transient ischemic
attack on postoperative Day 4, and 1 patient (È1%)
developed postoperative intracranial hemorrhage that
required surgical intervention.
In 2004, we reported the surgical volume of vestibular
schwannoma resected at our institution between 1987
and 2001 (32). In the current study, we found that
6.8% of surgically treated vestibular schwannoma
patients had CVS. Using this percentage to estimate the
number, we think an additional 23 CVS patients were
treated at our institution in the 10 years before 1998.
Therefore, based on senior authors’ experience of 119
CVS, the following recommendations are made.
Three factors need to be considered before CVS resec-
tion: thickness of the cyst wall, position of the cyst, and
extrameatal size of the lesion, including cystic and solid
components. In the senior authors’ experience, vestibular
schwannomas with centrally located cysts and thick cyst
walls or tumors with intratumoral cystic change (both
Type A) tend to be less difficult to remove.
Thin-walled, Type B tumors can present a more for-
midable challenge. Subtotal resection is frequently war-
ranted when tumors of this nature are encountered.
Figure 6 is an example of a thin-walled Type B CVS
that was recently operated at our institution. Preoperative
axial MRI images and intraoperative photographs
demonstrate the degree of tumor adherence to the brain-
stem. In this case, the vessels lying between the thin cyst
wall and brainstem were visible (Fig. 6D). Unable to
develop an adequate subarachnoid plane, the surgeon
left a portion of the cyst wall in place. There was no
immediate postoperative morbidity.
Although many important neurovascular structures are
encountered during the resection of any lesion in the
CPA, to simplify the resection of CVS, we recommend
that surgeons focus their attention on the brainstem, the
facial nerve, and the vessels in the posterior fossa. One
should correlate cyst position with these structures and
attempt to preoperatively plan their management of the
tumor. For example, with anteriorly based cysts, one
should consider subtotal removal leaving the capsule
on the facial nerve. When medially or posteromedially
based cysts are confronted, especially when that brain-
stem and the 4th ventricle are compressed, complete
resection can be difficult. In these situations, considera-
tion should be given to leaving a portion of the cyst wall
on the brainstem and vital vessels. On the other hand,
purely posterior cysts are typically less difficult to
remove, and complete resection is often achieved. Care-
ful dissection along the surface of the cerebellum is typi-
cally inconsequential.
We recommend looking for subarachnoid planes that
lend themselves to blunt or sharp dissection. In addition
to these conventional dissection methods, we have had
success using a bipolar to detach the cyst wall. When
activated at a safe distance from vital neurovascular
structures, the bipolar current can spread across the sur-
face of the cyst and begin to develop a subarachnoid
plane. If the cyst wall is thin, lying over the facial
nerve, the brainstem or vessels of the posterior fossa,
we advocate subtotal resection in these areas, leaving
portions of the cyst wall.
Finally, during the resection of any CVS, surgeons
need to pay particular attention to the depth of their dis-
section because it is possible to pass through the cyst and
unintentionally enter normal brainstem parenchyma. This
is a crucial point in the resection of polycystic tumors
due to the multiple layers of tissue that the surgeon
encounters.
CONCLUSION
In most cystic vestibular scwhannomas, complete
resection should be foreseen. Central and thick-walled
tumors can be removed in almost all cases. However,
when peripheral thin-walled, adherent, cystic tumors
are confronted and the cysts are medially or anteriorly
located, we recommend subtotal resection, leaving por-
tions of the cyst walls on neurovascular structures and on
the facial nerve. This surgical strategy allows us to im-
prove facial nerve outcomes and to reduce complications.
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Introduction
The first description of Kaposi’s
sarcoma (KS) was by Kaposi in
1872,1 who reported an unusual
tumour consisting of small brown-
ish-red cutaneous nodules, mainly
involving the skin of lower extrem-
ities in a multifocal fashion. 
The development of KS is relat-
ed to several factors: genetics due
to race and geographical distribu-
tion and infection because KS is
found principally in patients with
acquired immunodeficiency syn-
drome (AIDS). 
Infection by HHV-8, a new
human herpes virus described by
Chang in 1994,2 was considered
necessary but not sufficient for KS
development after HHV-8 DNA
was found in tissues of patients
affected by KS. The development
of KS also requires compromised
immune status.
Head and neck involvement in
Kaposi’s sarcoma (KS) is not
unusual.3 However, laryngeal
involvement is a somewhat infre-
quent manifestation. The literature
describes about 50 cases of laryn-
geal KS.
There are four types of epi-
demiological KS: AIDS-related or
epidemic, iatrogenic, African or
endemic, and the classic or
Mediterranean type. Three clinical
forms of KS have been noted:
localised nodular, locally aggres-
sive and generalised. HIV-nega-
tive patients with KS of the larynx
have been reported.4,5
Males seem to be affected most
(91%). The majority of patients
with laryngeal KS have advanced
HIV infection and were antiretro-
virally naive. 
Presenting symptoms may
include hoarseness, throat discom-
fort, cough, dysphagia, stridor and
dyspnoea. Laryngoscopy may
show laryngeal oedema or more
often a purple vascular mass
lesion. 
We report on the first case in
the literature in English of KS in
Morgagni’s ventricle.
Case report
A 65-year-old white male com-
plaining of cough and hoarseness
over the past three months attended
the emergency room of our
department for episodic dyspnoea
and stridor. The history was nega-
tive for cigarette smoking and
alcohol consumption. The patient
presented with dysphonia and
inspiratory stridor. The indirect
laryngoscopy showed a reddish
sessile mass arising from the supe-
rior aspect of the right true vocal
cord. The diameter of the lesion at
the largest point was 1.5 cm,
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 compromising the respiratory
 passage. Vocal cord motility was
normal, as was the rest of the
mucosa. Head and neck clinical
examination did not reveal lymph
node disease. 
The patient underwent an urgent
tracheotomy because of the stridor,
low oxygen saturation (average of
93%) and severe dyspnoea.
Pre-operative routine blood
tests results were normal, as were
thoracic radiographs.
The patient underwent a direct
microlaryngoscopy, revealing that
the true origin of the lesion was
above the arcuate line in the
 fundus of the right Morgagni’s
ventricle. The lesion was
 completely excised (Figure 1) by
means of laser-assisted surgery.
The tracheostomy was then closed
in the same intervention. 
Histopathology revealed the
proliferation of neoplastic spindle
cells arranged in intersecting fas-
cicles, which form slit-like vascu-
lar spaces of various dimensions
containing red cells (Figure 2).
The specimens were positive to
immunostain with CD-31 and
CD-34. Nuclear immunoreactivity
for HHV-8 was present, con -
firming the suspected diagnosis of
KS (Figure 3). 
The patient was then readmitted
for further analysis and to evaluate
the possibility of HIV infection.
No signs of HIV infection were
found. Blood tests were repeated
and ELISA examination for HIV,
CMV and EBV viruses were also
performed. All values were in the
normal range. No virus infection
was found. 
A total body dermatological
examination was then conducted,
showing typical KS nodular
lesions on both feet (Figure 4).
The definitive diagnosis of
Mediterranean or classic KS was
made.
The patient was then followed-
up. After one year, no recurrent
laryngeal lesions were detected,
Figure 1
Laryngeal Kaposi’s Sarcoma mass excised
Figure 2
Neoplastic cells showing nuclear immunoreactivity for HHV-8.
(Strept-ABC; original magnification 400×).
Figure 3
This section shows the proliferation of the neoplastic spindle
cells arranged in intersecting fascicles which form slit-like vas-
cular spaces of various dimensions containing red cells.
(Hematoxilin-Eosin staining; original magnification 200×).
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and the skin lesion did not show
any change. 
Discussion
Mediterranean type or classic KS
occurs in the older population of
the Mediterranean area and it
affects men 15 times more often
than women. The nodular lesions
are mainly situated in the lower
extremities; they are indolent and
infrequently cause morbidity.
Conversely, the epidemic form of
KS occurs in immunocompro-
mised subjects (AIDS-related).
The lesions in this form are
aggressive and multicentric. 
About 40% of AIDS patients
will develop KS during the course
of the disease, and two-thirds of
these patients will have head and
neck involvement.6
The lesions are reddish-purple,
multicentric macules and nodules.
Histologically, the typical features
of KS are spindle-shaped cells
with numerous vascular channels
and extravasated erythrocytes.
Deposits of haemosiderin are
present in a collagen stroma. An
inflammatory infiltrate may be
present. Immunostain is per-
formed with HHV-8 antibodies to
confirm the viral infection and
hence the diagnosis.
The two largest series of
patients affected by laryngeal KS
have been reported by Abramson et
al.7 in 1970 with 13 patients and by
Mochloulis8 in 1996 with 17 cases.
Classic KS of the larynx is a rare
Figure 4
Nodular skin lesions on the right foot,
 typical of Classic Kaposi’s Sarcoma.
Table I
The literature relating to Kaposi’s sarcoma, including the present case*
Author Year Cases Site involved Local treatment Type 
Reynolds10 1965 1 Arytenoids-Epiglottis Tracheotomy Classic
Coyas11 1983 1 Larynx Tracheotomy Classic
Abramson7 1970 13 Larynx Classic
Moritsch16 1978 1 Larynx-Hypopharynx Tracheotomy Classic
Abemayor3 1983 1 Epiglottis Epidemic
Gnepp12 1984 2 Anterior commissure (1)
Larynx-Hypopharynx (1)
Excision (1)
Tracheotomy (1)
Epidemic
Weidauer17 1986 1 Larynx Excision Epidemic
Levy18 1990 1 Glottic Epidemic
Friedman13 1996 6 Larynx Intralesional vinblastine (6)
Tracheotomy (1)
Epidemic
Mochloulis8 1996 17 Supraglottic (11)
Glottic (8)
Subglottic (3)
Tracheotomy (1)
Radiotherapy (5)
Epidemic
Schiff19 1997 2 Epiglottis (2) Biopsy (1) excision (1) Epidemic
Beitler9 1996 1 Larynx Tracheotomy (1) Epidemic
Gras20 1999 1 Supraglottic Intralesional injection Epidemic
Alkhuja21 2001 1 Larynx Tracheotomy Epidemic
Ares22 2005 1 Larynx Tracheotomy Epidemic
Angouridakis4 2006 1 Vocal cord Excision Classic
Ashurov5 2007 1 Larynx Classic
Dispenza* 2008 1 Larynx Tracheotomy and excision Classic
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entity with less than 20 cases
reported in the literature (Table 1). 
The clinical presentation of
laryngeal KS is variable, de -
pending on the site and the stage
of the disease. The symptoms
range from dysphonic voice to
stridor and dyspnoea due to upper
airway obstruction. In the litera-
ture, ten cases of laryngeal KS
needed tracheotomy,8-13 including
the present case (Table 1).
Diagnostic biopsies were per-
formed without complications in
several patients, but biopsies of
such vascular lesions have been
associated with brisk and poten-
tially fatal bleeding.8
The diagnosis of KS is general-
ly made after histopathology, par-
ticularly in Classic KS, because of
the lack of manifest extralaryngeal
symptoms. In AIDS patients, the
index of suspicion is higher than
in other patients affected by the
Mediterranean form.
Therapeutic options include:
low-dose irradiation, intralesional
chemotherapy, ablation and sys-
temic therapy if there is dissemi-
nated disease. Obstructing laryn-
geal lesions require urgent inter-
vention with tracheotomy.
Depending upon the location of
the lesion, a tracheotomy may
contribute to mortality as a result
of fatal haemorrhaging.9 A tra-
cheotomy is generally adopted in
these patients when transoral intu-
bation for general anaesthesia is
difficult or impossible, and in
cases of severe dyspnoea.
Furthermore, surgeons should
bear in mind that Kaposi’s nodules
may be bleeding lesions, and so
intraoperative haemorrhaging
during transoral surgery may be
well managed if the airways are
saved. Surgical excision is adopted
for isolated lesions and for those
obstructing the airway. The tran-
soral modality for the surgical
removal of the lesions is the first
choice because it allows for the
prompt and good visualisation of
the glottic plane and rapid postop-
erative healing.
In our case the lesion was
removed after airway patency
was restored by tracheotomy. Tra -
che otomy may be closed once the
lesion is removed. 
Friedman et al. adopted the
intralesional injection of Vinblas -
tine sulphate, with an appreciable
response in over 75% of cases.
Only one patient required a tra-
cheotomy for upper airway
obstruction.13
The Mediterranean type of KS
does not generally contribute to
patient mortality and the treat-
ment of asymptomatic laryngeal
lesions may be conservative8, as in
other laryngeal lesions.14,15 In the
 epidemic type, death is secondary
to other AIDS-related disease
processes.
Conclusion
Laryngeal KS is a rare clinical
entity. To the best of our knowl-
edge this is the first case reported
in the English literature of KS
affecting the laryngeal ventricle.
The clinical investigation generally
shows a mass without malignant
features. The definitive diagnosis
is established after histopathology,
but the index of suspicion is high,
especially in AIDS patients. It
must be included in the differen-
tial diagnosis of pigmented laryn-
geal lesions. Urgent treatment
may be required in cases of acute
stridor due to an occluding mass.
Classic KS is not an aggressive
disease and patients usually die
of other diseases, but follow-up
is mandatory to prevent loco-
regional recurrence or new pri-
mary lesions.
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Abstract
Objective: Evaluation of clinical and oncological safety of the modified fronto-lateral laryngectomy in the treatment of T1a-b glottic cancer.
Methods: Retrospective review of charts of patients managed with classical fronto-lateral laryngectomy or with our modified technique using
a cervical fascia flap and a false cord flap to reconstruct the defect.
Results: No recurrence of cancer was observed in the present series and slight dysphonia was present in all cases. The patients managed with
classical technique required a revision surgery for granulations or anterior synechia in 4 cases; those managed with modified technique did not
need a second intervention.
Conclusion: The fronto-lateral laryngectomy should be present in the head-neck surgeon armamentarium. In T1a-b glottic cancer this
technique gives a good oncological resection, but the postoperative period requires an intensive rehabilitation process. The modification of the
classical technique reduces the incidence of a second intervention.
# 2009 Elsevier Ireland Ltd. All rights reserved.
Keywords: Laryngectomy; Fronto-lateral laryngectomy; Glottic cancer; Larynx surgery; Vertical laryngectomy
1. Introduction
In the management of laryngeal cancer the choice of the
conservative surgical technique depends upon the TNM
staging, tumor location and laryngeal structures involved.
The anterior commissure (AC) of the glottis is a ‘‘risk
region’’ for two reasons: its anatomical structure and the
difficulty in delineating the deep extension of the tumor,
even with the help of radiological study. Anatomically the
AC constitutes thin mucosa with absence of internal
perichondrium of thyroid cartilage along with proximity
of the crico-thyroid membrane and of the caudal end of the
epiglottis. This may erroneously lead to clinical down
staging of the tumor, as cT1, which after histopathological
examination turns out to be pT4.
The role of the AC in the development of the tumor is a
matter of debate. Several authors consider the AC as a low
resistance area to neoplastic growth [1–4]. Others authors
suppose that AC is a barrier (wall) against anterior spreading
of the tumor in the early phases of the tumoral growth [5,6].
The Broyles’s tendon acts as a barrier against the deep
infiltration of the tumor in the early phases, but it does not
restrict superficial spread either in the supraglottic or
subglottic direction.
Carcinoma involving the AC is more aggressive than
carcinoma arising in other sites, with the consequent worse
prognosis. This observation led Fini-Storchi to add an
anatomical-oncological classification to TNM staging of
neoplasm involving the AC [7].
We present our oncologic and functional results in the
patients affected by laryngeal cancer involving the AC
treated with a modified frontal–lateral laryngectomy
(FLL), a surgical procedure described by Leroux-Robert
www.elsevier.com/locate/anl
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in 1956 [8] and popularized in Europe in 1970s [9], that
today may be helpful in selected cases not well managed
with endoscopic laser microsurgery or horizontal partial
laryngectomies.
2. Materials and methods
A retrospective chart review of patients treated for
laryngeal cancer with frontal–lateral laryngectomy in our
department from 1994 to 2000 was conducted. History and
symptoms were recorded in all cases. All patients underwent
complete head and neck check up, including upper aero-
digestive endoscopic examination. A computed tomography
with contrast enhancement of the neck and standard X-ray
chest projection were done in all patients. Patients were
classified in accordance with TNM staging system. Biopsy
of the laryngeal lesion was done under direct microlaryngo-
scopy in general anesthesia followed by FLL. Modified
fronto-lateral technique was performed in about half of the
patients since 1997, when we planned and introduced the
variation from the classical technique. Complete informa-
tion including all treatment options (i.e. surgery and
radiation therapy) was provided to all patients and informed
consent was obtained.
Surgical technique: the modification of the Leroux-
Robert technique consists of two additional surgical steps:
(1) the use of a superficial fascia flap, dissected at the
beginning of the operation, to reconstruct the defect due to
excision of thyroid cartilage (Figs. 1 and 2) and (2) a shifting
flap of false cord to reconstruct the glottic defect (Fig. 3).
In all cases temporary tracheostomy was performed and a
naso-gastric tube was positioned. The voice rehabilitation
was done after tracheostomy closure by speech-language
pathologist for a period of 3 months.
The minimum follow-up period was of 5 years. It was
accomplished with endoscopic evaluation of larynx and
head and neck clinical examination at 1, 2, 3, 6, and 9
months in the first year after operation, every 6 months in the
second and third year and once every year thereafter.
F. Dispenza et al. / Auris Nasus Larynx 37 (2010) 469–473470
Fig. 1. The cervical fascia flap used in the reconstruction of anterior aspect of the larynx: (a) anterior view; (b) lateral view; (c) final reconstructive suture.
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Our Institutional Review Board approved the present
study.
3. Results
Twenty-one male patients with fronto-lateral laryngect-
omy were treated in our Department, from 1994 to 2000, to
manage glottic cancer extending to the AC. All patients who
underwent surgery refused radiation therapy as treatment.
The mean age was 64 years (range 53–75 years). All patients
were heavy smokers: 6 patients more than 20 cigarettes per
day and 15 patients more than 30. In 13 cases more than
200 ml of daily alcohol consumption was associated with
smoking. The symptoms recorded were: dysphonia in 21
cases, productive cough in 7 cases and dry in 3 patients,
pharyngeal discomfort in 4 patients. The biopsy showed an
infiltrating squamous cell carcinoma in all cases. The
Leroux-Robert’s fronto-lateral laryngectomy was performed
in 8 cases until March 1997. Since June 1997 to December
2000 we performed the modified technique described above
in 13 patients.
The definitive histopathological examination confirmed
the presence of a squamous cell carcinoma in all series. In 5
(23%) out of 21 patients an early thyroid cartilage invasion
was present, but always contained by the cartilage.
The naso-gastric tube was positioned for an average of 6
days (range 4–13 days). The deglutition was normal in all
cases. The tracheostomy tube was kept for less than 10 days
in 10 patients, between 10 and 20 days in 10 patients and 25
days in one case.
The mean follow-up was 9.5 years (range 7–15 years).
All patients presented with slight dysphonia. In 4 patients
treated with the classical Leroux-Robert technique a
revision microlaryngoscopic surgery was necessary to
remove glottic granulations in 3 patients and anterior
synechia in 1 (Fig. 4). In the patients managed with the
modified fronto-lateral technique we noted glottic granula-
tions only in one case. All patients are without recurrence till
date (Fig. 5).
4. Discussion
The surgical treatment of T1a-b glottic cancer with AC
involvement, extending to the anterior third of the
F. Dispenza et al. / Auris Nasus Larynx 37 (2010) 469–473 471
Fig. 2. Scheme of the cervical fascia flap suture: (a) the thyroid cartilage gap created after tumor removal will be covered by the cervical fascia flap elevated as
first step of the operation; (b) the suture of the flap to the cartilage border and to the strap muscles, over the thyroid cartilage gap.
Fig. 3. Scheme of the false cord flap to reconstruct the glottic plane after
tumor removal; the flap is dissected and rotated downward to fill the glottic
plane gap and then sutured.
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contralateral vocal cord, has two main objectives: (1)
oncologically safe excision; (2) sparing of laryngeal
functions. The less invasive techniques, such as endoscopic
laser microsurgical approach, is often preferred because of
few postoperative complications and it allows preservation
of thyroid cartilage integrity thus leaving a natural barrier in
case of recurrence.
Sometimes doubt exists about the deep extension of
cancer involving the AC toward the thyroid cartilage. In this
case choice of a less invasive technique (transoral surgery)
may not be appropriate, while a supracricoid partial
laryngectomy as cricohyoidoepiglottopexy may represent
an overtreatment; therefore in our view the use of the vertical
partial surgery such as the FLL offers a more effective
control of the disease, with preservation of laryngeal
function in case of only one vocal cord and AC involvement.
Leroux-Robert demonstrated that the FLL permits the
excision of the vocal cord, the correspondent subglottic area,
AC and subcommissural region. The technique includes
resection of the dihedral angle of thyroid cartilage together
with the lesion. According to Leroux-Robert the indication
of FLL is a cancer that involves the vocal cord from the
arytenoid cartilage to the AC, even if the motility of such a
cord is impaired.
The Leroux-Robert’s indication enjoyed wide popularity
among several authors [3,10–13]. Other authors adopted the
FLL in the vocal cord carcinoma that crosses the midline in
the region of AC [14].
The posterior extension toward the arythenoid cartilage is
not an absolute contraindication to perform FLL. De
Campora and Radici limit the FLL application to vocal cord
cancer that does not involve the vocal process of the
arythenoid cartilage and disapproves this technique also in
cases with contralateral vocal cord involvement, subglottic
and ventricular extension [3].
The postoperative period after FLL requires hospitaliza-
tion for about 6 days because of tracheostomy tube
management and naso-gastric tube feeding. Tracheostomy
tube was needed for a mean period of 11 days (only one case
needed it for 25 days), until the healing of glottis was
considered safe for breathing. It is noticeable that Brumund
et al. reported a large series of patients treated with FLL
without performing a temporary tracheostomy and without
naso-gastric tube positioning. However, our data of post-
operative care are in accordance with the length of time
previously reported in literature [9,15,16].
The voice quality after a classic FLL is similar to that
obtained after a cordectomy via laryngofissure. The anterior
synechia seems to have a significant impact on the voice
quality in patients treated with FLL [17]. As suggested by
some authors, the reconstruction of the glottis with a false
cord flap results in a better phonatory outcome, because of
reduction of the risk of anterior synechia [18,19]. The
cervical fascia or mucochondral nasal septum free flap [20]
gives a good support to the pre-laryngeal tissues, avoiding its
herniation in the laryngeal space, and facilitating the glottic
healing (Fig. 5). In our experience the cervical fascia and the
false cord flap give a good functional result and for this
reason we adopted such technique in all patients since 1997.
The rate of complications in our patients was low. No
patients had infection of wound or fistula formation. The
modification of the classical technique allowed, in our
F. Dispenza et al. / Auris Nasus Larynx 37 (2010) 469–473472
Fig. 4. Anterior synechia in a patient treated with the classical Leroux-
Robert technique.
Fig. 5. Postoperative examination of cases treated with our modified fronto-lateral laryngectomy, the triangular shape of the new glottic plane obtained with
suggested modifications is noticeable.
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series, a drastic reduction of laryngeal granulation devel-
opment in the postoperative period.
We did not observe any problem in swallowing in our
series of patients; the nasal-gastric tube was removed in all
patients in about 6 days from operation.
The absence of local recurrence in our series is probably
due to strict selection of patients; we performed FLL only in
patients with a glottic cancer T1a-b with AC involvement.
Fiorella et al. showed that FLL was not sufficient for
advanced tumor involving AC [13]. We usually advocate a
supracricoid partial laryngectomy (i.e. cricohyoidoepiglot-
topexy) for glottic T2 stage, because of high risk of
recurrence noted in the other centre [21,22].
In the last decade we performed less FLL due to practice
of endoscopic CO2 laser surgery that permitted excision of
T1a-b glottic tumors. We reserve the modified FLL for
patients with AC involvement who have contraindication to
laser surgery, inadequate laryngeal exposure for endoscopic
surgery, and for patients with low performance status in
which reconstructive laryngectomy procedures are contra-
indicated.
5. Conclusions
Head and neck surgeons should consider fronto-lateral
laryngectomy for selected patients that choose surgical
therapy and are not well manageable with CO2 laser surgery.
In T1a-b glottic tumor with AC involvement this technique
gives a reasonable oncological safe resection. The recur-
rence rate is comparable with other procedures for T1a-b
glottic cancer, but the postoperative period is longer and
needs an intensive rehabilitation process. From the time
when we adopted the modified FLL we observed optimal
results in disease treatment and functional outcome. The
modified technique reduces the postoperative risk of
synechia and granulation tissue development thus improving
the quality of the voice.
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Abstract Objective: The aim of the study was to evaluate the true incidence, diagnosis, and treatment of
benign paroxysmal positional vertigo (BPPV) arising after whiplash injury and to distinguish this
type of posttraumatic vertigo from other types of dizziness complained after trauma.
Methods: This was a retrospective study comprising patients referred to our center after whiplash
injury. The patients were evaluated with neurotologic examination including bedside and
instrumental tests. A Dizziness Handicap Inventory evaluating the symptoms of patients was
submitted before and after treatment and was evaluated. The BPPV patients were separately
evaluated from those with cervicogenic vertigo, and a comparison between our data about idiopathic
BPPV was done.
Results: Eighteen patients of whiplash who had BPPV were evaluated. The mean age was 38.2
years. BPPV was the cause of vertigo in 33.9% of total whiplash patients. In 16 cases, the
posterior semicircular canal was involved; the lateral semicircular canal was involved in 2 cases.
The instrumental neurotologic assessment did not show any alteration of either vestibulospinal
reflexes or dynamic ocular movements. Duration of symptoms before treatment ranged from 3
to 26 days. A total of 55.5% of patients had relief from their symptoms after first repositioning
maneuver. The Dizziness Handicap Inventory score improved in all patients treated with
repositioning maneuvers, but no difference emerged with idiopathic BPPV data.
Conclusion: BPPV after whiplash injury could be unveiled with a simple bedside examination of
peripheral vestibular system, and a treatment could be done in the same session. The diagnosis of
posttraumatic BPPV is not different from the idiopathic form, but the treatment may require more
maneuvers to achieve satisfactory results.
© 2010 Elsevier Inc. All rights reserved.
1. Introduction
The equilibrium is the result of a perfect integration of
input from eyesight, proprioceptive receptors, and labyr-
inths. The whiplash injury is a traumatic lesion due to rapid
flexion-extension movement of the cervical column. This
causes disturbance signals reaching from the cervical
proprioceptive system to the central vestibular system and
thus has an adverse effect on equilibrium. Balance problems
affect 5% to 50% of patients of whiplash injury [1,2]. The
whiplash injury is generally due to car collision and is the
first cause of insurance claims. About 15% to 20% of cases
develop the so-called late whiplash syndrome with persistent
complaints including headache, vertigo, instability, nausea,
and tinnitus [2].
The cervical trauma may increase the discharge of
muscles' proprioceptive receptors of the neck [3] and may
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interfere with normal activity of vestibular system, resulting
in an alteration of vestibular-ocular reflexes [4,5]. The neck
pain, and related balance impairment, is the most common
symptom and may be the cause of the symptoms complained
by patients that is generally called cervicogenic vertigo.
The quantification of vestibular damage is difficult in
forensic cases. For these reasons, it is mandatory to detect
maligners and distinguishing them from patients with true
disequilibrium disturbance [6].
Labyrinthine vertigo and auditory disturbances are
present in 25% and 17% of subjects, respectively [7]. The
incidence of dizziness with even mild head injury ranges
from 15% to 78%, probably because of an unclear definition
of the trauma and of the concept of dizziness [8-10].
Benign paroxysmal positional vertigo (BPPV) is the most
frequent cause of peripheral vertigo [11]. It accounts for
approximately 24% of all cases of peripheral vestibular
disorders [12]. This type of vertigo is generally seen in
individuals 40 years and older, with the highest incidence
between 50 and 70 years [13].
The exact etiology of BPPV is still debatable. More than
50% of all reported cases are idiopathic in nature [14]. Adler
[15] was the first to describe manifestations of BPPV in
posttraumatic cases. Classic BPPV involves the posterior
semicircular canal (PSC) and represents the most common
type of BPPV [13,16-18].
Diagnosis of BPPV is based mainly on history of
characteristic positional vertigo along with the classic
clinical signs. Symptoms are characterized by rotating
vertigo with nausea and vomiting, elicited by movements
of the head. The nystagmus typically has a latency (of few
seconds) and is of limited duration (10–20 seconds),
transient, and fatigable [16].
In patients of BPPV, correct diagnostic evaluation and
appropriate management, in the great number of cases, solve
the problem quickly, without the need for any medical
treatment [19].
Our work's aims were to analyze the patients affected
by BPPV after whiplash injury and to evaluate
differences between idiopathic BPPV and so-called
cervicogenic vertigo.
2. Materials and methods
A retrospective study of patients of whiplash injury who
visited our department between January 2008 and September
2009 was conducted. Patients with a diagnosis of BPPV
following the trauma, occurring within 1 week before
presentation, were evaluated. The exclusion criteria were
history of vertigo before the whiplash injury, history of ear
diseases or hearing loss, central nervous system pathology,
psychiatric diseases, and history of vascular diseases. The
evaluation included clinical history, complete head and neck
examination, clinical vestibular tests, pure tone audiometry,
and videoculography/videonystagmography with infrared
system (ULMER, Synapsis Inc, Marseille, France). The
smooth-pursuit function was evaluated by following an
oscillating lighted target on a 29-in screen. The target
velocity was regular (18°/s); and the oscillating movements
were from center to right, back to the center, and center to
left. Each trial was of 20 cycles of 57 seconds each. The
saccadic test was performed by watching the target on a
horizontal plane; the frequency was 0.4 Hz, and the
amplitude was ±20°. The parameters analyzed in saccadic
movement evaluation were latency, velocity, and accuracy.
Our cutoff parameters to consider results as pathologic
were as follows: value more than 200 milliseconds for
latency, a score less than 77% for accuracy, and a highest
velocity less than 530°/s. The smooth-pursuit movement
analysis was evaluated measuring the gain (eye velocity/
target velocity), and the parameter of normality was a value
of 0.88 ± 0.2.
The same operator performed all instrumental tests.
The Dizziness Handicap Inventory (DHI) was used as
reference for clinical improvement and was submitted at first
contact and during the follow-up.
The clinical vestibular tests used to investigate the
positioning nystagmus were the Dix-Hallpike and
McClure-Pagnini tests (nystagmus observed in a supine
position while turning the head to the left and right). The
vestibulospinal function was evaluated by the Romberg
test, index deviation test, and Unterberger test [20]. The
dynamic ocular bedside examination included the head-
shaking test and Halmagyi test. The evaluation of
nystagmus and vestibular reflexes was done after a period
of at least 5 days from last dosage of vestibular suppressant
drugs.
Imaging is generally included in those patients with
uncommon clinical presentation or those with lack of
response to treatment [21].
After diagnosing BPPV, all patients were promptly
treated with canalith repositioning maneuver (CRM) accord-
ing to the affected semicircular canal. The Semont maneuver
or the Epley maneuver was used to treat a PSC BPPV; the
Gufoni maneuver was used to manage the lateral semicir-
cular canal (LSC) BPPV [19] The persistence of nystagmus
and vertigo spells after CRM was indicative of treatment
failure, and repetition of maneuver was done in the same
session or in the following 3 days. No medical treatment was
prescribed to patients after CRM. The follow-up was done at
1 week, 3 weeks, and 1 month; the patients were examined,
and a DHI questionnaire was submitted at the second and
sixth months after the treatment.
The patients with cervicogenic vertigo were treated
with a combination of physiotherapy, habituation exer-
cises, and analgesics.
Finally, the data where matched with our result in treating
idiopathic BPPV [19,22] and with patients complaining a
“cervicogenic vertigo” following a whiplash injury to
evaluate the differences.
Our Institutional Board reviewed and approved the study.
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3. Results
Out of 53 patients of whiplash injury who were referred to
our department, 33 were male. The mean age was 40.77
(range, 18–66) years. In all patients, the head trauma
occurred within 1 week before presentation.
In 20 patients, the history revealed the presence of
rotating vertigo after trauma. An unspecified imbalance or
dizziness was the chief complaint in 33 patients, which were
labeled as having cervicogenic vertigo. These patients did
not show any alteration on neurotologic examination. The
hearing was normal in all patients.
In 18 of 20 patients, the vertigo was related to head
position and movement on the bed. In the remaining 2 cases,
a labyrinthine concussion was diagnosed; and these 2
patients were excluded from present analysis. No patient
reported history of vertigo before the head trauma.
The result of the Dix-Hallpike diagnostic maneuver
was positive in 16 of 18 patients, whereas the result of
the McClure-Pagnini maneuver for the LSC was positive in
2 cases.
Out of 18 whiplash patients with BPPV, 11 were male.
The mean age of the group was 38.2 (range, 25–66) years.
The BPPV was the cause of vertigo in 33.9% of whiplash
patients. In 16 cases, PSC was involved, the right side in 9
patients and left side in 7 cases. The left LSC was involved in
the remaining 2 cases. The neurotologic assessment did not
show any alteration of either vestibulospinal reflexes or
dynamic ocular movement (Table 1).
Symptoms duration before treatment ranged from 3 to
26 days. A symptoms-free period was present in all cases,
with recurrence of vertigo spells after a period ranging from
1 week to 1 month.
The DHI score improved in all patients treated with
CRM, as shown in Table 2. Although the improvement
was remarkable if compared with cervicogenic vertigo
results, no difference emerged with DHI after treatment of
idiopathic BPPV.
A total of 55.5% (10 cases) of patients had relief from
their symptoms after first CRM. Two CRMs were
necessary in 6 (33.3%) patients, including the 2 patients
with LSC BPPV. The remaining 2 (11.1%) patients
required 3 sessions of CRM to achieve satisfactory results.
Comparing these results with the treatment of idiopathic
BPPV, we noted that the posttraumatic variant requires
more maneuvers to reach curative repositioning of otoliths
(Table 3).
4. Discussion
The effect of trauma on cervical column was first
described by Crowe [23] in 1928 and followed by Gray
and Abbott [24] in 1953. Significant injuries can occur
following even low-speed collision, but simulated accidents
have shown that a 5-mph rear-end car crash can result in a
positive acceleration of 8.2 G of the head [25].
The whiplash injury is a biomechanical event that
produces a distortion of the cervical column causing lesions
of several cervical sites, such as the muscles, ligaments,
vertebral joints, vessels, and nerves. The typical acute
symptoms after whiplash injury includes neck pain,
headache, paraesthesia of upper cervical dermatomes,
dizziness or imbalance, and tinnitus [26,27]. The majority
of patients recover spontaneously after few months of
symptomatic treatment. In some patients, the symptoms
may persist.
Pathophysiologically, there is central nervous system
weakness following a whiplash injury. With respect to inner
ear pathology due to whiplash, the exact nature of the lesion
Table 1
Analysis of eye movement results of the patients
Idiopathic BPPV
(110 cases)
Cervicogenic
vertigo (33 cases)
Posttraumatic
BPPV (18 cases)
Smooth-pursuit
gain (SD)
0.87 (±0.04) 0.86 (±0.03) 0.87 (±0.04)
Saccadic
velocity,
°/s (SD)
571 (±34.1) 572.05 (±24.35) 565.9 (±27.47)
Saccadic
latency,
°/s (SD)
155.3 (±13) 161.73 (±13.07) 155.4 (±14.35)
Saccadic
accuracy,
% (SD)
0.83 (±0.06) 0.83 (±0.06) 0.84 (±0.06)
The patients with cervicogenic vertigo and posttraumatic BPPV due to
whiplash injury.
Table 2
Dizziness Handicap Inventory in the patients pre- and posttreatment
DHI pretreatment DHI posttreatment (last)
Idiopathic BPPV Severe: 75 Severe: 0
Moderate: 33 Moderate: 1
Low: 2 Low: 109
Posttraumatic BPPV Severe: 15 Severe: 0
Moderate: 3 Moderate: 0
Low: 0 Low: 18
Cervicogenic vertigo Severe: 9 Severe: 3
Moderate: 18 Moderate: 15
Low: 6 Low: 11
The patients with cervicogenic vertigo and posttraumatic BPPV due to
whiplash injury. The score of DHI is as follows: severe (100–70 points),
moderate (69–40 points), and low (39–0 point).
Table 3
Canalith repositioning maneuver needed to reach the curative repositioning
of otoliths
Idiopathic BPPV Posttraumatic BPPV
1 CRM 81% 55.5%
2 CRMs 17% 33.3%
N2 CRMs 2% 11.1%
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is not known; but some possible explanations are transient
ischemia by vertebral artery compression, hemorrhage into
labyrinth, direct labyrinthine concussion, and noise of
the collision.
A neurotologic evaluation should be performed to find a
possible cause of symptoms. The examination includes the
assessment of peripheral labyrinth and vestibulo-ocular
reflex system by means of clinical vestibular tests, caloric
test, and videoculography/videonystagmography.
Previous studies have scarcely demonstrated any rela-
tionship between peripheral dysfunction and trauma. Some
studies present in the literature have shown positional
nystagmus and unilateral hyporeflexia in patients of
whiplash injury [9,28-33]. Ettlin et al [34] reported
peripheral vestibular deficits in only 2 cases among 18
cases after whiplash injury. However, all these reports have
not used the standard value as benchmark or any proper
control group. In a previous study, we did not find any
correlation between trauma and eye movements in patients
with recent trauma.
However, the whiplash injury is considered to be a direct
cause of the BPPV [35,36] especially when head trauma is
associated. The pathophysiology of the classic BPPV as a
disorder of otoliths was suspected first by Barany and later
supported by Schuknecht [37,38]. Following the trauma, the
otoliths are detached from the utricle and displaced within
the labyrinth. Generally, patients affected by idiopathic
BPPV are older than those due to trauma.
The patients experience severe vertigo when rolling in
one particular direction in bed and, less frequently, may also
report dizziness with head motion. For dizziness occurring at
times other than in bed, cervicogenic vertigo must be
considered after a whiplash trauma. Head injury may equally
affect both labyrinths; thus, bilateral BPPV is expected to
occur more frequently in the posttraumatic cases [35,39],
although we have not noted a high incidence of bilateral
cases in our series.
There is consensus on the incidence of posttraumatic
BPPV that accounts for 15% to 20% of all cases [40,41].
The diagnosis is confirmed by positional tests (Dix-
Hallpike [38], McClure-Pagnini [42]). Establishing a
diagnosis of BPPV is beneficial because it is treated by
relatively simple physical maneuvers without the need for
additional investigations or drug therapy. About 80% of
patients with posterior canal idiopathic BPPV become free of
symptoms and signs following a single maneuver [43-46].
The percentage of successful repositioning after the first
CRM decreases in posttraumatic cases. Our hypothesis is
that it may be due to the increased number of otoliths
displaced as consequence of trauma.
Although the improvement of patients affected by
BPPV is remarkable after treatment, if compared with
cervicogenic vertigo patients as shown in our results, any
difference emerged comparing DHI after treatment of
idiopathic BPPV vs posttraumatic cases. This may be
explicable considering that the pathophysiology of BPPV,
even if posttraumatic, is related to the same mechanism of
otolith movements into labyrinth.
It is widely believed that a whiplash injury may induce a
disorder of neck proprioceptors caused by forces applied to
the neck in the course of the accident. We concur with
Fischer et al [47] in distinguishing either spontaneous or
positional nystagmus arising in certain static head positions
from the previously reported “cervical nystagmus” because
static labyrinthine stimulation may exist. Several authors
have failed to demonstrate a relationship between nystagmus
and neck proprioceptors' stimulation [30,31,48].
5. Conclusions
A syndrome in which the dizziness is the main
complaint often follows a whiplash trauma. With simple
bedside examination of peripheral vestibular system, it is
possible to find out the patients with true vertigo; and a
treatment could be done in the same session. The diagnosis
of posttraumatic BPPV is not different from the idiopathic
form, but the treatment may require more CRMs to
achieve satisfactory results. In addition, the complete
neurotologic examination of vestibular system allows us
to recognize maligners who complain of vertigo or
dizziness with the aim of insurance claim.
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Abstract
Objective: The aims of present research were to analyze the visually guided eye movements of subjects suffering from the consequences of
whiplash injury and the possibility to differentiate patients from feigning subject. We analyzed the role of video-nystagmography for clinical
and forensic aspects.
Methods: It was a prospective case–control study. Detailed history was taken and patients were thoroughly investigated. Smooth pursuit and
saccadic eye movements were assessed in 33 patients affected by imbalance following a whiplash injury. A control group of 20 subjects was
also evaluated. All tests were executed in neutral neck position and after left and right trunk rotation.
Results: The t-test, applied to all parameters showed that difference of the parameter between the groups was not statistically significant.
Conclusion: The visually guided eye movement evaluation does not seem to offer a clinically relevant method to differentiate patients
suffering from the effects of whiplash injury from normal subjects.
# 2010 Elsevier Ireland Ltd. All rights reserved.
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1. Introduction
The evaluation of the vestibular system disease is always
a challenge for the clinician. Symptoms of imbalance or true
vertigo, complained by patients, may be present in numerous
diseases and can be due to lesion at different levels in
vestibular system. The quantification of vestibular damage is
also difficult in case forensic tests are done. For these
reasons it is mandatory to employ instrumental tests to verify
without bias the symptoms reported after an injury and to
detect patients who are feigning [1].
The equilibrium is the result of a perfect integration of
input from the ocular, proprioceptive and vestibular systems.
The whiplash injury is a traumatic lesion due to rapid
flexion–extension movement of the cervical column. Such
trauma to the neck causes an alteration of signals reaching
from the cervical proprioceptive system to the central
vestibular system and thus affects equilibrium. Balance
problems are reported by 5–50% of patients of whiplash
injury [1,2]. The whiplash injury is generally due to car
collision and is the first cause of insurance claims. About
15–20% of cases develop the so-called late whiplash
syndrome with persistent complaints including headache,
vertigo, instability, nausea and tinnitus [2].
The cervical trauma may increase the discharge of
muscles’ proprioceptive receptors of the neck [3]. As
described in literature the abnormal input coming from
neck receptors interfere with normal activity of vestibular
system and may result in alteration of vestibular–ocular
reflexes [4,5].
www.elsevier.com/locate/anl
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A whiplash injury can induce an elongation of the
cervical column that may reach 5 cm and, as consequence, a
stretching of the medulla, brainstem and also cerebellum as
reported in literature. Some clinicians noted also alteration
of saccadic and smooth pursuit movements [6–9].
The neural pathways of both system saccadic and
smooth pursuit extend from cerebral cortex to oculomotor
nuclei trough the cerebellum. The alterations of ocular
movements may represent a sensitive markers of central
nervous system damage. For such reason the attentions of
clinicians were focused on eye movements to find some
justification of dizziness after a whiplash injury. Further-
more Hinoki et al. founded an increased activity of
cervical proprioceptors and a concomitant dysfunction of
central nervous system after a traumatic distortion of
cervical tract [10].
Our work’s aim was to evaluate the visually guided eye
movements in patients of whiplash injury, by the analysis of
the saccadic eye movements and smooth pursuit movements
matching the data of whiplash patients with a control group,
to make an attempt to clarify such argument.
2. Materials and methods
A case–control clinical evaluation was done on two
groups in the year 2008. The first group included patients of
whiplash injury that were referred to our department. The
exclusion criteria for the first group were: history of vertigo
before thewhiplash injury, ear disease or hearing loss, and of
central nervous system pathology. The control group
consisted of normal subjects without vestibular symptoms
or general disease, negative history for head and neck
disease or trauma. The first group was subdivided in 3
subgroups, depending upon the interval of time between
trauma and evaluation: Group A (1–2 months), Group B (2
to 6 months) and Group C (7–12 months). This further
subdivision was done to find a relation between symptoms
persistence and time of injury.
The evaluation included: complete head and neck
examination, clinical vestibular tests, pure tone audio-
metry and video-oculography/video-nystagmography with
infrared system. All the tests were performed in an
isolated room with dim light. During the tests the patients
were seated at 42 cm from the display. The smooth-pursuit
movement was evaluated by following an oscillating
illuminated target on a 29-in. screen; the target velocity
was regular (188/s) and the oscillating movements were
from center to right, back to the center and then center to
left. Each trial was of 20 cycles of 57 s. The saccadic test
was performed by asking the patient to watch the target on
a horizontal plane; the frequency was 0.4 Hz and the
amplitude was !208. The tests were done in normal
position (central) and repeated after left and right 30-8
trunk rotation with hand-fixed head by operator for at least
60 s. The same operator performed all tests. The presence
of spontaneous nystagmus in the various positions was
recorded. The parameters analyzed in saccadic movement
evaluation were: latency, velocity and accuracy. Our cut-
off parameters to consider the results as pathological
were: value more than 200 ms for latency, a score under
77% for accuracy and a highest velocity under 5308/s. The
smooth-pursuit movement analysis was evaluated measur-
ing the gain (eye velocity/target velocity) and the
parameter of normality was a value of 0.88 ! 0.2.
The values of the data evaluated were averaged to
compare all the groups and subgroups. A parametric test (t-
test) was done to demonstrate any significant difference
between analyzed parameters.
All patients and normal subjects enrolled in the study
were informed and they signed the informed consent. Our
Institutional Review Board approved the study.
3. Results
The first group included 37 patients, of which 23 were
males. The mean age was 36.5 years (range 21–53 years).
All patients had a history of whiplash injury (without loss of
consciousness) of 12 months duration. All patients in the
first group complained of persistent imbalance after the
trauma. Four patients were excluded from the evaluation: 3
patients with post-traumatic benign paroxysmal positional
vertigo (BPPV) and 1 patient with asymptomatic bilateral
hearing loss in 4–8 kHz (PTA 45 dB). The audiological
examination did not show any hearing loss in the remaining
patients. The first group was subdivided 3 subgroups based
on interval of trauma to evaluation as mentioned before. The
group A comprised of 11 patients with mean age of 34.1
years. The group B included 11 patients with mean age of
37.6 years and the group C consisted of 11 patients with
mean age of 37.6 years.
The control group had 23 asymptomatic subjects, of
which 12 were male. The mean age of the control group was
30.4 years (range 19–49 years). All subject of the control
group matched the inclusion/exclusion criteria. The audio-
logical examination was normal in all cases but 3 (2 males
and 1 female) were excluded from the study.
The results of the analysis are summarized in Tables 1
and 2, where the mean and the standard deviation of all
parameters tested of both groups are reported. No
statistically significant differences ( p > 0.05) were noted
between the groups and between positions of the head as
respect to the trunk. No spontaneous nystagmus related to
the neck rotation was recorded. The sex and the age were not
related with results of the tests.
4. Discussion
The effects of trauma on cervical column were first
described by Crowe in 1928 and by Gray and Abbott in 1953
[11,12]. Significant injuries can occur even at low speed
collision but simulated accidents have shown that a 5-miles
an hour rear-end car crash can result in a positive
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acceleration of 8.2 G of the head [13]. The increasing
numbers of car collisions have resulted in an increased
number of hospital admissions due to the whiplash injury.
Consequently, the insurance claims and the need for forensic
evaluation of the damages have increased which spurred us
to conduct the present study.
The whiplash injury produces a distortion of the
cervical column causing lesions of several cervical sites:
muscles, ligaments, vertebral joints, vessels and nerves.
The more serious injury could be the stretching of the
cervical spine during the flexion–extension of the head.
Such sudden and violent movement may result in an
elongation of the medulla oblongata or a distention of the
cerebellum. Pathophisiologically it is possible to note a
central nervous system weakness following a whiplash
injury. With respect to inner ear, the exact nature of the
lesion is not known but some possible explanation may
be: transient ischemia by vertebral artery compression,
hemorrhage into labyrinth, direct labyrinthine concussion
and noise of the collision.
The typical acute symptoms after whiplash includes:
neck pain, headache, paraesthesia of upper cervical
dermatomes, dizziness or imbalance and tinnitus. The
majority of patients show spontaneous recovery after few
months of symptomatic treatment. In some patients the
symptoms may persist.
The imbalance is the most incapacitating symptom after
whiplash injury [14,15]. The cervicogenic dizziness may
occur after trauma of the cervical column however cervical
vertigo remains a highly controversial entity [7,15,16].
A neurotological evaluation should be performed in an
attempt to find a possible cause and to find out if treatment is
possible. The examination includes the assessment of
peripheral labyrinth and vestibulo–ocular reflex system by
clinical vestibular tests and caloric test. The tests include the
evaluation of visually guided eye movements by video-
oculography/video-nystagmography.
Previous studies have scarcely demonstrated any
relationship between peripheral dysfunction and trauma.
Some studies present in literature have shown positional
nystagmus and unilateral hyporeflexia in patients of
whiplash injury [9,17–22]. Ettlin et al. reported peripheral
vestibular deficits in only two cases among 18 after whiplash
injury [23]. However all these reports have not used a
standard value as benchmark or any proper control group.
The most common type of true vertigo following
whiplash injury is BPPV [24]. Following the trauma the
otoliths are detached from utricle and displaced within the
labyrinth. The diagnosis is confirmed by positional tests.
Such patients that present with a true inner ear disease
should be separated from those subjects with imbalance due
to neck trauma, as we have done in our series to find a true
cervical nystagmus, in other words the true presence of
nystagmus or eye movement disturbance related to the neck
proprioception abnormality (cervical nystagmus).
It is widely considered that a whiplash injury may induce
a disorder of neck proprioception caused by forces applied to
the neck in the course of the read-end accident. A clinical
sign of such disturbance is the so-called ‘‘cervical
nystagmus’’, a nystagmus arising from neck rotation with
no labyrinthine stimulation. We agree with Fischer et al. in
distinguishing either spontaneous or positional nystagmus
arising in certain static head positions from the previously
reported ‘‘cervical nystagmus’’, because static labyrinthine
stimulation may exist [25]. Several Authors failed to
demonstrate a relationship between nystagmus and neck
proprioceptors’ stimulation [18,19,26]. Also in our series
any spontaneous and/or ‘‘cervical nystagmus’’ was noted
neither in neutral position nor after 308 left/right rotation.
We preferred a 308 rotation to avoid any restriction of the
rotation due to the trauma because of testing the patients.
The infrared video-oculography/video-nystagmography
allowed us to detect even slight alterations of saccadic and
smooth-pursuit movements. This would have been to our
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Table 2
Mean and standard deviation (SD) of parameters tested in neutral position and after rotation in the patients group.
Neutral position 308 left rotation 308 right rotation
Smooth-pursuit average value of gain (SD) 0.87 (!0.04) 0.86 (!0.03) 0.87 (!0.04)
Saccadic average value of velocity in degree/sec (SD) 571 (!34.1) 572.05 (!24.35) 565.9 (!27.47)
Saccadic average value of latency in degree/sec (SD) 155.3 (!13) 161.73 (!13.07) 155.4 (!14.35)
Saccadic average value of accuracy in % (SD) 0.83 (!0.06) 0.83 (!0.06) 0.84 (!0.06)
Table 1
Mean and standard deviation (SD) of parameters tested in neutral position.
Control Group Group A Group B Group C
Smooth-pursuit gain (SD) 0.87 (!0.04) 0.85 (!0.03) 0.87 (!0.04) 0.87 (!0.03)
Saccadic velocity in degree/sec (SD) 573.05 (!25.25) 574 (!31.05) 564.9 (!28.67) 574.7 (!33.39)
Saccadic latency in degree/sec (SD) 161.63 (!15.67) 154.6 (!10.36) 155.2 (!14.25) 156.1 (!11.68)
Saccadic accuracy in % (SD) 0.84 (!0.05) 0.81 (!0.06) 0.84 (!0.07) 0.82 (!0.06)
advantage in revealing a feigning subjects if the damage of
neck proprioceptors had produced a recognizable nystag-
mus or some abnormality of cervico–ocular reflex.
As mentioned before, the neural pathways of ocular
movement systems extend from cerebral cortex to
oculomotor nuclei trough the cerebellum and the interrup-
tion of such ways induces an alteration of ocular move-
ments. Excluding those patients with a known lesion of
central nervous system (i.e.: spine, brainstem) after the
trauma of the head and focusing the attention only to
subjects that had a cervical column disturbance, the
prevalence of ocular movements alteration may be very
low or totally absent as our series showed, probably because
an interruption of the central ways is improbably for a
common whiplash trauma.
The functional performance of voluntary oculomotor
systems depends upon attentional processing and in patients
that had a whiplash injury was demonstrated a reduction of
the attention and of information processing velocity [27].
We believe that most of the alterations (increased latency or
decreased gain) of saccadic and smooth-pursuit move-
ments, reported elsewhere in whiplash patients, may be due
only to a diminishing of attention processing. AsMosimann
et al. demonstrated, only intentional saccades are impaired
in whiplash patients, while reflexive eye movements are
normal [28]. In fact also the searching of nystagmus after
cervical torsion in both sides was not significant. Our results
showed a normality of all parameters tested in patients of
whiplash injury; consequently we can exclude in whiplash
patients a correlation between cervical column distortion
and alteration of systems that control the saccadic and
smooth-pursuit movements. The data recorded in this study
is not in accordance with those reported by some authors
that noted alterations of optokinetic reflexes and saccadic in
theirs cases [7,10,29–31]. Our findings agree with those
reported by Fischer et al. [18,19] and Kongsted et al.
[32,33].
The absence of differences between normal subjects and
patients of whiplash injury underscores the futility of the
ocular movements analysis in patients complaining cervical
column trauma without central nervous system damages in
case of litigation following car collision.
5. Conclusions
Caution is required in interpreting the abnormalities of
eye movements in cases of whiplash injury as robust data is
not available to support the presence of abnormalities in eye
movements. Attention to methods of evaluation should be
kept in mind to avoid mixing up a nystagmus arising from
labyrinth stimulation with ‘‘cervical nystagmus’’. Further-
more, the reproducibility of the alteration found should be
verified to exclude any deliberate alteration by feigning
subjects or by decreasing of concentration. The study of
ocular movements does not offer a valid tool to differentiate
a true patient from a feigning subject after whiplash injury.
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